Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four tria...
Uložené v:
| Vydané v: | The Lancet (British edition) Ročník 397; číslo 10269; s. 99 - 111 |
|---|---|
| Hlavní autori: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
Elsevier Ltd
09.01.2021
Elsevier Limited Elsevier |
| Predmet: | |
| ISSN: | 0140-6736, 1474-547X, 1474-547X |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials.
This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674.
Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation.
ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials.
UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D’Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca. |
|---|---|
| AbstractList | A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials.
This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674.
Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation.
ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials.
UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D’Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca. A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 10 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; p =0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca. Summary Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. Findings Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. Interpretation ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. Funding UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D’Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca. A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials.BACKGROUNDA safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials.This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674.METHODSThis analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674.Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation.FINDINGSBetween April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation.ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials.INTERPRETATIONChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials.UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca.FUNDINGUK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca. |
| Author | Larkworthy, Colin W. Tighe, Patrick J. O’Reilly, Peter J Datta, Chandrabali Webb-Bridges, Alice Lillie, Patrick J Maoko, Takalani Dunachie, Susanna J. Finn, Adam Bates, Louise Júnior, Eduardo A.M.S. Piper, Jo Farooq, Mutjaba Ricamara, Marivic McLenaghan, Daniela O'Brien, Katie Ritchie, Adam J. El Muhanna, Omar M. McInroy, Lorna Rocchetti, Talita T. Pieterse, Sonja Gilbert, Sarah C Salvador, Natalia Casey, Helen R. Naik, Gurudutt Douglas, Naomi Morey, Ella Pipini, Dimitra Galiza, Eva Hanumunthadu, Brama Iyer, Vidyashankara Mathew, Moncy Silk, Sarah E. Farmer, Eoghan Frater, John Harris, Clair Kerr, David Kinch, Patrick Tinoco, Lygia Accioly Dheda, Keertan Corrah, Tumena Turner, Cheryl Bisnauthsing, Karen Sayed, Aakifah Fisher, Richard Ritchie, Neil Ulaszewska, Marta Price, David A. Pickup, Lorinda Solórzano, Carla Morshead, Gertraud Wand, Matthew Aley, Parvinder K Thomas, Tonia M. Sanders, Helen Elias, Sean C. Patrick-Smith, Maia Stein, Ricardo Moghaddas, Fiona Smith, Andrew Martins, Flávia J. Powers, Claire Barker, Debbie Andritsou, Foteini Arns, B |
| Author_xml | – sequence: 1 givenname: Merryn surname: Voysey fullname: Voysey, Merryn organization: Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK – sequence: 4 givenname: Lily Y surname: Weckx fullname: Weckx, Lily Y organization: Department of Pediatrics, Universidade Federal de São Paulo, São Paulo, Brazil – sequence: 14 givenname: Andrea M surname: Collins fullname: Collins, Andrea M organization: Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK – sequence: 32 givenname: Helen surname: Hill fullname: Hill, Helen organization: Department of Clinical Sciences, Liverpool School of Tropical Medicine and Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK – sequence: 42 givenname: Rajeka surname: Lazarus fullname: Lazarus, Rajeka organization: Severn Pathology, North Bristol NHS Trust, Bristol, UK – sequence: 43 givenname: Alison M surname: Lawrie fullname: Lawrie, Alison M organization: Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK – sequence: 51 givenname: Alastair surname: McGregor fullname: McGregor, Alastair organization: London Northwest University Healthcare, Harrow, UK – sequence: 75 givenname: Tonya L surname: Villafana fullname: Villafana, Tonya L organization: AstraZeneca BioPharmaceuticals, Cambridge, UK – sequence: 81 givenname: Sarah C surname: Gilbert fullname: Gilbert, Sarah C organization: Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK – sequence: 83 givenname: Marites surname: Aban fullname: Aban, Marites – sequence: 86 givenname: Jeremy surname: Aboagye fullname: Aboagye, Jeremy – sequence: 87 givenname: Matthew surname: Adam fullname: Adam, Matthew – sequence: 88 givenname: Kirsty surname: Adams fullname: Adams, Kirsty – sequence: 101 givenname: Mariana P.S. surname: Alves fullname: Alves, Mariana P.S. – sequence: 125 givenname: Eleanor surname: Barnes fullname: Barnes, Eleanor – sequence: 141 givenname: Eleanor surname: Berrie fullname: Berrie, Eleanor – sequence: 145 givenname: Kevin R. surname: Bewley fullname: Bewley, Kevin R. – sequence: 159 givenname: Heather surname: Bletchly fullname: Bletchly, Heather – sequence: 167 givenname: Nicola surname: Borthwick fullname: Borthwick, Nicola – sequence: 172 givenname: Phillip surname: Brown fullname: Brown, Phillip – sequence: 184 givenname: Karen R. surname: Buttigieg fullname: Buttigieg, Karen R. – sequence: 199 givenname: Paul surname: Cashen fullname: Cashen, Paul – sequence: 201 givenname: Lucia Carratala surname: Castro fullname: Castro, Lucia Carratala – sequence: 205 givenname: Jim surname: Chadwick fullname: Chadwick, Jim – sequence: 206 givenname: David surname: Chapman fullname: Chapman, David – sequence: 207 givenname: Sue surname: Charlton fullname: Charlton, Sue – sequence: 214 givenname: Matthew surname: Clark fullname: Clark, Matthew – sequence: 216 givenname: Elizabeth A. surname: Clutterbuck fullname: Clutterbuck, Elizabeth A. – sequence: 221 givenname: Cushla surname: Cooper fullname: Cooper, Cushla – sequence: 222 givenname: Rachel surname: Cooper fullname: Cooper, Rachel – sequence: 239 givenname: Paula surname: Darroch fullname: Darroch, Paula – sequence: 250 givenname: David surname: Dearlove fullname: Dearlove, David – sequence: 267 givenname: Rachael surname: Drake-Brockman fullname: Drake-Brockman, Rachael – sequence: 274 givenname: Samual surname: van Eck fullname: van Eck, Samual – sequence: 285 givenname: Madi surname: Farrar fullname: Farrar, Madi – sequence: 300 givenname: Pedro H.A. surname: Fraiman fullname: Fraiman, Pedro H.A. – sequence: 328 givenname: Lara surname: Gracie fullname: Gracie, Lara – sequence: 333 givenname: Leonardo surname: Grossi fullname: Grossi, Leonardo – sequence: 341 givenname: Aidan T. surname: Hanrath fullname: Hanrath, Aidan T. – sequence: 345 givenname: Tara surname: Harris fullname: Harris, Tara – sequence: 350 givenname: Shadin surname: Hassan fullname: Hassan, Shadin – sequence: 353 givenname: Jodie surname: Hay fullname: Hay, Jodie – sequence: 354 givenname: Ian surname: Head fullname: Head, Ian – sequence: 359 givenname: Gina surname: Hodges fullname: Hodges, Gina – sequence: 360 givenname: Elizea surname: Horne fullname: Horne, Elizea – sequence: 361 givenname: Mimi M. surname: Hou fullname: Hou, Mimi M. – sequence: 366 givenname: Holly E. surname: Humphries fullname: Humphries, Holly E. – sequence: 369 givenname: Angela surname: Hyder-Wright fullname: Hyder-Wright, Angela – sequence: 379 givenname: Helen surname: Jeffers fullname: Jeffers, Helen – sequence: 392 givenname: Konstantinos surname: Karampatsas fullname: Karampatsas, Konstantinos – sequence: 394 givenname: Jade surname: Keen fullname: Keen, Jade – sequence: 401 givenname: Liaquat surname: Khan fullname: Khan, Liaquat – sequence: 408 givenname: Thomas B. surname: King fullname: King, Thomas B. – sequence: 410 givenname: Paul surname: Klenerman fullname: Klenerman, Paul – sequence: 422 givenname: Emily A. surname: Lees fullname: Lees, Emily A. – sequence: 426 givenname: Yuanyuan surname: Li fullname: Li, Yuanyuan – sequence: 435 givenname: Lisa surname: Loew fullname: Loew, Lisa – sequence: 455 givenname: Gabriela N. surname: Marques fullname: Marques, Gabriela N. – sequence: 461 givenname: Mduduzi surname: Masilela fullname: Masilela, Mduduzi – sequence: 463 givenname: Moncy surname: Mathew fullname: Mathew, Moncy – sequence: 478 givenname: Wilma surname: Meijs fullname: Meijs, Wilma – sequence: 492 givenname: Susan surname: Morris fullname: Morris, Susan – sequence: 501 givenname: Mushiya surname: Mpelembue fullname: Mpelembue, Mushiya – sequence: 518 givenname: Helena surname: Noal fullname: Noal, Helena – sequence: 521 givenname: Fay L. surname: Nugent fullname: Nugent, Fay L. – sequence: 524 givenname: Daniel surname: O'Connor fullname: O'Connor, Daniel – sequence: 528 givenname: Victoria surname: Olchawski fullname: Olchawski, Victoria – sequence: 533 givenname: Paula surname: O'Reilly fullname: O'Reilly, Paula – sequence: 561 givenname: Daniel J. surname: Phillips fullname: Phillips, Daniel J. – sequence: 564 givenname: Lorinda surname: Pickup fullname: Pickup, Lorinda – sequence: 569 givenname: Joan surname: Du Plessis fullname: Du Plessis, Joan – sequence: 570 givenname: Samuel surname: Pollard fullname: Pollard, Samuel – sequence: 573 givenname: Ian surname: Poulton fullname: Poulton, Ian – sequence: 582 givenname: David surname: Pulido fullname: Pulido, David – sequence: 597 givenname: Jesús surname: Reiné fullname: Reiné, Jesús – sequence: 598 givenname: Mila surname: Resuello-Dauti fullname: Resuello-Dauti, Mila – sequence: 602 givenname: Alex surname: Richter fullname: Richter, Alex – sequence: 611 givenname: Sophie surname: Roche fullname: Roche, Sophie – sequence: 612 givenname: Christine surname: Rollier fullname: Rollier, Christine – sequence: 618 givenname: Sarah surname: Ruiz fullname: Ruiz, Sarah – sequence: 620 givenname: Claudia surname: Sala fullname: Sala, Claudia – sequence: 627 givenname: Amada surname: Sanchez-Gonzalez fullname: Sanchez-Gonzalez, Amada – sequence: 646 givenname: Hannah E. surname: Sharpe fullname: Sharpe, Hannah E. – sequence: 662 givenname: Daniel C. surname: Smith fullname: Smith, Daniel C. – sequence: 664 givenname: Holly E. surname: Smith fullname: Smith, Holly E. – sequence: 668 givenname: Tiago surname: Soares fullname: Soares, Tiago – sequence: 673 givenname: Cinthia M.C.D.L. surname: Souza fullname: Souza, Cinthia M.C.D.L. – sequence: 677 givenname: Fernanda surname: Spina fullname: Spina, Fernanda – sequence: 683 givenname: Jill surname: Steven fullname: Steven, Jill – sequence: 684 givenname: Lisa surname: Stockdale fullname: Stockdale, Lisa – sequence: 685 givenname: Lisa V. surname: Stockwell fullname: Stockwell, Lisa V. – sequence: 688 givenname: Ann surname: Sturdy fullname: Sturdy, Ann – sequence: 694 givenname: Alexander W. surname: Tarr fullname: Tarr, Alexander W. – sequence: 696 givenname: Ursula surname: Taylor fullname: Taylor, Ursula – sequence: 701 givenname: Andreas surname: Themistocleous fullname: Themistocleous, Andreas – sequence: 726 givenname: Betty Lebogang surname: Tsheko fullname: Tsheko, Betty Lebogang – sequence: 727 givenname: Aadil surname: Turabi fullname: Turabi, Aadil – sequence: 737 givenname: Claire S. surname: Waddington fullname: Waddington, Claire S. – sequence: 739 givenname: Erica surname: Wallis fullname: Wallis, Erica – sequence: 747 givenname: Stewart surname: Webb fullname: Webb, Stewart |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33306989$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkt1uEzEQhS1URNPCI4AscZNKXbC9Xm8WBFUafkWlSoQixI3l9Y4bl41d7E1EeCfeEW9SIshNufJI853jY88coD3nHSD0kJInlFDxdEooJ5koczFk5ChnQtCM3kEDykueFbz8socGW2QfHcR4RQjhghT30H6e50RUo2qAfk2VgW6FlWswGGO10ivsDe5mgCezcXP-g2I38Z8zWuGl0to6wMPx11eUMXaE1aWyLnZ4Ov44zXqKPUtO2LoOgp2nUrWraGNvaPwi4JCu8XMbocHauy74tk1lF6xqY1Lh06B-2vYYT_2im-GxCSnP8Tpbn-fiw3101yQUHtych-jizetPk3fZ2fnb95PxWaa54DSrGBRlUzS1YrxQqhElMGgqqpvSiFqoogamawVQjCpOmDGk1qkzMqOcFoTr_BC93PheL-o5NBpSVtXK6_QoFVbSKyv_7Tg7k5d-KcuS5ZwXyWB4YxD89wXETqZXa2hb5cAvomS8JCQvCK0S-ngHvUpflX5uTQlKq4r01KO_E22j_JlkAooNoIOPMYDZIpTIfmPkemNkvw6SEbneGEmT7vmOTttOdbYfj7LtreqTjRrSNJYWgozagtPQ2AC6k423tzq82HHQrXVp7u03WP2H_jf0iOxw |
| CitedBy_id | crossref_primary_10_1177_0976500X221138393 crossref_primary_10_1186_s12889_021_12082_z crossref_primary_10_3390_life12091338 crossref_primary_10_1016_j_ejca_2021_01_033 crossref_primary_10_1016_j_vaccine_2022_10_033 crossref_primary_10_1097_EDE_0000000000001415 crossref_primary_10_3390_ijerph191811523 crossref_primary_10_1080_14737140_2021_1991317 crossref_primary_10_1186_s12883_021_02427_x crossref_primary_10_1080_21645515_2023_2276624 crossref_primary_10_1016_S1473_3099_21_00147_X crossref_primary_10_2147_IDR_S356460 crossref_primary_10_1016_j_ajt_2024_07_031 crossref_primary_10_1038_s41582_022_00646_5 crossref_primary_10_1126_science_abg8663 crossref_primary_10_1016_j_ijregi_2022_06_001 crossref_primary_10_1016_j_resinv_2021_11_007 crossref_primary_10_1590_0074_02760240094 crossref_primary_10_3389_fimmu_2021_776933 crossref_primary_10_3390_vaccines9050498 crossref_primary_10_1080_21645515_2022_2039017 crossref_primary_10_1111_ncn3_12537 crossref_primary_10_1111_bjh_17836 crossref_primary_10_1080_22221751_2025_2471035 crossref_primary_10_1093_infdis_jiac406 crossref_primary_10_1007_s11010_022_04356_w crossref_primary_10_1002_jia2_25749 crossref_primary_10_1016_j_prp_2021_153565 crossref_primary_10_1016_j_jmp_2025_102942 crossref_primary_10_1007_s11910_022_01178_7 crossref_primary_10_1038_s41746_021_00533_1 crossref_primary_10_1371_journal_pone_0270327 crossref_primary_10_1155_2021_5557302 crossref_primary_10_1126_science_abl8912 crossref_primary_10_1016_j_pxur_2021_01_001 crossref_primary_10_1016_j_jns_2022_120327 crossref_primary_10_3390_vaccines13080833 crossref_primary_10_3390_v13040551 crossref_primary_10_3390_biom13010159 crossref_primary_10_3390_life12091358 crossref_primary_10_3390_vaccines11020208 crossref_primary_10_1097_MD_0000000000031389 crossref_primary_10_1055_s_0043_1761454 crossref_primary_10_1038_s41564_021_00947_3 crossref_primary_10_1007_s00249_023_01695_4 crossref_primary_10_1016_j_ebiom_2022_103904 crossref_primary_10_1097_SLA_0000000000005176 crossref_primary_10_1177_00368504211016936 crossref_primary_10_3389_fimmu_2023_1192395 crossref_primary_10_1016_j_puhe_2021_05_030 crossref_primary_10_1038_s41598_022_21207_2 crossref_primary_10_1080_22221751_2021_1898291 crossref_primary_10_1016_j_cmi_2025_02_030 crossref_primary_10_1007_s13760_022_02137_2 crossref_primary_10_1016_j_omtm_2024_101308 crossref_primary_10_1016_j_vaccine_2021_08_083 crossref_primary_10_1038_s41541_024_00895_z crossref_primary_10_1055_s_0041_1733934 crossref_primary_10_1080_21645515_2022_2095166 crossref_primary_10_1111_dth_15461 crossref_primary_10_1016_S1473_3099_21_00289_9 crossref_primary_10_3390_vaccines11091411 crossref_primary_10_1080_21645515_2021_1981086 crossref_primary_10_1111_phn_12907 crossref_primary_10_1016_j_bulcan_2021_02_004 crossref_primary_10_1016_j_msard_2021_103433 crossref_primary_10_1080_21645515_2024_2357424 crossref_primary_10_3390_vaccines10071153 crossref_primary_10_1126_sciadv_adq2887 crossref_primary_10_3390_v16101533 crossref_primary_10_1093_pnasnexus_pgac105 crossref_primary_10_1111_all_15406 crossref_primary_10_1182_blood_2021014684 crossref_primary_10_1016_j_ccell_2021_06_009 crossref_primary_10_3390_vaccines11091408 crossref_primary_10_1016_j_cmi_2021_09_036 crossref_primary_10_1016_j_jiph_2021_04_005 crossref_primary_10_1016_S1473_3099_21_00330_3 crossref_primary_10_1038_s41467_021_26449_8 crossref_primary_10_5021_ad_21_138 crossref_primary_10_1016_j_clinthera_2021_01_014 crossref_primary_10_3390_ijms232012231 crossref_primary_10_3390_vaccines9090989 crossref_primary_10_1136_postgradmedj_2020_139555 crossref_primary_10_1016_j_cmi_2022_04_012 crossref_primary_10_1016_j_ebiom_2022_103962 crossref_primary_10_1038_s41392_024_01917_x crossref_primary_10_1371_journal_pone_0266271 crossref_primary_10_3390_pathogens10040429 crossref_primary_10_1016_j_jstrokecerebrovasdis_2022_106440 crossref_primary_10_4103_ijmr_IJMR_474_21 crossref_primary_10_1016_j_vhri_2022_04_004 crossref_primary_10_1016_j_autrev_2021_102951 crossref_primary_10_1016_j_jbc_2021_101208 crossref_primary_10_1016_j_therap_2022_07_003 crossref_primary_10_1038_s41541_022_00452_6 crossref_primary_10_1055_a_1375_4471 crossref_primary_10_1016_S0140_6736_21_00765_0 crossref_primary_10_1038_s41467_024_49832_7 crossref_primary_10_1186_s43163_021_00167_w crossref_primary_10_2196_35121 crossref_primary_10_1016_S2352_3026_21_00201_5 crossref_primary_10_1080_14760584_2023_2191716 crossref_primary_10_1007_s11596_021_2461_8 crossref_primary_10_1371_journal_pone_0259513 crossref_primary_10_1007_s00520_022_06886_x crossref_primary_10_1016_j_msard_2022_103708 crossref_primary_10_1016_j_vaccine_2022_03_036 crossref_primary_10_1038_s41541_021_00331_6 crossref_primary_10_1038_s41392_021_00527_1 crossref_primary_10_1007_s11071_025_10917_7 crossref_primary_10_1016_j_jinf_2021_04_027 crossref_primary_10_1007_s11904_023_00647_z crossref_primary_10_1016_j_medcli_2021_05_008 crossref_primary_10_1371_journal_pone_0304616 crossref_primary_10_1016_j_vaccine_2025_127040 crossref_primary_10_1007_s40265_024_02013_8 crossref_primary_10_1055_a_1401_4901 crossref_primary_10_1097_EDE_0000000000001473 crossref_primary_10_1155_2023_1879554 crossref_primary_10_1177_26339447221111604 crossref_primary_10_1016_j_ijpharm_2021_120686 crossref_primary_10_7759_cureus_51583 crossref_primary_10_1182_blood_2021012479 crossref_primary_10_7774_cevr_2024_13_4_315 crossref_primary_10_2147_IDR_S390351 crossref_primary_10_1038_s41392_023_01408_5 crossref_primary_10_1007_s43440_022_00361_4 crossref_primary_10_1016_j_econlet_2021_109747 crossref_primary_10_1016_j_gastrohep_2021_06_005 crossref_primary_10_1016_j_cmet_2021_01_016 crossref_primary_10_1016_S0140_6736_21_00730_3 crossref_primary_10_3389_fcimb_2021_690621 crossref_primary_10_1002_iid3_592 crossref_primary_10_3389_fpubh_2021_773998 crossref_primary_10_4049_jimmunol_2100762 crossref_primary_10_1016_j_jinf_2022_01_038 crossref_primary_10_1093_cid_ciaf339 crossref_primary_10_1111_fcp_12715 crossref_primary_10_3390_vaccines11091455 crossref_primary_10_52586_4931 crossref_primary_10_1186_s41937_021_00082_0 crossref_primary_10_1093_ibd_izab299 crossref_primary_10_3389_fimmu_2022_814365 crossref_primary_10_1016_j_healun_2022_01_005 crossref_primary_10_3390_vaccines11091456 crossref_primary_10_1093_infdis_jiab579 crossref_primary_10_1097_EDE_0000000000001484 crossref_primary_10_1016_j_lanwpc_2022_100660 crossref_primary_10_1177_11795441221081061 crossref_primary_10_1038_s41598_021_96779_6 crossref_primary_10_3389_fimmu_2022_872683 crossref_primary_10_7759_cureus_18551 crossref_primary_10_1016_j_imlet_2023_08_002 crossref_primary_10_7759_cureus_40460 crossref_primary_10_2139_ssrn_3793540 crossref_primary_10_3389_fimmu_2022_892277 crossref_primary_10_3390_pathogens11020275 crossref_primary_10_1186_s12979_021_00246_9 crossref_primary_10_1016_j_vaccine_2024_06_041 crossref_primary_10_1056_NEJMoa2103055 crossref_primary_10_1164_rccm_202201_0011OC crossref_primary_10_1016_j_intimp_2021_108021 crossref_primary_10_1016_S0140_6736_22_00089_7 crossref_primary_10_1111_jdv_18269 crossref_primary_10_1007_s10072_021_05620_5 crossref_primary_10_2139_ssrn_3812375 crossref_primary_10_1017_ash_2021_261 crossref_primary_10_1371_journal_ppat_1009634 crossref_primary_10_3390_cancers15194777 crossref_primary_10_1016_j_curtheres_2021_100639 crossref_primary_10_1007_s15010_023_02001_2 crossref_primary_10_3390_vaccines10111785 crossref_primary_10_1002_cti2_1405 crossref_primary_10_1007_s11926_021_01046_2 crossref_primary_10_1371_journal_pone_0287179 crossref_primary_10_1016_j_biopha_2025_117936 crossref_primary_10_1097_MOH_0000000000000645 crossref_primary_10_1038_s41467_022_33036_y crossref_primary_10_1186_s12985_023_02167_z crossref_primary_10_3389_fimmu_2021_708848 crossref_primary_10_1016_j_jinf_2022_01_002 crossref_primary_10_1093_cid_ciac292 crossref_primary_10_1002_pbc_29295 crossref_primary_10_1002_mco2_95 crossref_primary_10_3390_vaccines10111783 crossref_primary_10_1200_GO_23_00458 crossref_primary_10_1056_NEJMoa2119451 crossref_primary_10_1093_cid_ciaf318 crossref_primary_10_1016_j_immuni_2021_08_016 crossref_primary_10_1016_j_virol_2022_09_003 crossref_primary_10_1016_j_jtha_2025_06_006 crossref_primary_10_3390_genes12111842 crossref_primary_10_1016_j_nrleng_2024_10_001 crossref_primary_10_1080_00015458_2021_2017600 crossref_primary_10_2196_31125 crossref_primary_10_1186_s12879_022_07180_1 crossref_primary_10_1001_jama_2021_3645 crossref_primary_10_1016_j_cger_2022_03_006 crossref_primary_10_1093_infdis_jiab159 crossref_primary_10_1016_j_ijbiomac_2024_134012 crossref_primary_10_1136_bmj_2021_068632 crossref_primary_10_1136_bmj_n414 crossref_primary_10_1038_s41598_023_47486_x crossref_primary_10_1056_NEJMoa2105290 crossref_primary_10_7705_biomedica_6254 crossref_primary_10_1016_j_ijheh_2021_113851 crossref_primary_10_3390_jcm13247610 crossref_primary_10_1002_rmv_2417 crossref_primary_10_1038_s41467_023_39288_6 crossref_primary_10_1007_s00432_022_03961_y crossref_primary_10_1080_14760584_2022_2021074 crossref_primary_10_3389_fmed_2024_1364657 crossref_primary_10_4103_aam_aam_13_23 crossref_primary_10_1590_s2175_97902022e20975 crossref_primary_10_1016_j_radcr_2022_02_082 crossref_primary_10_3390_vaccines10050649 crossref_primary_10_1186_s12879_022_07443_x crossref_primary_10_1002_ddr_21982 crossref_primary_10_3390_vaccines10050642 crossref_primary_10_5694_mja2_52390 crossref_primary_10_1080_22221751_2023_2187245 crossref_primary_10_3390_biomedicines9101342 crossref_primary_10_1016_j_puhe_2024_05_002 crossref_primary_10_1016_j_jstrokecerebrovasdis_2022_106860 crossref_primary_10_1136_bcr_2021_246049 crossref_primary_10_1155_2024_2667033 crossref_primary_10_1002_rmv_2430 crossref_primary_10_1039_D0RA09668G crossref_primary_10_1038_s41577_021_00662_4 crossref_primary_10_1016_j_cell_2021_12_026 crossref_primary_10_1016_j_jaci_2022_01_013 crossref_primary_10_1038_s43856_022_00075_x crossref_primary_10_1093_ibd_izab250 crossref_primary_10_3390_biomedicines10020338 crossref_primary_10_3390_v14040802 crossref_primary_10_1016_j_vaccine_2023_09_015 crossref_primary_10_1016_S0140_6736_21_00146_X crossref_primary_10_1016_j_msard_2022_103739 crossref_primary_10_1007_s12026_023_09373_5 crossref_primary_10_1136_bmj_n435 crossref_primary_10_1007_s40121_022_00748_z crossref_primary_10_1182_bloodadvances_2021006333 crossref_primary_10_3390_cimb47070519 crossref_primary_10_1080_14760584_2023_2262571 crossref_primary_10_3389_fpubh_2021_793533 crossref_primary_10_1016_S1473_3099_21_00467_9 crossref_primary_10_1111_ddg_14799 crossref_primary_10_1007_s00277_021_04743_1 crossref_primary_10_1080_21645515_2024_2326316 crossref_primary_10_1016_j_ijid_2021_11_024 crossref_primary_10_1128_jvi_01737_23 crossref_primary_10_3390_v13091779 crossref_primary_10_1016_j_vaccine_2021_08_019 crossref_primary_10_1007_s13671_022_00376_3 crossref_primary_10_1177_25151355251321697 crossref_primary_10_1159_000521343 crossref_primary_10_3390_ijms22094526 crossref_primary_10_3390_epidemiologia2030026 crossref_primary_10_1093_jacamr_dlab038 crossref_primary_10_1093_clinchem_hvab045 crossref_primary_10_3389_fmed_2023_1078022 crossref_primary_10_1016_j_vaccine_2021_08_022 crossref_primary_10_3389_fimmu_2023_1231276 crossref_primary_10_1016_j_jsps_2022_06_009 crossref_primary_10_3389_fimmu_2021_824728 crossref_primary_10_1038_s41392_021_00621_4 crossref_primary_10_3390_jpm11040285 crossref_primary_10_56294_hl202288 crossref_primary_10_1038_s41598_024_84100_0 crossref_primary_10_3390_v14020389 crossref_primary_10_3390_vaccines11040722 crossref_primary_10_1016_j_actbio_2021_05_003 crossref_primary_10_3390_cancers13225829 crossref_primary_10_1007_s10405_021_00402_4 crossref_primary_10_1016_j_ajoc_2022_101281 crossref_primary_10_1007_s10875_022_01354_x crossref_primary_10_1016_j_nrleng_2022_09_007 crossref_primary_10_3389_fpubh_2021_695139 crossref_primary_10_3390_vaccines11040735 crossref_primary_10_1093_cid_ciab381 crossref_primary_10_1016_j_jiph_2023_07_017 crossref_primary_10_1080_00325481_2022_2161249 crossref_primary_10_1016_j_jbc_2021_101266 crossref_primary_10_3390_vaccines13050524 crossref_primary_10_1038_s41746_022_00561_5 crossref_primary_10_1038_s41467_021_23473_6 crossref_primary_10_1177_10760296211056648 crossref_primary_10_1016_j_biologicals_2021_08_001 crossref_primary_10_1016_j_vacune_2024_05_005 crossref_primary_10_3389_fpubh_2023_1078023 crossref_primary_10_3390_jcm11102803 crossref_primary_10_3390_jcm12051749 crossref_primary_10_4103_ijmr_ijmr_1221_21 crossref_primary_10_1111_dth_15422 crossref_primary_10_3138_jammi_2021_0323 crossref_primary_10_1097_MCC_0000000000000817 crossref_primary_10_1097_TP_0000000000003747 crossref_primary_10_1136_bmjopen_2023_079071 crossref_primary_10_4014_jmb_2205_05023 crossref_primary_10_1080_09273948_2021_1976221 crossref_primary_10_1001_jamanetworkopen_2022_17375 crossref_primary_10_1111_ajt_16966 crossref_primary_10_3389_fmed_2022_802312 crossref_primary_10_3390_vaccines10071111 crossref_primary_10_1016_S0140_6736_21_01429_X crossref_primary_10_3390_vaccines11040744 crossref_primary_10_3390_life11111220 crossref_primary_10_1016_j_ijnurstu_2024_104705 crossref_primary_10_1097_JOM_0000000000002205 crossref_primary_10_1038_s41598_021_01930_y crossref_primary_10_1080_20477724_2022_2029301 crossref_primary_10_1128_cmr_00025_24 crossref_primary_10_3390_vaccines11121779 crossref_primary_10_1016_j_amjcard_2021_06_047 crossref_primary_10_1007_s11739_021_02685_0 crossref_primary_10_2174_0109298673264218231121104407 crossref_primary_10_1136_bmjopen_2021_050062 crossref_primary_10_3390_nu15153451 crossref_primary_10_1186_s12941_022_00525_3 crossref_primary_10_1016_j_wneu_2022_11_132 crossref_primary_10_1126_scitranslmed_adn1441 crossref_primary_10_1016_j_artd_2022_09_005 crossref_primary_10_1111_nuf_12791 crossref_primary_10_3389_fimmu_2023_941281 crossref_primary_10_1186_s12959_021_00340_4 crossref_primary_10_3390_vaccines10060948 crossref_primary_10_1016_j_vaccine_2023_07_012 crossref_primary_10_1111_jocd_14843 crossref_primary_10_1177_10815589221149191 crossref_primary_10_1111_1751_7915_13997 crossref_primary_10_3389_fimmu_2022_910136 crossref_primary_10_1002_ana_26172 crossref_primary_10_1038_s41417_022_00436_7 crossref_primary_10_1080_21645515_2022_2035573 crossref_primary_10_1093_rap_rkad005 crossref_primary_10_3390_ijms231810904 crossref_primary_10_1038_s41598_023_43578_w crossref_primary_10_1007_s11042_024_18761_4 crossref_primary_10_1016_j_medj_2023_08_005 crossref_primary_10_1016_j_vaccine_2025_127553 crossref_primary_10_1016_j_vaccine_2025_127556 crossref_primary_10_1016_j_medcle_2021_03_006 crossref_primary_10_1080_07357907_2022_2121966 crossref_primary_10_1093_cid_ciab1005 crossref_primary_10_1016_j_chom_2021_03_002 crossref_primary_10_3390_v14040748 crossref_primary_10_3390_vaccines10060959 crossref_primary_10_1016_S0140_6736_21_00432_3 crossref_primary_10_1038_s41467_023_37176_7 crossref_primary_10_1016_j_idnow_2021_08_004 crossref_primary_10_1080_21645515_2022_2100189 crossref_primary_10_3201_eid2807_212330 crossref_primary_10_1016_j_accpm_2022_101021 crossref_primary_10_1007_s11845_021_02584_5 crossref_primary_10_1007_s12038_021_00145_7 crossref_primary_10_1093_jacamr_dlab052 crossref_primary_10_12688_wellcomeopenres_16992_1 crossref_primary_10_3390_microorganisms12010089 crossref_primary_10_3389_fpubh_2022_1017337 crossref_primary_10_1007_s00432_022_04099_7 crossref_primary_10_3390_vaccines11010084 crossref_primary_10_1038_s41467_022_31142_5 crossref_primary_10_1038_s41598_022_19936_5 crossref_primary_10_3310_MTRS8833 crossref_primary_10_3390_ijms22083859 crossref_primary_10_3390_vaccines10060926 crossref_primary_10_1186_s12911_021_01594_8 crossref_primary_10_1038_s41541_022_00567_w crossref_primary_10_7759_cureus_71671 crossref_primary_10_3390_v16121932 crossref_primary_10_1016_j_jiac_2022_09_006 crossref_primary_10_3389_fendo_2022_900964 crossref_primary_10_3390_bioengineering9020072 crossref_primary_10_7759_cureus_21374 crossref_primary_10_1080_00207454_2021_2015348 crossref_primary_10_1016_j_vaccine_2024_02_010 crossref_primary_10_1016_j_smim_2021_101470 crossref_primary_10_1089_hum_2021_216 crossref_primary_10_1111_1348_0421_12978 crossref_primary_10_1016_j_ebiom_2023_104743 crossref_primary_10_1055_s_0042_1742628 crossref_primary_10_3389_fimmu_2023_1143451 crossref_primary_10_1080_14760584_2022_2071264 crossref_primary_10_1146_annurev_chembioeng_092220_111631 crossref_primary_10_1038_s41540_023_00269_6 crossref_primary_10_1016_j_ejim_2021_08_018 crossref_primary_10_2147_JMDH_S313626 crossref_primary_10_3390_v13112214 crossref_primary_10_3390_vaccines10060938 crossref_primary_10_4254_wjh_v13_i12_1850 crossref_primary_10_3389_fimmu_2022_828053 crossref_primary_10_1007_s15010_022_01758_2 crossref_primary_10_3390_v14071470 crossref_primary_10_1080_22221751_2021_1978823 crossref_primary_10_1016_j_molmed_2022_07_006 crossref_primary_10_3390_vaccines10060941 crossref_primary_10_1038_s41598_022_18208_6 crossref_primary_10_1136_bmj_2022_071249 crossref_primary_10_1056_NEJMe2103931 crossref_primary_10_3390_cells10102541 crossref_primary_10_1002_ana_26182 crossref_primary_10_1093_infdis_jiad393 crossref_primary_10_1038_s41598_025_04837_0 crossref_primary_10_1186_s12879_022_07175_y crossref_primary_10_1128_jcm_02283_21 crossref_primary_10_1042_BCJ20210244 crossref_primary_10_3390_ijtm3020018 crossref_primary_10_3390_tropicalmed7110375 crossref_primary_10_1016_j_hlpt_2024_100849 crossref_primary_10_1016_S0140_6736_21_00191_4 crossref_primary_10_3389_fgwh_2021_761511 crossref_primary_10_3390_vaccines10050702 crossref_primary_10_1038_s41598_022_09863_w crossref_primary_10_1002_path_5642 crossref_primary_10_1016_j_cjca_2021_04_012 crossref_primary_10_1038_s41541_021_00317_4 crossref_primary_10_1016_S1473_3099_20_30982_8 crossref_primary_10_3389_fimmu_2022_887230 crossref_primary_10_1038_s41421_021_00340_8 crossref_primary_10_1208_s12249_021_01974_3 crossref_primary_10_3389_ijph_2021_1604312 crossref_primary_10_1016_S0140_6736_21_01046_1 crossref_primary_10_1016_j_cell_2021_12_032 crossref_primary_10_1016_j_vaccine_2021_04_002 crossref_primary_10_3390_jpm12050694 crossref_primary_10_1038_s41541_023_00640_y crossref_primary_10_1136_bmj_n1201 crossref_primary_10_1016_j_healun_2022_05_014 crossref_primary_10_1136_bmj_2022_070344 crossref_primary_10_1038_s41541_023_00662_6 crossref_primary_10_1016_j_intimp_2023_109968 crossref_primary_10_1007_s11606_022_08007_0 crossref_primary_10_1007_s15007_021_4848_z crossref_primary_10_3390_vaccines9020109 crossref_primary_10_1016_j_socscimed_2021_113930 crossref_primary_10_3390_biomedicines10010171 crossref_primary_10_12688_f1000research_122820_1 crossref_primary_10_1016_j_jhep_2021_05_009 crossref_primary_10_1111_jep_13903 crossref_primary_10_1210_clinem_dgac550 crossref_primary_10_1007_s40261_021_01085_8 crossref_primary_10_1007_s00894_021_04779_0 crossref_primary_10_1016_j_jinf_2021_08_049 crossref_primary_10_12688_f1000research_122820_2 crossref_primary_10_1038_s41598_021_98308_x crossref_primary_10_1097_WNO_0000000000001537 crossref_primary_10_1016_j_bjid_2021_101600 crossref_primary_10_1038_s41375_021_01300_7 crossref_primary_10_1186_s12916_022_02663_z crossref_primary_10_1371_journal_pone_0283194 crossref_primary_10_1097_MD_0000000000030814 crossref_primary_10_4103_ijcm_ijcm_1388_21 crossref_primary_10_1007_s43441_021_00290_z crossref_primary_10_1136_rmdopen_2020_001553 crossref_primary_10_1093_infdis_jiac099 crossref_primary_10_1186_s12985_021_01526_y crossref_primary_10_1002_mus_27747 crossref_primary_10_1038_s41598_024_58498_6 crossref_primary_10_1016_j_ijpharm_2022_122223 crossref_primary_10_1183_16000617_0384_2020 crossref_primary_10_1002_jmv_27599 crossref_primary_10_1186_s40545_023_00528_1 crossref_primary_10_3390_vaccines10060977 crossref_primary_10_1177_13524585211040222 crossref_primary_10_1080_07391102_2022_2116601 crossref_primary_10_3390_vaccines10060970 crossref_primary_10_3390_vaccines10050718 crossref_primary_10_1002_jmv_27590 crossref_primary_10_1208_s12249_025_03220_6 crossref_primary_10_1590_0001_3765202120210543 crossref_primary_10_3390_v13081483 crossref_primary_10_1016_j_ymthe_2021_02_010 crossref_primary_10_1007_s11357_021_00352_y crossref_primary_10_1177_25151355211059791 crossref_primary_10_1128_spectrum_01837_22 crossref_primary_10_1007_s00417_022_05707_5 crossref_primary_10_4103_ijmr_ijmr_1626_21 crossref_primary_10_1111_imj_15884 crossref_primary_10_3389_fbioe_2021_727386 crossref_primary_10_1038_s41467_022_33169_0 crossref_primary_10_1111_imcb_12539 crossref_primary_10_1093_cid_ciac739 crossref_primary_10_1016_j_prrv_2021_07_002 crossref_primary_10_1111_imm_13661 crossref_primary_10_1016_j_prrv_2021_07_001 crossref_primary_10_3389_fimmu_2024_1513717 crossref_primary_10_3390_v13081493 crossref_primary_10_3390_vaccines11010021 crossref_primary_10_1093_cid_ciab881 crossref_primary_10_1007_s10753_022_01656_7 crossref_primary_10_1038_s41585_021_00481_1 crossref_primary_10_1177_13524585211057512 crossref_primary_10_3389_fimmu_2022_1026473 crossref_primary_10_3389_fmed_2022_821522 crossref_primary_10_1016_j_ijregi_2022_04_006 crossref_primary_10_1016_j_aprim_2023_102606 crossref_primary_10_2478_raon_2022_0002 crossref_primary_10_3389_fimmu_2023_1131051 crossref_primary_10_1002_iid3_532 crossref_primary_10_7759_cureus_20460 crossref_primary_10_1016_j_imu_2023_101387 crossref_primary_10_1097_ACI_0000000000000788 crossref_primary_10_1007_s10787_021_00850_7 crossref_primary_10_1098_rsos_231792 crossref_primary_10_3389_fmed_2021_758118 crossref_primary_10_3390_vaccines11010024 crossref_primary_10_2478_acph_2023_0029 crossref_primary_10_3390_ijerph182111098 crossref_primary_10_3390_v13081498 crossref_primary_10_3390_vaccines9121379 crossref_primary_10_1111_dme_14774 crossref_primary_10_1038_s42003_021_02443_0 crossref_primary_10_1016_j_cytogfr_2023_11_005 crossref_primary_10_1056_NEJMoa2102214 crossref_primary_10_3390_scipharm91030035 crossref_primary_10_1093_oncolo_oyac230 crossref_primary_10_3389_fimmu_2023_1172851 crossref_primary_10_1016_j_vaccine_2023_05_015 crossref_primary_10_1186_s12864_021_08061_8 crossref_primary_10_1186_s12961_025_01354_4 crossref_primary_10_3390_vaccines11020299 crossref_primary_10_1002_ctm2_297 crossref_primary_10_1136_annrheumdis_2021_220272 crossref_primary_10_1080_22221751_2022_2043728 crossref_primary_10_1038_s41541_025_01100_5 crossref_primary_10_3390_vaccines9050524 crossref_primary_10_1016_j_ijid_2021_09_022 crossref_primary_10_1007_s12015_022_10477_y crossref_primary_10_1097_QAD_0000000000003841 crossref_primary_10_3390_vaccines11020295 crossref_primary_10_1016_j_fri_2022_200520 crossref_primary_10_1016_j_medcle_2021_05_003 crossref_primary_10_1016_S1473_3099_21_00396_0 crossref_primary_10_3390_ijerph18147578 crossref_primary_10_1016_j_eswa_2024_123560 crossref_primary_10_1016_j_cmi_2022_02_028 crossref_primary_10_1016_j_ejca_2021_03_030 crossref_primary_10_1038_s41423_022_00924_8 crossref_primary_10_1208_s12249_022_02247_3 crossref_primary_10_1016_j_jiph_2021_06_007 crossref_primary_10_3390_life14060715 crossref_primary_10_3389_fpubh_2022_1016402 crossref_primary_10_1371_journal_pntd_0011493 crossref_primary_10_1038_s43586_023_00249_4 crossref_primary_10_1212_CON_0000000000001382 crossref_primary_10_3390_pathogens10070788 crossref_primary_10_3390_math11102238 crossref_primary_10_3389_fimmu_2022_804945 crossref_primary_10_3390_vaccines11020281 crossref_primary_10_1126_science_abm3425 crossref_primary_10_1093_labmed_lmad044 crossref_primary_10_3389_fmicb_2022_1056884 crossref_primary_10_1371_journal_pone_0264863 crossref_primary_10_1016_j_ypmed_2021_106694 crossref_primary_10_1016_j_ypmed_2022_106994 crossref_primary_10_1186_s12913_025_12482_6 crossref_primary_10_3390_jcm11164723 crossref_primary_10_1371_journal_ppat_1012456 crossref_primary_10_1016_j_biopha_2022_113089 crossref_primary_10_1136_bmjopen_2024_084345 crossref_primary_10_1172_JCI162581 crossref_primary_10_3748_wjg_v29_i14_2064 crossref_primary_10_1016_j_cmpbup_2024_100155 crossref_primary_10_1172_JCI149154 crossref_primary_10_1172_JCI150135 crossref_primary_10_1172_JCI149150 crossref_primary_10_3390_vaccines9121381 crossref_primary_10_3390_v13101972 crossref_primary_10_1177_13524585231154780 crossref_primary_10_1177_1357034X241293033 crossref_primary_10_3390_vaccines9121387 crossref_primary_10_12968_bjon_2021_30_2_116 crossref_primary_10_1007_s11064_023_04089_2 crossref_primary_10_1016_j_clinthera_2021_03_007 crossref_primary_10_12968_hmed_2021_0047 crossref_primary_10_1136_annrheumdis_2021_221558 crossref_primary_10_1186_s12877_024_05240_6 crossref_primary_10_1016_j_isci_2025_112511 crossref_primary_10_3390_jcm10235705 crossref_primary_10_1016_j_ihjccr_2021_05_003 crossref_primary_10_3390_vaccines11020266 crossref_primary_10_1038_s41590_022_01130_4 crossref_primary_10_1111_bcp_15116 crossref_primary_10_1016_j_biopha_2022_113499 crossref_primary_10_1016_j_ejim_2021_06_025 crossref_primary_10_1007_s10384_022_00962_9 crossref_primary_10_1111_bph_15620 crossref_primary_10_1007_s40279_021_01503_z crossref_primary_10_1038_s41541_021_00411_7 crossref_primary_10_3389_fmicb_2021_676314 crossref_primary_10_3390_v14061255 crossref_primary_10_3390_vaccines12080936 crossref_primary_10_1002_jia2_25793 crossref_primary_10_1038_s41467_021_24123_7 crossref_primary_10_34067_KID_0000000000000498 crossref_primary_10_1136_gutjnl_2020_324000 crossref_primary_10_3390_cells10092212 crossref_primary_10_1111_jdv_17762 crossref_primary_10_3390_ijms221910791 crossref_primary_10_3390_vaccines10060914 crossref_primary_10_1038_s41541_025_01148_3 crossref_primary_10_1016_j_dsx_2021_02_026 crossref_primary_10_1186_s12883_022_02575_8 crossref_primary_10_1016_j_ymthe_2025_08_037 crossref_primary_10_1097_QAD_0000000000003405 crossref_primary_10_1002_jmv_27501 crossref_primary_10_1016_j_rmed_2021_106355 crossref_primary_10_1371_journal_pone_0251992 crossref_primary_10_3390_vaccines12080927 crossref_primary_10_1016_j_imj_2023_08_005 crossref_primary_10_1038_s41577_021_00657_1 crossref_primary_10_1016_S0140_6736_21_02276_5 crossref_primary_10_1007_s10620_022_07641_2 crossref_primary_10_1016_j_vaccine_2022_10_011 crossref_primary_10_1016_j_vaccine_2022_10_012 crossref_primary_10_1128_msystems_00928_22 crossref_primary_10_3390_biom11070993 crossref_primary_10_1016_j_pbiomolbio_2021_05_007 crossref_primary_10_1177_08901171221075019 crossref_primary_10_1111_cen_14566 crossref_primary_10_1055_s_0042_1745788 crossref_primary_10_1097_QAD_0000000000003414 crossref_primary_10_1016_j_jfma_2021_04_026 crossref_primary_10_1038_s41598_022_23235_4 crossref_primary_10_1136_bcr_2021_243894 crossref_primary_10_5694_mja2_50978 crossref_primary_10_1016_j_ijid_2022_01_030 crossref_primary_10_1128_jvi_00207_24 crossref_primary_10_3390_jcm10245960 crossref_primary_10_1016_j_ijmmb_2022_03_003 crossref_primary_10_1016_j_immuni_2022_05_004 crossref_primary_10_1016_j_cmi_2022_02_010 crossref_primary_10_1016_S1473_3099_21_00143_2 crossref_primary_10_1177_20552076221109530 crossref_primary_10_1371_journal_pone_0261330 crossref_primary_10_1002_jcph_2017 crossref_primary_10_1016_S1473_3099_22_00140_2 crossref_primary_10_1097_CCE_0000000000000519 crossref_primary_10_3390_vaccines11020231 crossref_primary_10_1126_scitranslmed_abi4547 crossref_primary_10_1016_j_gastre_2021_06_003 crossref_primary_10_1016_j_vaccine_2023_07_065 crossref_primary_10_1016_S1473_3099_21_00472_2 crossref_primary_10_1038_s41571_021_00487_z crossref_primary_10_1002_iid3_521 crossref_primary_10_1002_sim_9014 crossref_primary_10_1016_j_ijid_2021_09_045 crossref_primary_10_3389_fneur_2022_796882 crossref_primary_10_3390_vaccines10060902 crossref_primary_10_1016_j_lana_2021_100123 crossref_primary_10_7759_cureus_19005 crossref_primary_10_3390_vaccines12030254 crossref_primary_10_1186_s12948_022_00167_y crossref_primary_10_3389_fimmu_2023_1133225 crossref_primary_10_3390_tropicalmed7050066 crossref_primary_10_1016_j_cyto_2024_156756 crossref_primary_10_1111_bcp_15552 crossref_primary_10_3390_cancers13194750 crossref_primary_10_1016_j_ebiom_2021_103761 crossref_primary_10_1016_j_qref_2023_08_002 crossref_primary_10_3390_vaccines9121415 crossref_primary_10_1016_j_ebiom_2021_103762 crossref_primary_10_3390_jcm13164617 crossref_primary_10_1177_17455057221112237 crossref_primary_10_3390_vaccines10071041 crossref_primary_10_1016_j_jaad_2020_12_058 crossref_primary_10_1016_S0140_6736_21_00624_3 crossref_primary_10_1038_s41467_022_30052_w crossref_primary_10_1038_s41598_022_05640_x crossref_primary_10_1128_JVI_00404_21 crossref_primary_10_1016_j_clim_2023_109700 crossref_primary_10_1016_j_rhum_2022_07_002 crossref_primary_10_3390_vaccines9040320 crossref_primary_10_1038_s41541_023_00622_0 crossref_primary_10_3389_fimmu_2022_836492 crossref_primary_10_1016_j_jddst_2021_102899 crossref_primary_10_1038_s41467_021_23761_1 crossref_primary_10_1016_j_ijmmb_2023_100372 crossref_primary_10_1146_annurev_med_012621_102252 crossref_primary_10_3390_vaccines9121412 crossref_primary_10_1016_S1473_3099_22_00141_4 crossref_primary_10_1016_j_clim_2025_110492 crossref_primary_10_1097_MPG_0000000000003260 crossref_primary_10_3390_vaccines9121409 crossref_primary_10_1186_s12916_023_02809_7 crossref_primary_10_3389_fimmu_2022_1062067 crossref_primary_10_1007_s00415_021_10849_3 crossref_primary_10_1210_clinem_dgab823 crossref_primary_10_1097_ICB_0000000000001196 crossref_primary_10_2105_AJPH_2023_307302 crossref_primary_10_1186_s12879_022_07823_3 crossref_primary_10_3389_fcvm_2024_1297824 crossref_primary_10_1016_j_ejca_2022_02_017 crossref_primary_10_1007_s11019_023_10184_6 crossref_primary_10_1016_S1473_3099_22_00502_3 crossref_primary_10_2174_1381612828666220701160116 crossref_primary_10_1016_j_addr_2021_01_014 crossref_primary_10_3389_fimmu_2021_654165 crossref_primary_10_1136_bmj_n1931 crossref_primary_10_1186_s12913_023_09788_8 crossref_primary_10_3390_ijms25179459 crossref_primary_10_7774_cevr_2022_11_1_125 crossref_primary_10_3390_vaccines11020326 crossref_primary_10_3390_vaccines9121435 crossref_primary_10_3390_vaccines9040349 crossref_primary_10_1016_j_jmii_2021_02_008 crossref_primary_10_1038_s41392_021_00733_x crossref_primary_10_3389_fpubh_2022_848120 crossref_primary_10_1016_j_dld_2021_03_013 crossref_primary_10_1177_10760296211021498 crossref_primary_10_1177_03331024231198792 crossref_primary_10_1056_NEJMoa2107715 crossref_primary_10_1080_14737159_2021_1917998 crossref_primary_10_1007_s15033_021_2705_0 crossref_primary_10_1080_1744666X_2021_1908887 crossref_primary_10_1017_S0950268821002430 crossref_primary_10_1038_s41562_021_01056_1 crossref_primary_10_1016_j_det_2021_05_016 crossref_primary_10_1016_j_jiac_2021_12_015 crossref_primary_10_1089_vim_2021_0054 crossref_primary_10_1016_j_clindermatol_2021_04_001 crossref_primary_10_3389_fmed_2022_924454 crossref_primary_10_1016_j_jacig_2023_100079 crossref_primary_10_1038_s41598_022_11374_7 crossref_primary_10_3390_idr13040084 crossref_primary_10_1016_j_mayocpiqo_2025_100642 crossref_primary_10_3390_vaccines9040341 crossref_primary_10_1038_s41598_022_06629_2 crossref_primary_10_3390_idr13040080 crossref_primary_10_1097_MRM_0000000000000335 crossref_primary_10_1056_NEJMoa2109908 crossref_primary_10_5812_archcid_127354 crossref_primary_10_3389_fimmu_2021_704773 crossref_primary_10_1172_JCI156083 crossref_primary_10_1186_s12916_022_02240_4 crossref_primary_10_1055_s_0041_1741432 crossref_primary_10_1016_j_jacig_2023_100083 crossref_primary_10_1038_s41467_022_32264_6 crossref_primary_10_1097_EDE_0000000000001562 crossref_primary_10_1038_s41541_021_00369_6 crossref_primary_10_1038_s41467_022_31259_7 crossref_primary_10_1097_MD_0000000000041079 crossref_primary_10_1007_s40264_022_01253_5 crossref_primary_10_1016_j_mjafi_2021_05_024 crossref_primary_10_2147_IDR_S332354 crossref_primary_10_1002_ueg2_12103 crossref_primary_10_4103_ijoem_ijoem_275_22 crossref_primary_10_1007_s40268_021_00358_z crossref_primary_10_3389_fphar_2021_660490 crossref_primary_10_1111_jep_13581 crossref_primary_10_1186_s13045_021_01099_x crossref_primary_10_1017_ice_2022_50 crossref_primary_10_1080_09537104_2022_2042237 crossref_primary_10_3390_vaccines9040365 crossref_primary_10_1016_j_tmaid_2023_102650 crossref_primary_10_1093_jnci_djab174 crossref_primary_10_1111_ejh_13788 crossref_primary_10_3390_v16030377 crossref_primary_10_3390_vaccines11111677 crossref_primary_10_1097_EDE_0000000000001573 crossref_primary_10_7759_cureus_21875 crossref_primary_10_1016_j_therap_2021_07_004 crossref_primary_10_1038_s41390_021_01479_6 crossref_primary_10_3389_fpubh_2022_977940 crossref_primary_10_3390_vaccines10071082 crossref_primary_10_1016_j_omtm_2023_101169 crossref_primary_10_3390_cells11020253 crossref_primary_10_4103_ijmr_ijmr_1917_21 crossref_primary_10_1590_1413_82712023280310 crossref_primary_10_1038_s41586_021_04120_y crossref_primary_10_3390_diagnostics11040579 crossref_primary_10_1002_ueg2_12115 crossref_primary_10_1007_s11908_022_00784_3 crossref_primary_10_1016_j_cmi_2025_09_005 crossref_primary_10_1016_j_jddst_2023_105273 crossref_primary_10_1097_TP_0000000000004535 crossref_primary_10_3390_jcm11040948 crossref_primary_10_2147_CIA_S295522 crossref_primary_10_1016_S0140_6736_21_00241_5 crossref_primary_10_3389_fimmu_2022_999693 crossref_primary_10_7759_cureus_51693 crossref_primary_10_1080_21645515_2022_2064134 crossref_primary_10_3389_fimmu_2022_1028102 crossref_primary_10_1002_cam4_6314 crossref_primary_10_1016_j_jiph_2025_102794 crossref_primary_10_1080_22221751_2021_1957401 crossref_primary_10_3389_fpubh_2022_873596 crossref_primary_10_1016_j_jpsychores_2022_111104 crossref_primary_10_1002_ange_202109965 crossref_primary_10_1186_s13256_022_03407_6 crossref_primary_10_1186_s13578_021_00723_0 crossref_primary_10_3390_vaccines9080836 crossref_primary_10_1016_j_ejim_2021_04_019 crossref_primary_10_7759_cureus_48046 crossref_primary_10_7861_clinmed_2020_1072 crossref_primary_10_1186_s43168_021_00109_3 crossref_primary_10_1212_WNL_0000000000201376 crossref_primary_10_4103_ijn_ijn_257_21 crossref_primary_10_1371_journal_pone_0331971 crossref_primary_10_1016_S2213_2600_23_00414_9 crossref_primary_10_1161_CIRCRESAHA_122_319954 crossref_primary_10_3390_ijms22168660 crossref_primary_10_7759_cureus_21848 crossref_primary_10_1016_j_cmi_2021_03_027 crossref_primary_10_1038_s41577_021_00592_1 crossref_primary_10_1007_s40267_021_00852_z crossref_primary_10_1016_S1470_2045_21_00017_6 crossref_primary_10_1038_d41586_020_03504_w crossref_primary_10_3390_vaccines10071067 crossref_primary_10_1016_j_ymthe_2022_08_002 crossref_primary_10_2147_IDR_S335414 crossref_primary_10_1038_s41467_021_26459_6 crossref_primary_10_3390_v13050898 crossref_primary_10_1038_s41531_025_00925_0 crossref_primary_10_1136_gutjnl_2021_326563 crossref_primary_10_1016_j_vaccine_2023_10_018 crossref_primary_10_3390_vaccines9040382 crossref_primary_10_1016_j_isci_2023_108086 crossref_primary_10_1182_bloodadvances_2021004904 crossref_primary_10_1007_s40620_023_01617_9 crossref_primary_10_1038_s41467_021_26557_5 crossref_primary_10_1007_s12035_023_03638_8 crossref_primary_10_1016_j_cmi_2022_09_001 crossref_primary_10_1183_23120541_00277_2024 crossref_primary_10_3390_medicina59020272 crossref_primary_10_3390_v14030481 crossref_primary_10_3390_vaccines9040399 crossref_primary_10_1016_j_ejca_2022_04_036 crossref_primary_10_4103_ohbl_ohbl_66_24 crossref_primary_10_2478_jtim_2023_0122 crossref_primary_10_7759_cureus_16491 crossref_primary_10_1016_j_medcle_2023_04_031 crossref_primary_10_7326_M20_8149 crossref_primary_10_1007_s40264_021_01138_z crossref_primary_10_1038_s41541_022_00560_3 crossref_primary_10_3390_vaccines9080815 crossref_primary_10_1186_s43162_023_00191_7 crossref_primary_10_1016_S0140_6736_23_02042_1 crossref_primary_10_1016_j_apm_2023_02_002 crossref_primary_10_3389_fimmu_2023_1160664 crossref_primary_10_1016_j_jaci_2022_04_002 crossref_primary_10_1016_j_medcli_2023_04_027 crossref_primary_10_1111_imj_16298 crossref_primary_10_1016_j_coi_2022_102210 crossref_primary_10_1038_s41541_022_00440_w crossref_primary_10_1177_2632010X231161222 crossref_primary_10_3390_vaccines9040393 crossref_primary_10_3390_toxins15020159 crossref_primary_10_1007_s12325_021_01761_3 crossref_primary_10_1016_j_vaccine_2023_10_034 crossref_primary_10_1016_j_amsu_2021_103028 crossref_primary_10_1016_S0140_6736_21_00628_0 crossref_primary_10_1016_j_biopha_2022_112756 crossref_primary_10_1002_hsr2_541 crossref_primary_10_3389_fimmu_2021_714170 crossref_primary_10_1016_j_ijid_2022_12_024 crossref_primary_10_1024_2673_8627_a000011 crossref_primary_10_1016_j_vaccine_2022_08_065 crossref_primary_10_1016_S0140_6736_21_00677_2 crossref_primary_10_1016_j_jtbi_2022_111063 crossref_primary_10_3389_fimmu_2021_794642 crossref_primary_10_3389_fimmu_2024_1325243 crossref_primary_10_1093_qjmed_hcad159 crossref_primary_10_3390_v13050873 crossref_primary_10_4254_wjh_v14_i7_1470 crossref_primary_10_1007_s00415_021_10747_8 crossref_primary_10_3390_vaccines10010059 crossref_primary_10_3390_vaccines11081340 crossref_primary_10_3390_vaccines13080789 crossref_primary_10_1038_s41598_024_57308_3 crossref_primary_10_3390_idr17040074 crossref_primary_10_3390_vaccines13040424 crossref_primary_10_1093_brain_awab302 crossref_primary_10_1186_s12916_023_02795_w crossref_primary_10_3390_vaccines10081258 crossref_primary_10_1080_14760584_2022_1997601 crossref_primary_10_1001_jamanetworkopen_2021_40364 crossref_primary_10_1007_s00277_023_05142_4 crossref_primary_10_1093_eurpub_ckae098 crossref_primary_10_1097_PSY_0000000000000932 crossref_primary_10_3390_ph17060807 crossref_primary_10_1136_bmjopen_2023_073866 crossref_primary_10_1007_s12328_023_01794_x crossref_primary_10_1136_bmjopen_2022_069065 crossref_primary_10_1128_spectrum_02857_23 crossref_primary_10_1007_s11756_021_00881_z crossref_primary_10_3389_fpubh_2025_1537049 crossref_primary_10_1080_21645515_2025_2467554 crossref_primary_10_1016_j_ijnurstu_2021_104142 crossref_primary_10_1111_imj_15783 crossref_primary_10_1073_pnas_2205412119 crossref_primary_10_1016_j_jim_2024_113680 crossref_primary_10_1016_j_mayocp_2021_08_013 crossref_primary_10_1016_j_jiph_2022_04_001 crossref_primary_10_1038_s41591_021_01408_4 crossref_primary_10_1038_s41541_024_00919_8 crossref_primary_10_3389_fimmu_2022_947602 crossref_primary_10_7189_jogh_12_05008 crossref_primary_10_1111_jns_12435 crossref_primary_10_1080_22221751_2022_2149353 crossref_primary_10_3390_vaccines10010075 crossref_primary_10_3389_ijph_2024_1605295 crossref_primary_10_1016_j_mjafi_2021_07_008 crossref_primary_10_1111_ajt_16818 crossref_primary_10_3390_vaccines10010072 crossref_primary_10_1016_S1473_3099_21_00070_0 crossref_primary_10_1111_imj_15339 crossref_primary_10_3390_ijerph182010929 crossref_primary_10_1016_j_anai_2022_03_030 crossref_primary_10_1016_j_ijpharm_2021_121053 crossref_primary_10_3390_v16030391 crossref_primary_10_1016_j_jff_2021_104850 crossref_primary_10_1016_j_therap_2021_05_010 crossref_primary_10_3390_vaccines13040406 crossref_primary_10_1080_08830185_2021_1925267 crossref_primary_10_1016_j_csbj_2021_01_032 crossref_primary_10_14309_ajg_0000000000002702 crossref_primary_10_3389_fimmu_2024_1359475 crossref_primary_10_1002_uog_23631 crossref_primary_10_3390_vaccines10010082 crossref_primary_10_3390_medicina58121799 crossref_primary_10_1002_jmv_28256 crossref_primary_10_1016_j_heliyon_2023_e14828 crossref_primary_10_1016_j_ijbiomac_2021_11_020 crossref_primary_10_1016_S0140_6736_21_00709_1 crossref_primary_10_1007_s13668_021_00356_2 crossref_primary_10_1038_s41598_022_23471_8 crossref_primary_10_3390_v14050957 crossref_primary_10_1071_MA21009 crossref_primary_10_1371_journal_pcbi_1009288 crossref_primary_10_1007_s12026_021_09193_5 crossref_primary_10_1016_j_therap_2021_05_007 crossref_primary_10_3389_fmed_2022_1095194 crossref_primary_10_3390_vaccines9080852 crossref_primary_10_1016_j_vaccine_2022_08_039 crossref_primary_10_1016_j_vaccine_2022_08_038 crossref_primary_10_1186_s43168_021_00090_x crossref_primary_10_7189_jogh_12_05022 crossref_primary_10_1016_j_celrep_2023_112991 crossref_primary_10_1371_journal_pone_0312377 crossref_primary_10_7326_M21_2452 crossref_primary_10_3390_vaccines10081223 crossref_primary_10_4103_jfmpc_jfmpc_1714_24 crossref_primary_10_1002_rmv_2346 crossref_primary_10_1016_j_msard_2021_103321 crossref_primary_10_3390_vaccines10071009 crossref_primary_10_1001_jamanetworkopen_2022_33730 crossref_primary_10_1016_j_ejps_2021_105820 crossref_primary_10_1186_s12879_022_07239_z crossref_primary_10_3390_vaccines12040404 crossref_primary_10_1073_pnas_2313681121 crossref_primary_10_4103_NJM_NJM_172_21 crossref_primary_10_1016_j_ejphar_2021_174548 crossref_primary_10_1136_bmj_2021_068946 crossref_primary_10_1097_WNO_0000000000001482 crossref_primary_10_14785_lymphosign_2024_0007 crossref_primary_10_1002_cti2_1326 crossref_primary_10_1016_j_cmi_2021_10_005 crossref_primary_10_1186_s12959_021_00362_y crossref_primary_10_3390_v14020277 crossref_primary_10_1016_j_jacig_2023_100091 crossref_primary_10_1007_s40120_021_00288_7 crossref_primary_10_1007_s10875_022_01231_7 crossref_primary_10_2147_IDR_S337699 crossref_primary_10_1038_s41423_021_00743_3 crossref_primary_10_1038_d41573_022_00178_z crossref_primary_10_7774_cevr_2021_10_3_293 crossref_primary_10_1002_ijc_33762 crossref_primary_10_1016_j_amjoto_2023_103970 crossref_primary_10_1097_MRM_0000000000000393 crossref_primary_10_1038_s41394_024_00642_5 crossref_primary_10_1007_s13760_023_02373_0 crossref_primary_10_3390_ijms22157919 crossref_primary_10_12688_wellcomeopenres_19811_2 crossref_primary_10_12688_wellcomeopenres_19811_1 crossref_primary_10_7189_jogh_11_05021 crossref_primary_10_1111_jns_12482 crossref_primary_10_1007_s40120_021_00266_z crossref_primary_10_1038_s41541_024_00981_2 crossref_primary_10_1016_j_jinf_2023_10_012 crossref_primary_10_1111_1742_6723_14012 crossref_primary_10_1080_29947677_2025_2508712 crossref_primary_10_1056_NEJMoa2035389 crossref_primary_10_1111_jdv_18184 crossref_primary_10_1002_rmv_2338 crossref_primary_10_1093_ndt_gfab064 crossref_primary_10_3390_v14050933 crossref_primary_10_7189_jogh_11_05019 crossref_primary_10_1016_j_ijid_2024_107179 crossref_primary_10_3389_fams_2022_872284 crossref_primary_10_1155_2022_7493087 crossref_primary_10_1038_s41598_021_93366_7 crossref_primary_10_1080_21645515_2025_2517931 crossref_primary_10_2217_fvl_2021_0100 crossref_primary_10_1016_j_vacune_2023_04_003 crossref_primary_10_1093_aje_kwac157 crossref_primary_10_1177_25151355241278832 crossref_primary_10_2174_0929867328666210526111318 crossref_primary_10_26633_RPSP_2024_94 crossref_primary_10_1016_j_neurol_2022_11_003 crossref_primary_10_1016_S0140_6736_21_00258_0 crossref_primary_10_12688_f1000research_53089_1 crossref_primary_10_1186_s12879_025_11410_7 crossref_primary_10_1055_s_0041_1728831 crossref_primary_10_7861_clinmed_2021_0470 crossref_primary_10_2147_PPA_S330689 crossref_primary_10_1007_s00109_022_02208_0 crossref_primary_10_1016_j_puhe_2023_11_021 crossref_primary_10_3389_fimmu_2022_917905 crossref_primary_10_1016_j_vaccine_2023_03_065 crossref_primary_10_1093_ofid_ofac515 crossref_primary_10_1111_all_14868 crossref_primary_10_3390_vaccines11040849 crossref_primary_10_3390_vaccines9080887 crossref_primary_10_7759_cureus_25378 crossref_primary_10_1016_j_esmorw_2025_100125 crossref_primary_10_1016_j_vaccine_2022_08_007 crossref_primary_10_1097_MD_0000000000033013 crossref_primary_10_3389_fimmu_2023_1174406 crossref_primary_10_4103_lungindia_lungindia_141_22 crossref_primary_10_1016_j_nerep_2022_100074 crossref_primary_10_2459_JCM_0000000000001693 crossref_primary_10_1038_s41467_024_53842_w crossref_primary_10_1038_s41541_022_00493_x crossref_primary_10_3390_cancers13174312 crossref_primary_10_1055_a_1372_5595 crossref_primary_10_1371_journal_pone_0290652 crossref_primary_10_1212_WNL_0000000000012576 crossref_primary_10_1080_09273948_2022_2044058 crossref_primary_10_1177_17407745211024764 crossref_primary_10_1016_j_ijid_2022_06_045 crossref_primary_10_1038_s41467_022_33649_3 crossref_primary_10_1016_j_vaccine_2023_01_003 crossref_primary_10_7759_cureus_47136 crossref_primary_10_1136_bmjopen_2022_061126 crossref_primary_10_1053_j_ajkd_2020_12_003 crossref_primary_10_1038_s41541_024_00861_9 crossref_primary_10_1002_rmv_2359 crossref_primary_10_1016_j_nerep_2022_100089 crossref_primary_10_3390_idr16060088 crossref_primary_10_1007_s10273_021_2894_5 crossref_primary_10_3390_ijerph18105111 crossref_primary_10_3390_v13050805 crossref_primary_10_1016_j_vaccine_2023_01_009 crossref_primary_10_1038_s41591_021_01230_y crossref_primary_10_3389_fimmu_2021_747032 crossref_primary_10_1055_a_1401_2691 crossref_primary_10_1002_bimj_202100035 crossref_primary_10_1212_NXI_0000000000001104 crossref_primary_10_1007_s12033_021_00353_4 crossref_primary_10_1038_s41467_023_35949_8 crossref_primary_10_1055_a_1585_6264 crossref_primary_10_1111_bjh_18138 crossref_primary_10_1016_j_jcv_2022_105119 crossref_primary_10_3390_vaccines9111299 crossref_primary_10_7189_jogh_11_10003 crossref_primary_10_1007_s00011_021_01520_8 crossref_primary_10_1016_j_asoc_2021_107708 crossref_primary_10_3389_fimmu_2022_985938 crossref_primary_10_1016_j_healun_2021_04_003 crossref_primary_10_1111_ijlh_13774 crossref_primary_10_1080_14760584_2022_2015331 crossref_primary_10_1097_MS9_0000000000000193 crossref_primary_10_1001_jamanetworkopen_2021_47042 crossref_primary_10_1038_s41598_022_10307_8 crossref_primary_10_1371_journal_pmed_1003927 crossref_primary_10_1016_j_immuni_2021_06_003 crossref_primary_10_7326_M21_4269 crossref_primary_10_1080_14760584_2022_2093193 crossref_primary_10_1136_bmj_2022_071594 crossref_primary_10_1177_0025817221990520 crossref_primary_10_1038_s41541_024_00878_0 crossref_primary_10_1177_00490857211051305 crossref_primary_10_1016_j_jebo_2023_07_010 crossref_primary_10_1016_j_biologicals_2023_101668 crossref_primary_10_1016_j_vaccine_2022_06_054 crossref_primary_10_2217_fvl_2021_0072 crossref_primary_10_1371_journal_pone_0263014 crossref_primary_10_1016_j_medcli_2021_03_001 crossref_primary_10_1016_j_vaccine_2021_11_001 crossref_primary_10_1111_ene_15147 crossref_primary_10_1016_j_ijid_2022_06_028 crossref_primary_10_1136_bmj_n937 crossref_primary_10_1172_JCI162282 crossref_primary_10_1016_j_vacune_2022_11_007 crossref_primary_10_3390_vaccines9111286 crossref_primary_10_1093_intimm_dxab013 crossref_primary_10_1038_s41598_022_14558_3 crossref_primary_10_1097_TP_0000000000004178 crossref_primary_10_3390_vaccines10091563 crossref_primary_10_2196_31409 crossref_primary_10_1016_j_sste_2023_100621 crossref_primary_10_3390_vaccines10060841 crossref_primary_10_3390_vaccines10060846 crossref_primary_10_1002_jmv_27425 crossref_primary_10_3389_fneur_2021_721502 crossref_primary_10_1186_s13098_023_01059_0 crossref_primary_10_1038_s41575_021_00426_4 crossref_primary_10_31260_RepertMedCir_01217372_1329 crossref_primary_10_1186_s12882_022_02843_2 crossref_primary_10_1080_14760584_2021_1903878 crossref_primary_10_3389_fpubh_2023_1067218 crossref_primary_10_3390_vaccines12121396 crossref_primary_10_1111_ddg_14799_g crossref_primary_10_3390_vaccines12080883 crossref_primary_10_4103_2773_0344_387693 crossref_primary_10_1007_s00521_021_06434_4 crossref_primary_10_1038_s41467_024_46673_2 crossref_primary_10_1111_imj_15731 crossref_primary_10_1016_j_lana_2021_100062 crossref_primary_10_3389_fimmu_2022_968105 crossref_primary_10_3390_medicines11060012 crossref_primary_10_1128_Spectrum_01298_21 crossref_primary_10_1073_pnas_2106433118 crossref_primary_10_4102_jphia_v16i3_709 crossref_primary_10_1055_a_1658_4852 crossref_primary_10_1097_MOT_0000000000000888 crossref_primary_10_1371_journal_pcbi_1009697 crossref_primary_10_1016_j_ijid_2021_11_009 crossref_primary_10_3892_etm_2021_10843 crossref_primary_10_1111_nyas_14739 crossref_primary_10_1016_j_janxdis_2022_102574 crossref_primary_10_1016_j_jfma_2024_05_006 crossref_primary_10_1186_s12967_022_03371_1 crossref_primary_10_3390_pharmaceutics14051066 crossref_primary_10_3390_vaccines10091540 crossref_primary_10_1016_S2213_2600_21_00380_5 crossref_primary_10_1080_21645515_2025_2514356 crossref_primary_10_1038_s41467_021_25982_w crossref_primary_10_1111_ajt_16766 crossref_primary_10_1371_journal_pone_0265698 crossref_primary_10_1007_s40290_021_00381_0 crossref_primary_10_1016_j_virol_2021_09_001 crossref_primary_10_1057_s41599_022_01185_6 crossref_primary_10_3390_vaccines10091546 crossref_primary_10_29392_001c_26142 crossref_primary_10_1016_j_coviro_2021_11_012 crossref_primary_10_1186_s13073_021_00910_1 crossref_primary_10_1038_s41578_021_00413_w crossref_primary_10_1016_j_ajoc_2022_101620 crossref_primary_10_1073_pnas_2122090119 crossref_primary_10_3390_vaccines10010126 crossref_primary_10_1016_j_puhip_2022_100303 crossref_primary_10_1002_VIW_20200103 crossref_primary_10_3390_vaccines10091538 crossref_primary_10_3390_ph15050540 crossref_primary_10_26633_RPSP_2022_110 crossref_primary_10_3748_wjg_v29_i26_4099 crossref_primary_10_1002_ana_26065 crossref_primary_10_1080_14760584_2021_1891889 crossref_primary_10_1038_s41598_022_18302_9 crossref_primary_10_3389_fpubh_2022_1041586 crossref_primary_10_1016_j_jcv_2022_105156 crossref_primary_10_1155_2022_6913772 crossref_primary_10_1089_jir_2020_0156 crossref_primary_10_3390_vaccines9111259 crossref_primary_10_1007_s00228_023_03510_7 crossref_primary_10_1007_s00204_021_03221_x crossref_primary_10_1136_bcr_2021_245092 crossref_primary_10_1007_s12144_023_04770_3 crossref_primary_10_1016_j_jhqr_2021_05_002 crossref_primary_10_4103_ijo_IJO_1333_21 crossref_primary_10_1016_S0140_6736_21_00468_2 crossref_primary_10_3390_ijms25084556 crossref_primary_10_1002_jmv_28786 crossref_primary_10_1016_j_biomaterials_2021_121159 crossref_primary_10_1080_14760584_2022_2027240 crossref_primary_10_1515_jpm_2021_0246 crossref_primary_10_1002_ana_26494 crossref_primary_10_1002_ccr3_5471 crossref_primary_10_3390_vaccines11030514 crossref_primary_10_1111_imm_13572 crossref_primary_10_1016_j_vaccine_2022_06_011 crossref_primary_10_1001_jamainternmed_2021_5814 crossref_primary_10_1093_cid_ciac407 crossref_primary_10_1093_jtm_taab191 crossref_primary_10_1093_cid_ciab555 crossref_primary_10_1182_blood_2021011958 crossref_primary_10_1016_j_vaccine_2025_126787 crossref_primary_10_1002_jmv_28309 crossref_primary_10_4103_IJO_IJO_2029_23 crossref_primary_10_1186_s12979_022_00303_x crossref_primary_10_1080_22221751_2024_2427792 crossref_primary_10_1038_s41467_022_29159_x crossref_primary_10_3390_vaccines9111246 crossref_primary_10_1016_j_ijid_2023_01_022 crossref_primary_10_1007_s10157_022_02231_y crossref_primary_10_3390_vaccines9111249 crossref_primary_10_1002_jmv_27463 crossref_primary_10_1371_journal_pmed_1003979 crossref_primary_10_1038_s41591_021_01440_4 crossref_primary_10_1016_j_jneuroim_2021_577599 crossref_primary_10_1016_j_amjoto_2022_103723 crossref_primary_10_2217_fvl_2021_0029 crossref_primary_10_3389_fcvm_2022_990108 crossref_primary_10_1038_s41385_022_00517_8 crossref_primary_10_3390_vaccines12121358 crossref_primary_10_1007_s00108_022_01368_y crossref_primary_10_1016_j_vaccine_2025_127604 crossref_primary_10_1002_rai2_12126 crossref_primary_10_3390_vaccines9111277 crossref_primary_10_1002_jmv_29648 crossref_primary_10_1093_ofid_ofac124 crossref_primary_10_3390_jpm11080789 crossref_primary_10_1002_cti2_1388 crossref_primary_10_1186_s12916_023_02924_5 crossref_primary_10_3390_vaccines10060853 crossref_primary_10_3390_app11188767 crossref_primary_10_3389_fimmu_2022_1014309 crossref_primary_10_1016_j_revmed_2021_02_001 crossref_primary_10_1007_s00108_021_01164_0 crossref_primary_10_1186_s13690_022_00904_4 crossref_primary_10_3389_fmed_2021_738049 crossref_primary_10_1016_j_jemermed_2021_04_018 crossref_primary_10_1016_j_autrev_2023_103508 crossref_primary_10_3389_fimmu_2023_1118378 crossref_primary_10_1038_s41467_023_43798_8 crossref_primary_10_1111_1756_185X_14372 crossref_primary_10_3389_fimmu_2021_753319 crossref_primary_10_5501_wjv_v10_i2_62 crossref_primary_10_3389_fpubh_2022_796467 crossref_primary_10_1177_01410768231207536 crossref_primary_10_4103_ijot_ijot_52_21 crossref_primary_10_1016_j_healun_2021_04_018 crossref_primary_10_1016_j_cytogfr_2021_03_001 crossref_primary_10_1038_s41591_021_01377_8 crossref_primary_10_1016_j_mmifmc_2022_07_001 crossref_primary_10_1126_science_abf0874 crossref_primary_10_1038_s41467_023_38020_8 crossref_primary_10_1016_j_vaccine_2021_11_027 crossref_primary_10_1016_j_vaccine_2024_126465 crossref_primary_10_1097_CM9_0000000000001688 crossref_primary_10_1093_ofid_ofab259 crossref_primary_10_1002_jmv_27487 crossref_primary_10_1038_s41467_022_33146_7 crossref_primary_10_3390_vaccines9070697 crossref_primary_10_1016_j_vaccine_2022_06_008 crossref_primary_10_1136_bmjopen_2022_061643 crossref_primary_10_3390_ijms24054398 crossref_primary_10_1007_s13760_021_01862_4 crossref_primary_10_1038_s41577_021_00578_z crossref_primary_10_1515_scid_2022_0003 crossref_primary_10_3390_jcdd9050150 crossref_primary_10_4103_ijn_ijn_7_23 crossref_primary_10_1016_j_jcv_2022_105151 crossref_primary_10_1016_j_ijid_2023_01_040 crossref_primary_10_1136_bmj_n1114 crossref_primary_10_2478_jtim_2022_0026 crossref_primary_10_1080_21645515_2021_1997297 crossref_primary_10_1371_journal_pmed_1003991 crossref_primary_10_1016_j_vaccine_2024_07_019 crossref_primary_10_1073_pnas_2311584120 crossref_primary_10_1093_cid_ciac852 crossref_primary_10_1111_tid_13935 crossref_primary_10_7759_cureus_28066 crossref_primary_10_1038_s41392_021_00692_3 crossref_primary_10_1080_14760584_2023_2232020 crossref_primary_10_1080_14737167_2021_1931128 crossref_primary_10_1136_bmjmed_2021_000104 crossref_primary_10_3233_JPD_212573 crossref_primary_10_1182_blood_2021014195 crossref_primary_10_3390_vaccines11030553 crossref_primary_10_1002_jmv_27810 crossref_primary_10_4103_sjg_sjg_223_21 crossref_primary_10_1136_bmjinnov_2021_000677 crossref_primary_10_51847_1LBLzTVHfO crossref_primary_10_1007_s11910_022_01247_x crossref_primary_10_1002_mds_28796 crossref_primary_10_1016_S1473_3099_21_00079_7 crossref_primary_10_1038_s41598_023_40172_y crossref_primary_10_3390_ijerph18084240 crossref_primary_10_3390_cancers13143573 crossref_primary_10_1016_j_ejim_2021_11_017 crossref_primary_10_1177_19418744221145054 crossref_primary_10_1016_j_jaut_2021_102663 crossref_primary_10_14348_molcells_2021_0075 crossref_primary_10_1093_ofid_ofac177 crossref_primary_10_1371_journal_pone_0273676 crossref_primary_10_1111_2047_3095_12354 crossref_primary_10_1371_journal_pone_0274526 crossref_primary_10_3390_ijerph181910271 crossref_primary_10_1080_17425255_2023_2280221 crossref_primary_10_1111_jdv_17609 crossref_primary_10_1016_j_vaccine_2021_11_081 crossref_primary_10_1111_hdi_13011 crossref_primary_10_1002_2211_5463_13337 crossref_primary_10_1007_s11239_021_02626_w crossref_primary_10_1016_j_vaccine_2021_11_083 crossref_primary_10_1136_bmj_n2061 crossref_primary_10_1002_jmv_27820 crossref_primary_10_1016_j_jhealeco_2022_102589 crossref_primary_10_1128_spectrum_00224_24 crossref_primary_10_1126_scitranslmed_abd1525 crossref_primary_10_1016_j_virol_2024_110026 crossref_primary_10_3390_vaccines9121489 crossref_primary_10_1080_00223980_2022_2101419 crossref_primary_10_3389_fimmu_2022_809285 crossref_primary_10_1016_j_cell_2021_01_007 crossref_primary_10_1016_j_amsu_2021_102951 crossref_primary_10_1080_19420862_2023_2220150 crossref_primary_10_3390_vaccines10020312 crossref_primary_10_3389_fpubh_2024_1455718 crossref_primary_10_3390_vaccines10020313 crossref_primary_10_3390_pathogens12121408 crossref_primary_10_1093_intimm_dxab061 crossref_primary_10_1111_jcmm_18452 crossref_primary_10_1038_s41467_021_23173_1 crossref_primary_10_3389_fimmu_2023_1166059 crossref_primary_10_1097_HCO_0000000000000846 crossref_primary_10_1136_bcr_2021_246841 crossref_primary_10_1016_j_ebiom_2023_104475 crossref_primary_10_1097_MBC_0000000000001113 crossref_primary_10_4081_acbr_2022_174 crossref_primary_10_3390_diagnostics11040676 crossref_primary_10_3389_fimmu_2025_1578427 crossref_primary_10_1089_vim_2021_0108 crossref_primary_10_2174_1574893618666230727160507 crossref_primary_10_2147_IDR_S320771 crossref_primary_10_1080_09273948_2021_1957123 crossref_primary_10_3389_fimmu_2023_1257265 crossref_primary_10_1016_j_biopha_2021_111956 crossref_primary_10_1038_s41581_021_00406_6 crossref_primary_10_1016_j_vaccine_2024_126424 crossref_primary_10_3389_fcimb_2021_777212 crossref_primary_10_3390_vaccines9111229 crossref_primary_10_1016_j_dld_2022_09_010 crossref_primary_10_1080_14760584_2021_1988854 crossref_primary_10_1016_j_vaccine_2021_11_061 crossref_primary_10_2217_fmb_2021_0130 crossref_primary_10_1093_abt_tbad024 crossref_primary_10_1016_j_jcv_2022_105191 crossref_primary_10_3389_fimmu_2022_879157 crossref_primary_10_3390_medicina58030441 crossref_primary_10_3390_v14030449 crossref_primary_10_1016_j_chaos_2022_111844 crossref_primary_10_1016_j_msard_2022_104141 crossref_primary_10_1016_S0140_6736_21_02000_6 crossref_primary_10_1515_cclm_2021_0214 crossref_primary_10_1017_S0950268821001205 crossref_primary_10_3390_vaccines10020333 crossref_primary_10_1016_j_ajo_2022_02_011 crossref_primary_10_3389_fimmu_2021_673699 crossref_primary_10_1007_s10198_022_01505_2 crossref_primary_10_1016_j_cmi_2023_04_014 crossref_primary_10_1136_bmjopen_2021_051503 crossref_primary_10_1007_s42770_024_01600_x crossref_primary_10_3390_vaccines10020337 crossref_primary_10_1002_jcph_2120 crossref_primary_10_3390_biomedicines11102813 crossref_primary_10_3390_vaccines10091535 crossref_primary_10_1038_s41467_024_49634_x crossref_primary_10_1097_MD_0000000000028471 crossref_primary_10_1177_20480040231169464 crossref_primary_10_1186_s13613_023_01103_2 crossref_primary_10_1016_j_mjafi_2022_02_001 crossref_primary_10_1111_sji_70000 crossref_primary_10_1111_1348_0421_13043 crossref_primary_10_1038_s44161_022_00029_5 crossref_primary_10_1136_bmj_n2015 crossref_primary_10_1136_bmjopen_2021_057281 crossref_primary_10_3389_fimmu_2022_846248 crossref_primary_10_3389_fimmu_2023_1204314 crossref_primary_10_1007_s10875_022_01382_7 crossref_primary_10_1038_s41598_024_55477_9 crossref_primary_10_1016_S0140_6736_21_00370_6 crossref_primary_10_1136_medethics_2021_107956 crossref_primary_10_3390_vaccines9121449 crossref_primary_10_1016_S2213_2600_21_00158_2 crossref_primary_10_3389_fphar_2023_1118203 crossref_primary_10_1111_imcb_12482 crossref_primary_10_7759_cureus_18291 crossref_primary_10_1016_j_ajog_2021_01_022 crossref_primary_10_1126_scitranslmed_abi5735 crossref_primary_10_3390_vaccines11020377 crossref_primary_10_1093_ecco_jcc_jjab046 crossref_primary_10_3390_bioengineering9110714 crossref_primary_10_1111_jcmm_17186 crossref_primary_10_3390_jcm12041388 crossref_primary_10_1186_s12879_022_07385_4 crossref_primary_10_1016_S0140_6736_21_01817_1 crossref_primary_10_3389_fimmu_2021_808932 crossref_primary_10_1186_s13690_021_00709_x crossref_primary_10_3389_fmed_2021_664179 crossref_primary_10_1016_j_cell_2021_03_055 crossref_primary_10_1080_22221751_2021_1902245 crossref_primary_10_1007_s10096_021_04345_9 crossref_primary_10_1007_s10620_021_07040_z crossref_primary_10_1007_s12020_023_03337_3 crossref_primary_10_1093_eurheartj_ehab592 crossref_primary_10_3390_vaccines11020365 crossref_primary_10_1186_s12874_025_02573_7 crossref_primary_10_1080_15569527_2024_2408683 crossref_primary_10_3390_v13071397 crossref_primary_10_1056_NEJMoa2116747 crossref_primary_10_1007_s11115_022_00679_w crossref_primary_10_1080_09273948_2022_2042325 crossref_primary_10_3390_coatings12111679 crossref_primary_10_3390_ijerph19095372 crossref_primary_10_1080_00207543_2023_2254394 crossref_primary_10_1590_0074_02760240193 crossref_primary_10_3390_jdb9040054 crossref_primary_10_1016_j_intimp_2023_110439 crossref_primary_10_1007_s11739_021_02723_x crossref_primary_10_3389_fpubh_2024_1179268 crossref_primary_10_1136_postgradmedj_2021_140654 crossref_primary_10_1016_j_ebiom_2021_103810 crossref_primary_10_1007_s12275_024_00159_4 crossref_primary_10_1016_S1473_3099_21_00680_0 crossref_primary_10_1097_TP_0000000000004151 crossref_primary_10_3390_v14061127 crossref_primary_10_3390_vaccines10091504 crossref_primary_10_1134_S2079057022040063 crossref_primary_10_1002_jmv_27882 crossref_primary_10_26508_lsa_202101116 crossref_primary_10_1016_j_mayocp_2021_04_012 crossref_primary_10_1002_hep4_1853 crossref_primary_10_1007_s10067_022_06253_5 crossref_primary_10_3390_tropicalmed6030129 crossref_primary_10_1016_S2352_3018_21_00103_X crossref_primary_10_3390_vaccines9121460 crossref_primary_10_1016_j_asoc_2022_108973 crossref_primary_10_3389_fimmu_2022_938378 crossref_primary_10_3390_vaccines9121462 crossref_primary_10_3390_v13061135 crossref_primary_10_58395_dvaah470 crossref_primary_10_1371_journal_pone_0257191 crossref_primary_10_3390_v13030418 crossref_primary_10_2196_35310 crossref_primary_10_1016_j_jiph_2021_12_014 crossref_primary_10_1111_ene_15811 crossref_primary_10_1016_j_vaccine_2022_02_037 crossref_primary_10_1136_heartjnl_2024_324470 crossref_primary_10_1016_j_micinf_2021_104841 crossref_primary_10_3389_fimmu_2022_812393 crossref_primary_10_1093_bib_bbab496 crossref_primary_10_3390_vaccines11020464 crossref_primary_10_3390_vaccines11020467 crossref_primary_10_1016_S1473_3099_21_00813_6 crossref_primary_10_1016_j_rmed_2021_106569 crossref_primary_10_1002_hsr2_1377 crossref_primary_10_1007_s10067_022_06247_3 crossref_primary_10_1080_14760584_2021_1949294 crossref_primary_10_1080_14760584_2021_1949293 crossref_primary_10_1155_2022_4729844 crossref_primary_10_1007_s40273_021_01037_2 crossref_primary_10_1080_21645515_2022_2040239 crossref_primary_10_18311_ajprhc_2021_27078 crossref_primary_10_3748_wjg_v27_i33_5502 crossref_primary_10_1016_j_semerg_2024_102343 crossref_primary_10_1016_j_cell_2022_01_018 crossref_primary_10_3389_fgene_2023_1085864 crossref_primary_10_1200_GO_23_00294 crossref_primary_10_1016_j_cyto_2023_156350 crossref_primary_10_1016_j_jiph_2021_12_002 crossref_primary_10_3390_vaccines9080907 crossref_primary_10_4103_ijmr_ijmr_1771_21 crossref_primary_10_1016_j_jinf_2021_05_018 crossref_primary_10_1111_imj_15263 crossref_primary_10_3390_vaccines9080910 crossref_primary_10_1016_j_arr_2021_101455 crossref_primary_10_1016_S1473_3099_21_00354_6 crossref_primary_10_1136_bmj_o102 crossref_primary_10_1007_s00277_021_04701_x crossref_primary_10_3390_vaccines12010081 crossref_primary_10_3390_healthcare9121692 crossref_primary_10_1136_bmjgh_2021_004997 crossref_primary_10_3390_vaccines12050541 crossref_primary_10_1038_s41562_021_01155_z crossref_primary_10_1038_s41598_021_86606_3 crossref_primary_10_7759_cureus_28560 crossref_primary_10_3390_life14111350 crossref_primary_10_1016_j_vaccine_2022_02_054 crossref_primary_10_3390_jpm12020259 crossref_primary_10_1002_prp2_1224 crossref_primary_10_7759_cureus_30881 crossref_primary_10_1016_j_cell_2021_06_020 crossref_primary_10_3390_vaccines13030315 crossref_primary_10_3390_vaccines13030312 crossref_primary_10_1016_j_fhj_2024_100023 crossref_primary_10_1016_j_hlpt_2021_100574 crossref_primary_10_3390_vaccines11020442 crossref_primary_10_1172_JCI149412 crossref_primary_10_1016_j_heliyon_2023_e23246 crossref_primary_10_1155_2022_2449068 crossref_primary_10_3390_ijms24108746 crossref_primary_10_3390_vaccines12050554 crossref_primary_10_1136_bmjopen_2021_055565 crossref_primary_10_1007_s00761_021_00972_1 crossref_primary_10_1186_s12889_021_10987_3 crossref_primary_10_2147_JIR_S306849 crossref_primary_10_11124_JBIES_20_00516 crossref_primary_10_1016_j_ijid_2021_01_035 crossref_primary_10_1007_s12035_021_02399_6 crossref_primary_10_1007_s00595_023_02649_1 crossref_primary_10_1007_s00430_022_00729_6 crossref_primary_10_1080_17476348_2022_2027758 crossref_primary_10_7759_cureus_21919 crossref_primary_10_3390_neurolint13030030 crossref_primary_10_3390_pr9081430 crossref_primary_10_3748_wjg_v29_i3_425 crossref_primary_10_1080_07853890_2022_2031274 crossref_primary_10_3390_vaccines11020432 crossref_primary_10_1038_s41598_025_92742_x crossref_primary_10_3389_fimmu_2022_945930 crossref_primary_10_1007_s10067_022_06149_4 crossref_primary_10_3390_vaccines10081189 crossref_primary_10_1016_j_jbc_2022_102624 crossref_primary_10_1016_j_biopha_2022_114208 crossref_primary_10_3390_ijerph18137004 crossref_primary_10_1016_j_cmi_2022_03_003 crossref_primary_10_3389_fmicb_2021_720437 crossref_primary_10_3390_jcm13185462 crossref_primary_10_3390_vaccines10081184 crossref_primary_10_3389_fmed_2022_809154 crossref_primary_10_3389_fphar_2022_900610 crossref_primary_10_1016_S0140_6736_21_00384_6 crossref_primary_10_1038_s41598_022_12591_w crossref_primary_10_1155_2022_6289211 crossref_primary_10_2147_IDR_S335745 crossref_primary_10_1016_j_vaccine_2022_02_063 crossref_primary_10_1097_GRF_0000000000000670 crossref_primary_10_1002_pst_2217 crossref_primary_10_1136_bmjopen_2021_048856 crossref_primary_10_1007_s40588_021_00172_w crossref_primary_10_1177_1934578X231188861 crossref_primary_10_1057_s41599_023_01593_2 crossref_primary_10_3390_vaccines11020429 crossref_primary_10_1097_RHU_0000000000001871 crossref_primary_10_1056_NEJMoa2107659 crossref_primary_10_3390_polym14163263 crossref_primary_10_1371_journal_pbio_3001211 crossref_primary_10_3390_vaccines9080939 crossref_primary_10_1038_s41586_021_03530_2 crossref_primary_10_3390_cancers13184621 crossref_primary_10_1016_j_idnow_2021_03_001 crossref_primary_10_1182_blood_2021012251 crossref_primary_10_3390_pharmaceutics13101585 crossref_primary_10_1007_s11356_021_16427_4 crossref_primary_10_3390_ijerph19053111 crossref_primary_10_1371_journal_pone_0255382 crossref_primary_10_1038_s41598_023_41051_2 crossref_primary_10_1152_japplphysiol_00420_2021 crossref_primary_10_1038_s41598_022_05325_5 crossref_primary_10_1111_sji_13345 crossref_primary_10_1016_j_heliyon_2023_e15211 crossref_primary_10_7759_cureus_33962 crossref_primary_10_3390_vaccines11101522 crossref_primary_10_3389_fimmu_2022_843928 crossref_primary_10_1038_s41582_024_01000_7 crossref_primary_10_1007_s10309_021_00404_5 crossref_primary_10_1016_j_micinf_2021_104811 crossref_primary_10_3390_ijerph18147260 crossref_primary_10_1093_cid_ciac080 crossref_primary_10_3389_fpubh_2024_1338208 crossref_primary_10_7189_jogh_14_05026 crossref_primary_10_1016_j_jmaa_2021_125975 crossref_primary_10_2478_fzm_2023_0019 crossref_primary_10_1093_cei_uxad013 crossref_primary_10_1111_ijcp_14714 crossref_primary_10_3390_vaccines10030414 crossref_primary_10_1007_s00115_021_01154_5 crossref_primary_10_1016_j_cegh_2022_101001 crossref_primary_10_1111_jog_14748 crossref_primary_10_25259_IJMR_923_2024 crossref_primary_10_3390_v16020203 crossref_primary_10_1371_journal_pone_0260733 crossref_primary_10_4103_ijmr_ijmr_2544_21 crossref_primary_10_1016_j_jcte_2021_100285 crossref_primary_10_1093_femsre_fuac042 crossref_primary_10_3390_ijerph182312695 crossref_primary_10_1126_scitranslmed_abj7211 crossref_primary_10_3390_vaccines11101533 crossref_primary_10_1038_s41591_021_01449_9 crossref_primary_10_1016_j_therap_2023_01_005 crossref_primary_10_1056_NEJMoa2116597 crossref_primary_10_3390_v16030479 crossref_primary_10_1038_s41467_021_23938_8 crossref_primary_10_3390_vaccines10111920 crossref_primary_10_3390_vaccines9080918 crossref_primary_10_1136_bmj_2021_069741 crossref_primary_10_3390_vaccines9080926 crossref_primary_10_5114_aoms_2019_88320 crossref_primary_10_1002_anie_202109965 crossref_primary_10_3389_fpubh_2022_1002910 crossref_primary_10_3390_vaccines9030223 crossref_primary_10_1177_11207000231151617 crossref_primary_10_3389_fneur_2022_1018785 crossref_primary_10_3390_vaccines9030227 crossref_primary_10_1038_s41578_021_00399_5 crossref_primary_10_1016_j_chom_2021_08_002 crossref_primary_10_1080_0035919X_2021_2011801 crossref_primary_10_3390_vaccines9121502 crossref_primary_10_1016_j_jvir_2021_10_010 crossref_primary_10_1016_j_ebiom_2021_103410 crossref_primary_10_1016_j_bios_2022_114079 crossref_primary_10_1016_j_vaccine_2022_04_090 crossref_primary_10_1016_j_ebiom_2021_103414 crossref_primary_10_1093_eurheartj_ehae335 crossref_primary_10_2217_fon_2022_0148 crossref_primary_10_1371_journal_pone_0272729 crossref_primary_10_2147_IJGM_S324349 crossref_primary_10_3390_tropicalmed8030175 crossref_primary_10_2147_PPA_S334757 crossref_primary_10_3389_fimmu_2022_966416 crossref_primary_10_3390_vaccines9080927 crossref_primary_10_1128_JCM_01788_21 crossref_primary_10_4014_jmb_2111_11026 crossref_primary_10_1136_bmj_2021_067570 crossref_primary_10_36660_ijcs_20210270 crossref_primary_10_3390_vaccines10030434 crossref_primary_10_1016_j_intimp_2021_107763 crossref_primary_10_3390_vaccines10030437 crossref_primary_10_1097_RLU_0000000000004041 crossref_primary_10_3390_vaccines9030238 crossref_primary_10_3390_cancers14061544 crossref_primary_10_1038_s41467_022_32321_0 crossref_primary_10_1080_07853890_2023_2265298 crossref_primary_10_3390_vaccines9030241 crossref_primary_10_1111_bju_15339 crossref_primary_10_1212_WNL_0000000000200996 crossref_primary_10_12968_bjon_2021_30_6_344 crossref_primary_10_3390_vaccines9030243 crossref_primary_10_3390_epidemiologia2040036 crossref_primary_10_1016_j_cmi_2022_05_018 crossref_primary_10_1038_s41551_025_01517_2 crossref_primary_10_3390_vaccines12121419 crossref_primary_10_3390_vaccines9101086 crossref_primary_10_3390_vaccines9101082 crossref_primary_10_3390_vaccines9101083 crossref_primary_10_3390_vaccines9070701 crossref_primary_10_1111_jep_13655 crossref_primary_10_3390_vaccines9030248 crossref_primary_10_1186_s40779_021_00360_1 crossref_primary_10_1007_s40664_021_00448_4 crossref_primary_10_3390_pharmaceutics13111759 crossref_primary_10_3390_vaccines10101748 crossref_primary_10_1038_s43587_022_00328_3 crossref_primary_10_4103_ijo_IJO_66_22 crossref_primary_10_1056_NEJMoa2116185 crossref_primary_10_1371_journal_pone_0265159 crossref_primary_10_1016_j_vaccine_2021_05_017 crossref_primary_10_1038_s43856_022_00207_3 crossref_primary_10_1038_s41564_022_01143_7 crossref_primary_10_1080_21645515_2024_2370605 crossref_primary_10_1016_j_jinf_2021_03_025 crossref_primary_10_1208_s12249_024_02778_x crossref_primary_10_3390_vaccines9101096 crossref_primary_10_1016_j_jviromet_2023_114835 crossref_primary_10_3390_ijms23116083 crossref_primary_10_1016_S1473_3099_21_00127_4 crossref_primary_10_1007_s11904_021_00588_5 crossref_primary_10_1002_ejhf_2356 crossref_primary_10_1016_j_jceh_2021_06_013 crossref_primary_10_3390_genes13111941 crossref_primary_10_3389_fpubh_2025_1461436 crossref_primary_10_1016_j_jiph_2023_06_014 crossref_primary_10_2196_28169 crossref_primary_10_1017_S0950268822001078 crossref_primary_10_1002_jmv_27260 crossref_primary_10_3390_vaccines12091018 crossref_primary_10_3390_vaccines9070718 crossref_primary_10_1007_s00296_021_04917_0 crossref_primary_10_1038_s41541_023_00630_0 crossref_primary_10_1038_s41598_025_07895_6 crossref_primary_10_1080_14760584_2022_2092472 crossref_primary_10_1136_bmjopen_2023_072627 crossref_primary_10_1111_dth_14765 crossref_primary_10_1097_TXD_0000000000001171 crossref_primary_10_1016_j_clim_2025_110523 crossref_primary_10_1007_s40264_021_01131_6 crossref_primary_10_1093_cei_uxac113 crossref_primary_10_26508_lsa_202201381 crossref_primary_10_3390_vaccines10040602 crossref_primary_10_12998_wjcc_v10_i33_12268 crossref_primary_10_1002_jmv_27279 crossref_primary_10_1186_s12916_023_03064_6 crossref_primary_10_1016_j_jddst_2022_103762 crossref_primary_10_3389_fcimb_2021_729622 crossref_primary_10_1038_s41467_022_34668_w crossref_primary_10_1002_ccr3_4883 crossref_primary_10_1038_s41541_023_00665_3 crossref_primary_10_1016_j_ab_2023_115079 crossref_primary_10_1016_j_vaccine_2025_127257 crossref_primary_10_1108_AGJSR_04_2023_0144 crossref_primary_10_3390_jcm11226855 crossref_primary_10_3390_vaccines10101751 crossref_primary_10_1136_bmjopen_2023_071789 crossref_primary_10_2196_30010 crossref_primary_10_1016_S0140_6736_21_01854_7 crossref_primary_10_1016_j_dsx_2021_05_024 crossref_primary_10_1016_j_vaccine_2021_09_055 crossref_primary_10_1093_qjmed_hcae139 crossref_primary_10_1177_01410768231216332 crossref_primary_10_1089_vim_2023_0001 crossref_primary_10_1136_bmj_o522 crossref_primary_10_3389_fcvm_2022_967926 crossref_primary_10_1038_s43018_022_00502_x crossref_primary_10_3389_fmed_2023_1155727 crossref_primary_10_1007_s10875_023_01527_2 crossref_primary_10_1038_s41467_021_24579_7 crossref_primary_10_1089_whr_2024_0202 crossref_primary_10_1007_s00415_021_10648_w crossref_primary_10_1007_s00262_021_03133_w crossref_primary_10_3389_fpubh_2024_1402527 crossref_primary_10_1111_ane_13550 crossref_primary_10_3389_fimmu_2021_631139 crossref_primary_10_1016_j_vaccine_2021_09_060 crossref_primary_10_22207_JPAM_17_2_21 crossref_primary_10_1007_s11938_022_00370_5 crossref_primary_10_3390_vaccines11111710 crossref_primary_10_1007_s10072_022_05898_z crossref_primary_10_1016_j_ymthe_2021_10_008 crossref_primary_10_2196_35754 crossref_primary_10_3390_v15112181 crossref_primary_10_1016_j_chom_2021_06_016 crossref_primary_10_1007_s12033_023_00749_4 crossref_primary_10_1002_ajh_26209 crossref_primary_10_3390_vaccines10040623 crossref_primary_10_1136_bmj_2023_070464 crossref_primary_10_3390_vaccines9030289 crossref_primary_10_1016_S1470_2045_22_00505_8 crossref_primary_10_1186_s40035_024_00458_1 crossref_primary_10_1631_jzus_B2200054 crossref_primary_10_1016_j_vaccine_2021_07_045 crossref_primary_10_1002_jcph_1822 crossref_primary_10_1016_j_vaccine_2022_02_087 crossref_primary_10_1016_j_jtho_2021_10_015 crossref_primary_10_1038_s41467_022_29301_9 crossref_primary_10_2147_IDR_S409200 crossref_primary_10_3390_vaccines9030299 crossref_primary_10_1038_s41467_022_29225_4 crossref_primary_10_1080_17512433_2022_2120466 crossref_primary_10_1038_s41541_022_00592_9 crossref_primary_10_1016_j_dsx_2021_05_003 crossref_primary_10_3390_vaccines10040608 crossref_primary_10_3390_vaccines9101052 crossref_primary_10_1371_journal_ppat_1010807 crossref_primary_10_1186_s12961_022_00883_6 crossref_primary_10_1007_s11357_023_00931_1 crossref_primary_10_1093_ofid_ofac408 crossref_primary_10_1093_qjmed_hcab046 crossref_primary_10_1111_dom_14643 crossref_primary_10_1080_07391102_2023_2193981 crossref_primary_10_1016_j_isci_2024_110728 crossref_primary_10_3390_vaccines12091057 crossref_primary_10_1590_0102_311xes155023 crossref_primary_10_3389_fpubh_2023_1245464 crossref_primary_10_1038_s41598_024_67967_x crossref_primary_10_1136_bmj_n1868 crossref_primary_10_3390_vaccines13060564 crossref_primary_10_1007_s40119_021_00248_0 crossref_primary_10_1016_j_cmi_2021_06_043 crossref_primary_10_1093_qjmed_hcae103 crossref_primary_10_3390_jcm12247578 crossref_primary_10_5694_mja2_51263 crossref_primary_10_4103_jpgm_jpgm_1047_21 crossref_primary_10_1016_S0140_6736_21_00870_9 crossref_primary_10_1177_10732748221106266 crossref_primary_10_1016_j_addr_2021_114002 crossref_primary_10_1016_j_jiph_2021_10_021 crossref_primary_10_3390_v13050935 crossref_primary_10_1007_s40267_024_01124_2 crossref_primary_10_1007_s00253_023_12545_w crossref_primary_10_1007_s13555_021_00610_z crossref_primary_10_1016_S2665_9913_22_00228_4 crossref_primary_10_1016_j_ijid_2021_10_030 crossref_primary_10_1016_j_ijid_2021_10_032 crossref_primary_10_1038_s41440_022_01134_5 crossref_primary_10_1038_s41467_022_35168_7 crossref_primary_10_3389_fimmu_2022_807454 crossref_primary_10_1038_s41541_024_00907_y crossref_primary_10_2147_CCID_S416460 crossref_primary_10_3390_microorganisms9030556 crossref_primary_10_1007_s00284_023_03603_7 crossref_primary_10_1136_rmdopen_2022_002839 crossref_primary_10_3390_vaccines11071225 crossref_primary_10_1515_znc_2022_0092 crossref_primary_10_3390_v15020397 crossref_primary_10_1016_j_jtbi_2024_111959 crossref_primary_10_1111_imj_15247 crossref_primary_10_4103_cmrp_cmrp_11_21 crossref_primary_10_1038_s41598_024_52748_3 crossref_primary_10_3390_jcm10235499 crossref_primary_10_3390_neurolint14020033 crossref_primary_10_1093_qjmed_hcab069 crossref_primary_10_1016_j_chom_2021_06_009 crossref_primary_10_1126_scitranslmed_abn6868 crossref_primary_10_3390_cancers14153746 crossref_primary_10_1126_sciimmunol_abj3684 crossref_primary_10_3390_ijerph18137042 crossref_primary_10_1007_s11684_021_0893_y crossref_primary_10_3389_fimmu_2022_910383 crossref_primary_10_7326_M21_0111 crossref_primary_10_1016_j_genrep_2021_101417 crossref_primary_10_1080_17843286_2021_1909447 crossref_primary_10_1371_journal_pone_0316893 crossref_primary_10_1128_jvi_01912_23 crossref_primary_10_1016_j_jvacx_2025_100698 crossref_primary_10_1186_s40249_022_00977_x crossref_primary_10_1126_scitranslmed_ade3901 crossref_primary_10_1038_s41408_022_00776_5 crossref_primary_10_3389_fcvm_2021_645172 crossref_primary_10_1016_j_cct_2022_106700 crossref_primary_10_1016_j_metabol_2023_155412 crossref_primary_10_1038_s41591_022_01736_z crossref_primary_10_1016_j_dsx_2022_102424 crossref_primary_10_3390_vaccines9070781 crossref_primary_10_1002_bies_202100087 crossref_primary_10_1016_j_jiph_2022_02_005 crossref_primary_10_3390_v15020326 crossref_primary_10_1080_21645515_2025_2526231 crossref_primary_10_1007_s12035_023_03788_9 crossref_primary_10_1093_infdis_jiad163 crossref_primary_10_1186_s43045_021_00126_4 crossref_primary_10_1016_j_vaccine_2021_03_004 crossref_primary_10_3390_cancers13153883 crossref_primary_10_1093_cid_ciab239 crossref_primary_10_3390_vaccines10020252 crossref_primary_10_1038_s41591_021_01454_y crossref_primary_10_3390_vaccines9101124 crossref_primary_10_1038_s41467_024_47463_6 crossref_primary_10_1093_cid_ciab234 crossref_primary_10_3390_vaccines10101692 crossref_primary_10_1097_TP_0000000000004059 crossref_primary_10_3390_vaccines10020265 crossref_primary_10_3390_vaccines10101693 crossref_primary_10_1016_j_jaip_2020_12_047 crossref_primary_10_1016_j_vaccine_2021_05_098 crossref_primary_10_3390_v15020330 crossref_primary_10_1016_j_vaccine_2024_126167 crossref_primary_10_1002_jmv_27783 crossref_primary_10_1056_NEJMoa2110475 crossref_primary_10_1016_j_ijregi_2022_03_022 crossref_primary_10_1016_j_puhe_2022_03_004 crossref_primary_10_1016_j_scitotenv_2021_148949 crossref_primary_10_1080_22221751_2021_1885998 crossref_primary_10_1177_1721727X231211458 crossref_primary_10_1002_jmv_27782 crossref_primary_10_1016_j_jbspin_2022_105380 crossref_primary_10_3390_ijms232315003 crossref_primary_10_1186_s13690_021_00741_x crossref_primary_10_1002_cti2_1260 crossref_primary_10_1038_s41541_024_00844_w crossref_primary_10_1017_S0950268822001595 crossref_primary_10_3201_eid2803_212210 crossref_primary_10_1093_cid_ciab229 crossref_primary_10_3390_vaccines10020260 crossref_primary_10_12968_jpar_2021_13_2_56 crossref_primary_10_1136_bmjmed_2021_000040 crossref_primary_10_1016_S2665_9913_22_00130_8 crossref_primary_10_1093_cid_ciab226 crossref_primary_10_1016_j_vaccine_2021_05_069 crossref_primary_10_1016_j_epidem_2021_100506 crossref_primary_10_3389_fimmu_2021_809244 crossref_primary_10_3390_vaccines10020279 crossref_primary_10_3390_ijerph19116445 crossref_primary_10_1007_s00467_022_05835_4 crossref_primary_10_1111_1753_6405_13300 crossref_primary_10_1186_s12882_022_02940_2 crossref_primary_10_1371_journal_pone_0278878 crossref_primary_10_3389_fonc_2022_879876 crossref_primary_10_1016_j_lfs_2021_119251 crossref_primary_10_1038_s41577_021_00522_1 crossref_primary_10_1007_s13337_024_00894_7 crossref_primary_10_1371_journal_pmed_1003823 crossref_primary_10_3390_vaccines9101148 crossref_primary_10_3389_fimmu_2021_653786 crossref_primary_10_7759_cureus_33108 crossref_primary_10_1016_j_intimp_2023_109784 crossref_primary_10_1093_cid_ciab213 crossref_primary_10_1186_s40249_021_00924_2 crossref_primary_10_3390_life14081027 crossref_primary_10_3390_vaccines10070984 crossref_primary_10_1111_jdv_17542 crossref_primary_10_3390_vaccines10070985 crossref_primary_10_3390_vaccines10070986 crossref_primary_10_1136_bmjopen_2021_050303 crossref_primary_10_3390_vaccines11071147 crossref_primary_10_1016_j_csbj_2021_03_021 crossref_primary_10_1371_journal_pone_0290974 crossref_primary_10_3390_vaccines10091427 crossref_primary_10_1017_S0950268824000219 crossref_primary_10_3390_molecules26040986 crossref_primary_10_1038_s41390_022_02421_0 crossref_primary_10_26508_lsa_202201415 crossref_primary_10_3389_fcomm_2022_1004139 crossref_primary_10_1146_annurev_pharmtox_121120_012309 crossref_primary_10_3390_vaccines9070770 crossref_primary_10_1136_bcr_2021_243629 crossref_primary_10_1002_jmv_27320 crossref_primary_10_1038_s43856_022_00176_7 crossref_primary_10_1016_j_compbiomed_2021_105098 crossref_primary_10_3389_fpubh_2021_735902 crossref_primary_10_1080_17512433_2021_1900728 crossref_primary_10_3390_vaccines9070779 crossref_primary_10_1186_s12879_024_10345_9 crossref_primary_10_1016_j_msard_2022_104495 crossref_primary_10_1016_j_coviro_2021_04_008 crossref_primary_10_3390_cancers14225512 crossref_primary_10_3389_fpubh_2022_994206 crossref_primary_10_1016_j_msard_2022_104014 crossref_primary_10_1016_j_jiac_2022_08_013 crossref_primary_10_1111_liv_14984 crossref_primary_10_1136_bmjmed_2022_000302 crossref_primary_10_3389_fpubh_2022_893871 crossref_primary_10_3390_vaccines11071172 crossref_primary_10_1097_JCMA_0000000000000682 crossref_primary_10_1111_imj_15636 crossref_primary_10_3389_fimmu_2023_1098461 crossref_primary_10_3389_fphar_2022_849628 crossref_primary_10_3390_v13020332 crossref_primary_10_1111_anae_15442 crossref_primary_10_1007_s00296_021_04792_9 crossref_primary_10_1038_s41577_021_00544_9 crossref_primary_10_1016_j_jinf_2023_06_022 crossref_primary_10_2174_0929867328666210521164809 crossref_primary_10_3389_fonc_2022_1029325 crossref_primary_10_1093_ckj_sfad184 crossref_primary_10_3390_vaccines11030635 crossref_primary_10_1016_j_vaccine_2023_08_020 crossref_primary_10_1038_s41467_022_31495_x crossref_primary_10_1016_j_ebiom_2023_104523 crossref_primary_10_3389_fgene_2021_637362 crossref_primary_10_1093_omcr_omac154 crossref_primary_10_1093_oncolo_oyac032 crossref_primary_10_3389_fonc_2024_1380492 crossref_primary_10_1038_s41568_023_00602_5 crossref_primary_10_1016_j_tim_2021_03_004 crossref_primary_10_1371_journal_ppat_1010092 crossref_primary_10_3390_vaccines9111364 crossref_primary_10_1080_03796205_2024_2355963 crossref_primary_10_1002_jmv_27338 crossref_primary_10_1097_MD_0000000000030609 crossref_primary_10_1080_09273948_2021_1946567 crossref_primary_10_1016_j_jfma_2023_04_017 crossref_primary_10_3390_membranes12060635 crossref_primary_10_1007_s11547_023_01664_z crossref_primary_10_1111_bph_15452 crossref_primary_10_1001_jamanetworkopen_2022_56208 crossref_primary_10_3390_vaccines10010023 crossref_primary_10_3390_vaccines10122137 crossref_primary_10_1186_s12879_025_11254_1 crossref_primary_10_3390_vaccines10101655 crossref_primary_10_1016_j_compbiomed_2022_106264 crossref_primary_10_1016_j_jcv_2022_105292 crossref_primary_10_1007_s11468_022_01754_0 crossref_primary_10_1371_journal_pcbi_1010724 crossref_primary_10_1016_j_vaccine_2023_08_034 crossref_primary_10_3389_fbioe_2022_1052436 crossref_primary_10_1016_j_ebiom_2022_104264 crossref_primary_10_1080_10408363_2021_1979462 crossref_primary_10_1016_j_accpm_2021_100848 crossref_primary_10_3390_vaccines10091474 crossref_primary_10_3390_vaccines9101108 crossref_primary_10_1056_NEJMoa2201300 crossref_primary_10_1016_j_intimp_2021_108280 crossref_primary_10_1093_ectj_utae005 crossref_primary_10_3390_cancers14225537 crossref_primary_10_3390_vaccines9060559 crossref_primary_10_2174_0929867328666210902094254 crossref_primary_10_3389_fimmu_2022_992370 crossref_primary_10_3390_bios13030371 crossref_primary_10_1016_j_bmcl_2023_129530 crossref_primary_10_1111_ene_16321 crossref_primary_10_1016_j_matcom_2025_09_010 crossref_primary_10_1089_derm_2022_29019_pwu crossref_primary_10_1097_ID9_0000000000000073 crossref_primary_10_1080_17474086_2024_2436973 crossref_primary_10_1186_s40001_023_00992_0 crossref_primary_10_3390_vaccines10010037 crossref_primary_10_1186_s12865_024_00625_z crossref_primary_10_1016_j_jneuroim_2021_577686 crossref_primary_10_1007_s00018_021_04096_y crossref_primary_10_1016_j_lansea_2022_100121 crossref_primary_10_3390_vaccines9101106 crossref_primary_10_1038_s41467_022_34669_9 crossref_primary_10_1038_s41541_022_00436_6 crossref_primary_10_3390_vaccines11030655 crossref_primary_10_3390_vaccines9101101 crossref_primary_10_1126_science_abj7364 crossref_primary_10_1016_j_vaccine_2024_126582 crossref_primary_10_1016_j_jneuroim_2021_577691 crossref_primary_10_1038_s41598_022_18750_3 crossref_primary_10_1371_journal_pone_0299747 crossref_primary_10_1038_s41598_022_12543_4 crossref_primary_10_1002_advs_202201294 crossref_primary_10_1007_s10238_023_01005_4 crossref_primary_10_3389_fimmu_2023_1211388 crossref_primary_10_1038_s41467_022_28738_2 crossref_primary_10_3389_fimmu_2025_1535014 crossref_primary_10_3390_microorganisms9030605 crossref_primary_10_3390_vaccines10122117 crossref_primary_10_1002_mco2_238 crossref_primary_10_1080_14760584_2022_2116008 crossref_primary_10_1093_infdis_jiad195 crossref_primary_10_1111_tid_13696 crossref_primary_10_1136_bmj_n2320 crossref_primary_10_1016_j_cell_2021_11_026 crossref_primary_10_1016_j_ijregi_2021_10_013 crossref_primary_10_3390_v16091481 crossref_primary_10_4103_ijmr_ijmr_3330_21 crossref_primary_10_3390_vaccines9060572 crossref_primary_10_7759_cureus_32688 crossref_primary_10_3390_vaccines9060577 crossref_primary_10_1371_journal_ppat_1012246 crossref_primary_10_1038_s41591_022_01780_9 crossref_primary_10_1093_ije_dyac199 crossref_primary_10_4103_ijcm_ijcm_671_21 crossref_primary_10_1111_bjh_18894 crossref_primary_10_1016_S2468_1253_21_00024_8 crossref_primary_10_1080_22221751_2022_2088406 crossref_primary_10_1016_j_ejca_2021_02_003 crossref_primary_10_3390_vaccines10030465 crossref_primary_10_1016_j_jinf_2021_07_020 crossref_primary_10_1136_bmj_n1087 crossref_primary_10_3390_medicina57090891 crossref_primary_10_1016_j_jbc_2021_101529 crossref_primary_10_1136_bmj_n1088 crossref_primary_10_1136_bcr_2021_242344 crossref_primary_10_2196_28973 crossref_primary_10_1038_s41541_022_00454_4 crossref_primary_10_1016_j_accpm_2021_100866 crossref_primary_10_1016_j_ebiom_2022_104298 crossref_primary_10_3390_biologics1010002 crossref_primary_10_1038_s41598_024_54886_0 crossref_primary_10_1080_22221751_2021_1969291 crossref_primary_10_1093_cid_ciab630 crossref_primary_10_3390_s21103491 crossref_primary_10_17269_s41997_021_00554_z crossref_primary_10_1038_s41467_021_27063_4 crossref_primary_10_1371_journal_pcbi_1008849 crossref_primary_10_3390_vaccines12010009 crossref_primary_10_1111_all_15101 crossref_primary_10_3389_fimmu_2022_1063679 crossref_primary_10_1016_j_diagmicrobio_2024_116643 crossref_primary_10_3389_fimmu_2021_612807 crossref_primary_10_3390_vaccines9111325 crossref_primary_10_3390_vaccines9111322 crossref_primary_10_3389_fcimb_2021_768883 crossref_primary_10_3390_vaccines9111328 crossref_primary_10_1139_cjc_2021_0139 crossref_primary_10_3390_ijms25010215 crossref_primary_10_1002_mco2_615 crossref_primary_10_1097_ID9_0000000000000003 crossref_primary_10_1007_s40472_021_00322_5 crossref_primary_10_1016_j_jgo_2021_03_003 crossref_primary_10_3390_cells10040821 crossref_primary_10_1016_j_idnow_2022_04_007 crossref_primary_10_1016_j_vhri_2022_01_009 crossref_primary_10_1016_S2352_3018_21_00157_0 crossref_primary_10_1111_1346_8138_16799 crossref_primary_10_1371_journal_pone_0296669 crossref_primary_10_3390_vaccines9060596 crossref_primary_10_1016_j_msard_2022_104032 crossref_primary_10_1136_bmjopen_2021_048874 crossref_primary_10_3389_fcvm_2023_1123385 crossref_primary_10_1042_BST20220415 crossref_primary_10_1016_j_jaut_2022_102830 crossref_primary_10_3390_v13020317 crossref_primary_10_7554_eLife_68808 crossref_primary_10_1016_j_jaip_2021_06_006 crossref_primary_10_1177_25166026211053485 crossref_primary_10_1016_j_ijbiomac_2021_08_076 crossref_primary_10_1007_s11739_022_03028_3 crossref_primary_10_1016_j_clineuro_2022_107374 crossref_primary_10_1016_j_vaccine_2022_11_019 crossref_primary_10_3390_vaccines10030480 crossref_primary_10_1089_hum_2021_052 crossref_primary_10_3390_jcm10132920 crossref_primary_10_1016_j_vaccine_2021_03_066 crossref_primary_10_1038_s43856_022_00123_6 crossref_primary_10_1093_oxfimm_iqac005 crossref_primary_10_4049_jimmunol_2001287 crossref_primary_10_1002_iid3_1259 crossref_primary_10_1093_cid_ciab614 crossref_primary_10_1007_s40122_021_00296_3 crossref_primary_10_1016_j_jfma_2021_05_020 crossref_primary_10_1016_j_yebeh_2021_108072 crossref_primary_10_1097_EDE_0000000000001720 crossref_primary_10_3389_fvets_2021_654289 crossref_primary_10_1016_j_jfma_2021_05_022 crossref_primary_10_1007_s42690_024_01379_2 crossref_primary_10_1016_j_mbs_2024_109370 crossref_primary_10_1186_s12879_022_07284_8 crossref_primary_10_1177_25166026211053495 crossref_primary_10_1016_j_vaccine_2024_126542 crossref_primary_10_1007_s40629_021_00178_2 crossref_primary_10_3390_biomedicines11082203 crossref_primary_10_3390_v15061276 crossref_primary_10_1371_journal_pone_0269091 crossref_primary_10_2106_JBJS_CC_21_00090 crossref_primary_10_3389_fpubh_2021_730611 crossref_primary_10_1093_cid_ciab608 crossref_primary_10_1093_ofid_ofab180 crossref_primary_10_1016_j_ebiom_2023_104585 crossref_primary_10_3389_ijph_2025_1607727 crossref_primary_10_1186_s12879_025_10786_w crossref_primary_10_1007_s10157_021_02157_x crossref_primary_10_1038_s41433_022_02341_7 crossref_primary_10_1177_17407745211018613 crossref_primary_10_3389_fimmu_2022_811020 crossref_primary_10_3389_fneur_2022_995875 crossref_primary_10_1038_s41541_021_00292_w crossref_primary_10_1302_0301_620X_103B4_BJJ_2021_0317 crossref_primary_10_3390_ijerph20105863 crossref_primary_10_5501_wjv_v12_i2_100 crossref_primary_10_3390_pathogens14010023 crossref_primary_10_1136_emermed_2021_211796 crossref_primary_10_54101_ACEN_2023_2_7 crossref_primary_10_1016_j_cca_2021_03_007 crossref_primary_10_3389_fpsyt_2021_774504 crossref_primary_10_1080_21645515_2024_2363016 crossref_primary_10_3390_cells10112949 crossref_primary_10_3389_fimmu_2023_1270187 crossref_primary_10_1186_s12879_022_07186_9 crossref_primary_10_3390_jcm13237291 crossref_primary_10_1038_s41577_021_00526_x crossref_primary_10_3390_pharmaceutics14081619 crossref_primary_10_1002_prot_26140 crossref_primary_10_1007_s12010_022_04181_3 crossref_primary_10_1038_s41467_022_31991_0 crossref_primary_10_1038_s41591_021_01410_w crossref_primary_10_2298_MPNS2312344B crossref_primary_10_1016_j_chom_2021_02_002 crossref_primary_10_1186_s12889_023_16419_8 crossref_primary_10_1371_journal_pone_0272664 crossref_primary_10_3390_cells11111843 crossref_primary_10_1002_oby_23251 crossref_primary_10_1038_s41591_021_01334_5 crossref_primary_10_1080_21645515_2021_1895644 crossref_primary_10_1001_jamanetworkopen_2022_38871 crossref_primary_10_1186_s12916_021_02059_5 crossref_primary_10_1016_j_vaccine_2023_06_008 crossref_primary_10_1136_bmj_2022_069989 crossref_primary_10_1093_jcag_gwab033 crossref_primary_10_1097_MPG_0000000000003339 crossref_primary_10_3390_biomedicines9081035 crossref_primary_10_1016_S2352_3026_21_00278_7 crossref_primary_10_1016_j_jneuroim_2021_577632 crossref_primary_10_1093_jleuko_qiad031 crossref_primary_10_1016_j_jfma_2023_06_007 crossref_primary_10_3390_ijerph19031853 crossref_primary_10_1038_s41591_022_02078_6 crossref_primary_10_3389_fimmu_2022_898192 crossref_primary_10_1590_s1679_49742022000100020 crossref_primary_10_1038_s41416_022_01951_y crossref_primary_10_1016_j_ebiom_2025_105847 crossref_primary_10_1038_s41584_022_00755_x crossref_primary_10_3389_fneur_2021_820049 crossref_primary_10_3390_vaccines10122180 crossref_primary_10_3389_fcimb_2024_1345683 crossref_primary_10_1177_03331024221131337 crossref_primary_10_1111_ejh_13722 crossref_primary_10_1016_S1470_2045_22_00202_9 crossref_primary_10_1016_j_canlet_2022_215652 crossref_primary_10_1016_j_chom_2021_02_019 crossref_primary_10_3390_vaccines12020211 crossref_primary_10_1093_inthealth_ihac023 crossref_primary_10_3390_jcm13020334 crossref_primary_10_3390_vaccines12020210 crossref_primary_10_1002_gps_5567 crossref_primary_10_1016_j_jeurea_2022_08_004 crossref_primary_10_1089_thy_2022_0010 crossref_primary_10_1136_bmj_m4777 crossref_primary_10_1016_j_jneuroim_2021_577606 crossref_primary_10_21926_obm_transplant_2501236 crossref_primary_10_1080_14656566_2023_2239154 crossref_primary_10_3390_microorganisms10081666 crossref_primary_10_1016_j_vaccine_2023_06_037 crossref_primary_10_1002_jmv_28602 crossref_primary_10_1136_bmj_2021_068373 crossref_primary_10_1186_s12961_021_00704_2 crossref_primary_10_1016_j_vaccine_2021_03_025 crossref_primary_10_7774_cevr_2022_11_2_173 crossref_primary_10_1038_s43856_025_00941_4 crossref_primary_10_1016_j_jaci_2024_01_025 crossref_primary_10_1093_rap_rkab043 crossref_primary_10_1111_bjh_17508 crossref_primary_10_2147_JMDH_S347669 crossref_primary_10_1089_heq_2022_0068 crossref_primary_10_1016_j_ijbiomac_2024_130754 crossref_primary_10_3390_v13030532 crossref_primary_10_20396_sss_v23i00_8678308 crossref_primary_10_3390_vaccines12111284 crossref_primary_10_3389_fonc_2020_631611 crossref_primary_10_3748_wjg_v28_i48_6791 crossref_primary_10_1016_S2468_2667_21_00167_5 crossref_primary_10_1016_j_ijregi_2023_11_002 crossref_primary_10_4103_1995_7645_338430 crossref_primary_10_3390_biomedicines9111740 crossref_primary_10_3390_vaccines9111307 crossref_primary_10_1016_j_molmed_2022_04_012 crossref_primary_10_1016_S0140_6736_22_00194_5 crossref_primary_10_1177_23779608231172358 crossref_primary_10_3389_fimmu_2023_1167214 crossref_primary_10_3390_metabo11060341 crossref_primary_10_1016_S0140_6736_22_00096_4 crossref_primary_10_3389_fonc_2021_734963 crossref_primary_10_1126_sciimmunol_adr6787 crossref_primary_10_1016_j_intimp_2022_109046 crossref_primary_10_2478_jvetres_2023_0037 crossref_primary_10_3389_fimmu_2022_940357 crossref_primary_10_1007_s11908_021_00752_3 crossref_primary_10_1016_j_cpcardiol_2023_101756 crossref_primary_10_1080_21645515_2022_2101835 crossref_primary_10_1038_s41418_020_00720_9 crossref_primary_10_1155_2021_8160860 crossref_primary_10_1007_s40264_023_01281_9 crossref_primary_10_7759_cureus_41200 crossref_primary_10_1016_j_jbc_2021_101362 crossref_primary_10_5812_ijpr_124228 crossref_primary_10_1016_j_jtbi_2025_112156 crossref_primary_10_1016_j_str_2025_02_009 crossref_primary_10_1016_j_ijid_2021_07_003 crossref_primary_10_1055_a_1423_8961 crossref_primary_10_1007_s40121_021_00547_y crossref_primary_10_7759_cureus_86115 crossref_primary_10_3390_biomedicines9091163 crossref_primary_10_3390_life12122046 crossref_primary_10_1038_s41598_022_17071_9 crossref_primary_10_3389_fimmu_2022_1017232 crossref_primary_10_1038_s41467_022_33985_4 crossref_primary_10_1111_dth_15129 crossref_primary_10_1016_j_ejca_2022_11_030 crossref_primary_10_1016_j_vaccine_2023_04_058 crossref_primary_10_3390_vaccines10111818 crossref_primary_10_1007_s00391_022_02102_x crossref_primary_10_1080_07357907_2022_2112693 crossref_primary_10_1002_rth2_12596 crossref_primary_10_1038_s41541_024_00992_z crossref_primary_10_1016_j_ebiom_2021_103519 crossref_primary_10_1016_j_compbiomed_2022_105814 crossref_primary_10_3389_fpubh_2024_1348170 crossref_primary_10_1016_j_jinf_2023_02_037 crossref_primary_10_1126_science_abe6522 crossref_primary_10_1016_j_csbj_2022_08_009 crossref_primary_10_1001_jama_2021_2828 crossref_primary_10_1016_j_lanwpc_2021_100224 crossref_primary_10_1080_07391102_2022_2075468 crossref_primary_10_3389_fmed_2022_894755 crossref_primary_10_1515_biol_2022_0035 crossref_primary_10_1128_JVI_00117_21 crossref_primary_10_3389_fimmu_2021_748103 crossref_primary_10_3390_medicina57030199 crossref_primary_10_1080_14760584_2021_1987223 crossref_primary_10_1111_ced_14898 crossref_primary_10_3390_v13101911 crossref_primary_10_3389_fimmu_2024_1328905 crossref_primary_10_1136_bmjgh_2021_006854 crossref_primary_10_1016_S0140_6736_21_01699_8 crossref_primary_10_1186_s12916_021_02149_4 crossref_primary_10_1186_s13073_022_01013_1 crossref_primary_10_1038_s41392_022_00904_4 crossref_primary_10_1007_s11030_022_10515_4 crossref_primary_10_1192_bjo_2025_10803 crossref_primary_10_1016_j_ijpharm_2021_121212 crossref_primary_10_1080_13543784_2021_1901883 crossref_primary_10_1016_j_heliyon_2021_e07314 crossref_primary_10_1093_ehjcr_ytad102 crossref_primary_10_1038_s41467_025_59870_4 crossref_primary_10_1183_20734735_0146_2021 crossref_primary_10_1016_j_intimp_2022_108847 crossref_primary_10_1097_QAD_0000000000003579 crossref_primary_10_1016_j_ejmech_2021_113966 crossref_primary_10_1016_j_ijid_2022_03_042 crossref_primary_10_1016_S2213_2600_21_00126_0 crossref_primary_10_1016_j_ijid_2022_03_043 crossref_primary_10_1016_j_vaccine_2023_04_062 crossref_primary_10_1080_14760584_2022_2110073 crossref_primary_10_1084_jem_20202756 crossref_primary_10_1002_mus_27251 crossref_primary_10_3390_pathogens11070800 crossref_primary_10_3390_vaccines10111837 crossref_primary_10_1093_ibd_izac068 crossref_primary_10_1136_bmj_2020_061402 crossref_primary_10_7326_M21_1757 crossref_primary_10_1136_medhum_2021_012156 crossref_primary_10_1016_j_jri_2021_103428 crossref_primary_10_3390_pathogens10081030 crossref_primary_10_1007_s12033_024_01358_5 crossref_primary_10_1016_j_bpobgyn_2021_03_009 crossref_primary_10_1136_bmj_2021_069676 crossref_primary_10_3389_fimmu_2021_772240 crossref_primary_10_3389_fimmu_2022_896310 crossref_primary_10_1016_j_bpobgyn_2021_03_010 crossref_primary_10_3389_fmed_2022_844004 crossref_primary_10_1053_j_gastro_2020_12_066 crossref_primary_10_1016_j_bpobgyn_2021_03_012 crossref_primary_10_1186_s12889_024_18864_5 crossref_primary_10_1016_j_ajpath_2021_10_019 crossref_primary_10_1096_fba_2021_00158 crossref_primary_10_1124_pharmrev_120_000285 crossref_primary_10_3390_vaccines10040550 crossref_primary_10_1016_S0140_6736_21_01642_1 crossref_primary_10_1002_jmv_28097 crossref_primary_10_3390_ijerph18126217 crossref_primary_10_1017_S0950268822000966 crossref_primary_10_4254_wjh_v13_i5_522 crossref_primary_10_1007_s15005_021_2149_4 crossref_primary_10_3389_fpubh_2022_938108 crossref_primary_10_1007_s00393_022_01213_5 crossref_primary_10_3389_fcimb_2021_781429 crossref_primary_10_3390_hematolrep14040050 crossref_primary_10_1016_j_cmi_2023_12_010 crossref_primary_10_3390_ijerph181910081 crossref_primary_10_1136_rmdopen_2022_002301 crossref_primary_10_1093_oxfimm_iqab010 crossref_primary_10_3389_fimmu_2023_1055457 crossref_primary_10_1371_journal_pone_0282871 crossref_primary_10_2500_aap_2021_42_210063 crossref_primary_10_1016_S0140_6736_21_00528_6 crossref_primary_10_1016_S2468_1253_21_00008_X crossref_primary_10_3390_vaccines12050459 crossref_primary_10_3390_microorganisms10010004 crossref_primary_10_1093_oxfimm_iqab018 crossref_primary_10_1016_j_biopha_2021_112282 crossref_primary_10_1186_s12941_021_00438_7 crossref_primary_10_1186_s13027_023_00487_x crossref_primary_10_1126_sciimmunol_abj1750 crossref_primary_10_3389_fimmu_2022_834098 crossref_primary_10_1186_s12879_024_10250_1 crossref_primary_10_2147_IJN_S334298 crossref_primary_10_1016_j_vaccine_2023_04_012 crossref_primary_10_1080_08830185_2022_2079642 crossref_primary_10_3389_fpubh_2022_914121 crossref_primary_10_1371_journal_pcbi_1011383 crossref_primary_10_1016_j_jamda_2023_05_024 crossref_primary_10_1016_j_jcvp_2025_100222 crossref_primary_10_1146_annurev_vision_100419_111701 crossref_primary_10_1186_s12910_022_00764_1 crossref_primary_10_1200_GO_22_00331 crossref_primary_10_1016_S1473_3099_22_00143_8 crossref_primary_10_3390_biomedicines12030535 crossref_primary_10_3390_vaccines12050466 crossref_primary_10_1007_s15033_021_2716_x crossref_primary_10_1016_j_isci_2022_104457 crossref_primary_10_1016_j_lpm_2022_104131 crossref_primary_10_3390_app12115546 crossref_primary_10_3390_vaccines10040578 crossref_primary_10_1136_bmjopen_2021_056106 crossref_primary_10_1186_s12912_021_00591_6 crossref_primary_10_1007_s11468_023_01867_0 crossref_primary_10_1016_j_ijid_2022_03_034 crossref_primary_10_1016_j_mjafi_2021_04_003 crossref_primary_10_1038_s41467_021_25010_x crossref_primary_10_3390_vaccines10040572 crossref_primary_10_1002_jmv_70408 crossref_primary_10_1097_QCO_0000000000000739 crossref_primary_10_1136_postgradmedj_2021_140947 crossref_primary_10_1038_s41392_021_00481_y crossref_primary_10_1007_s40120_021_00260_5 crossref_primary_10_3390_vaccines10111807 crossref_primary_10_1001_jama_2021_8565 crossref_primary_10_1002_btm2_10258 crossref_primary_10_1093_infdis_jiab447 crossref_primary_10_1136_emermed_2021_211373 crossref_primary_10_3389_fimmu_2024_1501908 crossref_primary_10_4103_ijcm_ijcm_1105_21 crossref_primary_10_3389_fimmu_2023_1157263 crossref_primary_10_7759_cureus_16261 crossref_primary_10_1126_science_abj0299 crossref_primary_10_1098_rsos_231971 crossref_primary_10_1016_j_lanwpc_2022_100534 crossref_primary_10_3390_healthcare10030438 crossref_primary_10_1038_s41467_024_45495_6 crossref_primary_10_1007_s00415_021_10780_7 crossref_primary_10_1111_dom_16071 crossref_primary_10_1016_j_jaip_2021_07_016 crossref_primary_10_1007_s42399_021_00992_3 crossref_primary_10_1039_D2SC00534D crossref_primary_10_3390_vaccines10040591 crossref_primary_10_1007_s11102_023_01364_x crossref_primary_10_1016_j_vaccine_2023_04_033 crossref_primary_10_1016_j_ijid_2021_07_052 crossref_primary_10_1038_s41598_021_01522_w crossref_primary_10_1017_S0950268821002247 crossref_primary_10_3390_ijerph191912532 crossref_primary_10_1016_j_arcmed_2022_03_008 crossref_primary_10_1038_s41577_024_01067_9 crossref_primary_10_3390_jcm12113640 crossref_primary_10_1038_s41598_025_11103_w crossref_primary_10_1080_08830185_2021_1939696 crossref_primary_10_3389_fimmu_2024_1353903 crossref_primary_10_1016_j_jinf_2024_106205 crossref_primary_10_1097_EDE_0000000000001366 crossref_primary_10_1038_s41590_021_01021_0 crossref_primary_10_3390_vaccines12020180 crossref_primary_10_1136_bmjopen_2021_055239 crossref_primary_10_1016_j_chembiol_2024_03_008 crossref_primary_10_1038_s41467_023_43703_3 crossref_primary_10_1007_s00115_021_01155_4 crossref_primary_10_1002_art_42060 crossref_primary_10_4103_0970_258X_323453 crossref_primary_10_1016_j_virusres_2021_198454 crossref_primary_10_1016_j_medj_2021_06_007 crossref_primary_10_1136_bcr_2021_247472 crossref_primary_10_3390_vaccines10050742 crossref_primary_10_1016_j_ejca_2022_01_035 crossref_primary_10_1098_rsos_211021 crossref_primary_10_1016_j_vaccine_2025_127383 crossref_primary_10_3390_vaccines10050740 crossref_primary_10_1016_j_healun_2020_12_009 crossref_primary_10_1016_j_athoracsur_2021_07_016 crossref_primary_10_1002_ygh2_473 crossref_primary_10_1038_s41467_021_26154_6 crossref_primary_10_1016_j_jaip_2022_10_046 crossref_primary_10_1111_bcp_14859 crossref_primary_10_1016_j_ejim_2021_03_016 crossref_primary_10_4103_2773_0344_329027 crossref_primary_10_1016_j_cmi_2021_11_011 crossref_primary_10_1080_14760584_2024_2346589 crossref_primary_10_1016_j_ejim_2021_03_015 crossref_primary_10_1016_j_kint_2021_03_007 crossref_primary_10_1002_jmv_28461 crossref_primary_10_52586_5024 crossref_primary_10_1136_jitc_2021_002392 crossref_primary_10_1590_1806_9282_20210073 crossref_primary_10_1016_j_vaccine_2025_127394 crossref_primary_10_1016_j_vaccine_2022_07_021 crossref_primary_10_1099_jgv_0_001625 crossref_primary_10_1186_s12916_022_02656_y crossref_primary_10_1038_s41467_022_29477_0 crossref_primary_10_1186_s12890_024_03333_x crossref_primary_10_2147_IDR_S362848 crossref_primary_10_1038_s41576_021_00408_x crossref_primary_10_1128_spectrum_01137_22 crossref_primary_10_1080_21642850_2023_2249534 crossref_primary_10_3389_fimmu_2022_876306 crossref_primary_10_1136_bmj_n771 crossref_primary_10_1136_bmjopen_2022_063525 crossref_primary_10_1111_nyas_15080 crossref_primary_10_1080_14760584_2023_2156861 crossref_primary_10_1098_rsos_211016 crossref_primary_10_1177_2050313X221100876 crossref_primary_10_1007_s11673_021_10148_6 crossref_primary_10_1136_bmjopen_2021_051254 crossref_primary_10_1007_s00115_022_01363_6 crossref_primary_10_1186_s12874_021_01404_9 crossref_primary_10_3390_vaccines10101613 crossref_primary_10_4049_jimmunol_2100036 crossref_primary_10_1016_j_dsx_2021_102207 crossref_primary_10_3389_fimmu_2022_989685 crossref_primary_10_1038_s41541_024_00961_6 crossref_primary_10_1371_journal_pcbi_1010042 crossref_primary_10_1590_1806_9282_20210084 crossref_primary_10_1016_j_anpedi_2021_05_019 crossref_primary_10_3390_jcm14051767 crossref_primary_10_2147_IJGM_S328486 crossref_primary_10_1136_rmdopen_2021_001594 crossref_primary_10_7759_cureus_33190 crossref_primary_10_1097_QCO_0000000000000724 crossref_primary_10_3390_biology14010067 crossref_primary_10_1016_j_dsx_2022_102482 crossref_primary_10_1056_NEJMoa2108891 crossref_primary_10_1128_spectrum_02376_22 crossref_primary_10_1177_20420986231165674 crossref_primary_10_1371_journal_pcbi_1012211 crossref_primary_10_1016_j_heliyon_2022_e12594 crossref_primary_10_7759_cureus_16624 crossref_primary_10_1016_j_msard_2024_106253 crossref_primary_10_7759_cureus_18805 crossref_primary_10_1056_NEJMoa2105385 crossref_primary_10_1038_s43856_022_00108_5 crossref_primary_10_1177_00368504211025927 crossref_primary_10_1126_scitranslmed_adn5651 crossref_primary_10_3389_fpsyt_2021_638359 crossref_primary_10_3390_vaccines11101621 crossref_primary_10_1016_S1473_3099_21_00224_3 crossref_primary_10_3390_vaccines9010042 crossref_primary_10_1016_S0140_6736_21_02753_7 crossref_primary_10_1186_s12941_021_00491_2 crossref_primary_10_3390_vaccines11101625 crossref_primary_10_7759_cureus_34030 crossref_primary_10_3389_fimmu_2023_1141794 crossref_primary_10_3389_fpubh_2022_911518 crossref_primary_10_3390_vaccines12060644 crossref_primary_10_1007_s11356_021_16786_y crossref_primary_10_1128_JCM_00527_21 crossref_primary_10_2147_POR_S381836 crossref_primary_10_1016_j_glmedi_2025_100197 crossref_primary_10_1016_j_adoms_2021_100061 crossref_primary_10_3390_vaccines10101639 crossref_primary_10_1111_bcp_14828 crossref_primary_10_1007_s10787_021_00847_2 crossref_primary_10_1080_14760584_2021_1911653 crossref_primary_10_1097_CM9_0000000000001892 crossref_primary_10_7759_cureus_23386 crossref_primary_10_7759_cureus_17942 crossref_primary_10_3390_vaccines10101637 crossref_primary_10_3390_diagnostics11112110 crossref_primary_10_1016_j_ejpn_2022_08_006 crossref_primary_10_1016_j_ajhg_2023_12_005 crossref_primary_10_1016_j_coi_2023_102370 crossref_primary_10_1097_TP_0000000000003835 crossref_primary_10_3389_fimmu_2022_834942 crossref_primary_10_1016_j_molmed_2023_01_003 crossref_primary_10_1016_j_mucimm_2024_06_012 crossref_primary_10_1148_radiol_2021211546 crossref_primary_10_3390_vaccines10111864 crossref_primary_10_1016_j_vaccine_2022_09_067 crossref_primary_10_1128_jvi_00177_22 crossref_primary_10_1155_2022_8999853 crossref_primary_10_1177_20503121221108616 crossref_primary_10_1111_apm_13284 crossref_primary_10_1016_j_biopha_2025_117855 crossref_primary_10_1038_s41591_022_01721_6 crossref_primary_10_12688_wellcomeopenres_16880_1 crossref_primary_10_1016_S0140_6736_21_00234_8 crossref_primary_10_12688_wellcomeopenres_16880_3 crossref_primary_10_12688_wellcomeopenres_16880_2 crossref_primary_10_1016_j_lana_2022_100196 crossref_primary_10_1016_S0140_6736_21_00675_9 crossref_primary_10_1080_09273948_2022_2129694 crossref_primary_10_1210_clinem_dgac049 crossref_primary_10_1186_s13048_021_00772_6 crossref_primary_10_1016_j_heliyon_2023_e16813 crossref_primary_10_3390_v14102284 crossref_primary_10_3389_fcimb_2021_763687 crossref_primary_10_3389_fimmu_2025_1603612 crossref_primary_10_1111_jth_15352 crossref_primary_10_1016_S0140_6736_22_00011_3 crossref_primary_10_1097_QAD_0000000000004053 crossref_primary_10_1016_j_omtm_2021_05_004 crossref_primary_10_2174_0126667975285693240427073251 crossref_primary_10_1016_j_mjafi_2021_06_034 crossref_primary_10_1038_s41467_022_32248_6 crossref_primary_10_1002_bit_27945 crossref_primary_10_1016_j_mjafi_2021_06_032 crossref_primary_10_1123_jpah_2023_0370 crossref_primary_10_1371_journal_pone_0270801 crossref_primary_10_1111_ane_13417 crossref_primary_10_3390_vaccines9101174 crossref_primary_10_1038_s41379_022_01069_9 crossref_primary_10_1038_s42256_022_00470_y crossref_primary_10_1080_1744666X_2024_2346584 crossref_primary_10_1002_cpt_2452 crossref_primary_10_1016_j_worlddev_2024_106762 crossref_primary_10_3390_biomedicines11071812 crossref_primary_10_3389_fmed_2021_817845 crossref_primary_10_1016_S1473_3099_21_00677_0 crossref_primary_10_1016_S1473_3099_23_00134_2 crossref_primary_10_1016_j_ijid_2022_11_006 crossref_primary_10_1016_j_cll_2021_10_005 crossref_primary_10_3390_ijerph19031073 crossref_primary_10_1097_WCO_0000000000000929 crossref_primary_10_3389_fimmu_2025_1487066 crossref_primary_10_1016_j_ejca_2021_08_007 crossref_primary_10_1016_j_eprac_2021_01_013 crossref_primary_10_1109_ACCESS_2021_3112036 crossref_primary_10_1038_s41598_023_34244_2 crossref_primary_10_1055_a_1509_8916 crossref_primary_10_1016_j_ejca_2022_01_019 crossref_primary_10_3390_vaccines12060676 crossref_primary_10_1080_14760584_2023_2227699 crossref_primary_10_1155_2022_9944727 crossref_primary_10_3389_fmed_2022_879120 crossref_primary_10_1016_j_tim_2024_01_005 crossref_primary_10_1177_01926233251326089 crossref_primary_10_1016_j_isci_2021_103699 crossref_primary_10_3390_vaccines10040527 crossref_primary_10_3390_pharmaceutics13101641 crossref_primary_10_3389_fmolb_2021_635337 crossref_primary_10_3390_jcm12175475 crossref_primary_10_1093_qjmed_hcac041 crossref_primary_10_1002_jmv_27196 crossref_primary_10_4103_ijcm_ijcm_71_22 crossref_primary_10_1093_cid_ciac108 crossref_primary_10_3390_ijms231710071 crossref_primary_10_3389_fmed_2022_994160 crossref_primary_10_1016_j_mjafi_2021_06_017 crossref_primary_10_1016_j_jfma_2023_02_011 crossref_primary_10_3390_ph14050406 crossref_primary_10_1371_journal_pone_0248918 crossref_primary_10_1002_med_21941 crossref_primary_10_3390_vaccines10050799 crossref_primary_10_3389_fimmu_2021_697074 crossref_primary_10_1016_S1773_035X_22_00097_1 crossref_primary_10_1097_TP_0000000000003860 crossref_primary_10_1080_21645515_2022_2094149 crossref_primary_10_3390_vaccines10040519 crossref_primary_10_3390_vaccines9101195 crossref_primary_10_3390_vaccines9101196 crossref_primary_10_1177_08971900221097248 crossref_primary_10_3390_vetsci11080353 crossref_primary_10_1016_j_therap_2021_04_003 crossref_primary_10_1111_jth_15347 crossref_primary_10_1016_j_puhe_2021_01_011 crossref_primary_10_3389_ijph_2021_1603975 crossref_primary_10_7759_cureus_24277 crossref_primary_10_4103_jpbs_jpbs_1149_23 crossref_primary_10_3390_vaccines10040511 crossref_primary_10_1016_S0140_6736_23_01181_9 crossref_primary_10_3389_fimmu_2023_1118523 crossref_primary_10_3390_biomedicines10123069 crossref_primary_10_3390_diseases11030105 crossref_primary_10_1128_JCM_01105_21 crossref_primary_10_7554_eLife_80556 crossref_primary_10_3390_cells10123367 crossref_primary_10_1111_dme_15119 crossref_primary_10_3390_vaccines9060618 crossref_primary_10_1002_clt2_12152 crossref_primary_10_1007_s10389_022_01707_1 crossref_primary_10_1177_03331024211038654 crossref_primary_10_1016_j_clim_2021_108850 crossref_primary_10_1038_s41593_022_01242_y crossref_primary_10_1016_j_vaccine_2021_12_046 crossref_primary_10_3390_ijerph191610308 crossref_primary_10_3390_v15020448 crossref_primary_10_1073_pnas_2204336119 crossref_primary_10_1016_j_omtm_2022_06_011 crossref_primary_10_3390_v15051180 crossref_primary_10_7759_cureus_22123 crossref_primary_10_3389_fneur_2023_1097799 crossref_primary_10_1136_gutjnl_2022_327570 crossref_primary_10_1097_ICO_0000000000002844 crossref_primary_10_1111_ajt_16541 crossref_primary_10_1080_14712598_2021_1965985 crossref_primary_10_1093_cid_ciab351 crossref_primary_10_1016_j_medj_2021_12_004 crossref_primary_10_1093_oncolo_oyac196 crossref_primary_10_3390_biomedicines10050940 crossref_primary_10_1016_j_jinf_2022_03_006 crossref_primary_10_3390_vaccines10122056 crossref_primary_10_3390_biom13111565 crossref_primary_10_1038_s43856_021_00038_8 crossref_primary_10_1038_s41598_025_05746_y crossref_primary_10_3389_fpubh_2021_745630 crossref_primary_10_3390_v13122391 crossref_primary_10_1002_jmv_27666 crossref_primary_10_3390_microorganisms11081963 crossref_primary_10_3389_fimmu_2022_812606 crossref_primary_10_3389_fimmu_2023_1166664 crossref_primary_10_1038_s41591_021_01540_1 crossref_primary_10_1080_08820139_2021_1904977 crossref_primary_10_3389_fimmu_2022_822885 crossref_primary_10_1016_j_ebiom_2022_104341 crossref_primary_10_3390_vaccines10020140 crossref_primary_10_1007_s00415_021_10647_x crossref_primary_10_3390_vaccines10020157 crossref_primary_10_1016_j_lana_2025_101031 crossref_primary_10_3390_vaccines9060633 crossref_primary_10_3390_vaccines9060632 crossref_primary_10_1136_bmj_n728 crossref_primary_10_1016_j_ymthe_2021_08_001 crossref_primary_10_3390_ijerph19084842 crossref_primary_10_3390_biomimetics10070439 crossref_primary_10_1016_j_vaccine_2021_12_023 crossref_primary_10_1136_bmjopen_2024_089508 crossref_primary_10_1007_s44229_022_00006_x crossref_primary_10_3390_jpm13060910 crossref_primary_10_1097_CRD_0000000000000457 crossref_primary_10_1016_j_jhep_2022_06_031 crossref_primary_10_3390_healthcare9101292 crossref_primary_10_3390_vaccines10020151 crossref_primary_10_1016_j_totert_2022_100007 crossref_primary_10_1007_s10389_023_02120_y crossref_primary_10_1016_j_clinimag_2021_08_021 crossref_primary_10_3390_vaccines10122033 crossref_primary_10_1038_s41541_021_00362_z crossref_primary_10_1080_10408363_2022_2045250 crossref_primary_10_3390_vaccines9060628 crossref_primary_10_1186_s42269_021_00607_w crossref_primary_10_1007_s10072_021_05761_7 crossref_primary_10_1136_bmj_n710 crossref_primary_10_4103_1995_7645_348158 crossref_primary_10_3390_vaccines10122038 crossref_primary_10_1136_bmj_n2244 crossref_primary_10_1128_JVI_00203_21 crossref_primary_10_1007_s11904_021_00562_1 crossref_primary_10_1002_pds_5419 crossref_primary_10_1016_j_clinpr_2025_100507 crossref_primary_10_3390_biomedicines10050996 crossref_primary_10_3390_vaccines10091373 crossref_primary_10_1016_j_jinf_2021_10_008 crossref_primary_10_1186_s12916_022_02379_0 crossref_primary_10_1080_21645515_2024_2410579 crossref_primary_10_3390_vaccines10122002 crossref_primary_10_1002_bab_2413 crossref_primary_10_3390_jcm10235667 crossref_primary_10_1002_jmv_70073 crossref_primary_10_1093_qjmed_hcab208 crossref_primary_10_1186_s12961_021_00769_z crossref_primary_10_3390_vaccines10091378 crossref_primary_10_3390_v16081331 crossref_primary_10_1038_s41577_021_00567_2 crossref_primary_10_1002_jmv_27210 crossref_primary_10_3390_vaccines12030326 crossref_primary_10_3390_vaccines10122003 crossref_primary_10_1016_j_meegid_2021_105191 crossref_primary_10_1371_journal_pone_0266701 crossref_primary_10_1002_iid3_1353 crossref_primary_10_1097_ICB_0000000000001319 crossref_primary_10_3390_pathogens10020138 crossref_primary_10_1007_s00281_023_00996_2 crossref_primary_10_1016_S0140_6736_21_02754_9 crossref_primary_10_4103_ijo_IJO_1619_22 crossref_primary_10_1186_s40902_021_00330_6 crossref_primary_10_2217_fvl_2021_0277 crossref_primary_10_3390_biology10100960 crossref_primary_10_1080_08923973_2021_1993894 crossref_primary_10_1371_journal_pone_0264541 crossref_primary_10_1016_j_humimm_2022_08_004 crossref_primary_10_3390_vaccines9060649 crossref_primary_10_3390_vaccines10122012 crossref_primary_10_3390_vaccines9060648 crossref_primary_10_1111_1756_185X_14107 crossref_primary_10_1136_bmj_n18 crossref_primary_10_3390_v14071570 crossref_primary_10_1371_journal_pone_0284130 crossref_primary_10_1051_e3sconf_202344006006 crossref_primary_10_1371_journal_pone_0254734 crossref_primary_10_1093_ije_dyad138 crossref_primary_10_3390_v15122378 crossref_primary_10_1111_obr_13313 crossref_primary_10_1111_imcb_12635 crossref_primary_10_2147_JMDH_S331140 crossref_primary_10_5005_jp_journals_10071_24282 crossref_primary_10_1038_s41591_021_01464_w crossref_primary_10_1208_s12248_024_00963_1 crossref_primary_10_3390_bios11030066 crossref_primary_10_3390_vaccines10020182 crossref_primary_10_1016_j_ejim_2021_01_030 crossref_primary_10_3390_biomedicines9080903 crossref_primary_10_1016_j_intimp_2021_108162 crossref_primary_10_3390_vaccines9060674 crossref_primary_10_3390_vaccines9060673 crossref_primary_10_1038_s43856_024_00488_w crossref_primary_10_1080_14760584_2024_2320327 crossref_primary_10_1111_jdv_17476 crossref_primary_10_3390_medicina59030627 crossref_primary_10_3390_molecules27092745 crossref_primary_10_7554_eLife_70330 crossref_primary_10_1111_bjh_18312 crossref_primary_10_4102_sajhivmed_v23i1_1391 crossref_primary_10_1002_psp4_12700 crossref_primary_10_1016_j_micpath_2022_105828 crossref_primary_10_1016_j_jocs_2022_101660 crossref_primary_10_1111_imcb_12645 crossref_primary_10_2147_COPD_S394101 crossref_primary_10_3390_jcm10132844 crossref_primary_10_1002_jmv_29416 crossref_primary_10_1016_j_jamda_2022_08_013 crossref_primary_10_1038_s41598_022_05788_6 crossref_primary_10_1111_1751_7915_13818 crossref_primary_10_3390_diagnostics12061388 crossref_primary_10_1016_j_crmeth_2022_100181 crossref_primary_10_1016_j_identj_2021_01_015 crossref_primary_10_1038_s41467_023_42408_x crossref_primary_10_1128_JVI_02260_20 crossref_primary_10_1097_JCMA_0000000000000774 crossref_primary_10_1212_WNL_0000000000011882 crossref_primary_10_3390_v14122727 crossref_primary_10_3390_vaccines9060666 crossref_primary_10_1186_s40001_023_01456_1 crossref_primary_10_1080_22221751_2022_2056524 crossref_primary_10_1128_spectrum_02981_23 crossref_primary_10_1186_s12879_024_09861_5 crossref_primary_10_12688_wellcomeopenres_19150_1 crossref_primary_10_12688_wellcomeopenres_19150_2 crossref_primary_10_1016_j_jiph_2023_04_008 crossref_primary_10_1038_s41392_021_00796_w crossref_primary_10_1016_j_drudis_2022_08_004 crossref_primary_10_1080_21645515_2025_2546195 crossref_primary_10_1186_s13643_025_02856_6 crossref_primary_10_1017_S0950268822000528 crossref_primary_10_1016_j_jfma_2022_03_006 crossref_primary_10_1177_01945998211064275 crossref_primary_10_1371_journal_pone_0248007 crossref_primary_10_1016_j_nerep_2021_100019 crossref_primary_10_1016_j_nerep_2021_100016 crossref_primary_10_1002_eji_202249823 crossref_primary_10_1038_s41598_022_14155_4 crossref_primary_10_3389_bjbs_2022_10426 crossref_primary_10_4103_njms_njms_454_21 crossref_primary_10_1016_j_vaccine_2022_03_001 crossref_primary_10_1016_j_molmed_2022_10_001 crossref_primary_10_1016_j_vaccine_2022_05_082 crossref_primary_10_4103_injms_injms_87_22 crossref_primary_10_1002_cam4_7032 crossref_primary_10_1371_journal_pmed_1003769 crossref_primary_10_1016_j_jneuroim_2021_577785 crossref_primary_10_1097_CCM_0000000000005591 crossref_primary_10_3390_vaccines10030349 crossref_primary_10_1016_S0140_6736_21_02834_8 crossref_primary_10_1136_bmjopen_2021_059661 crossref_primary_10_1183_23120541_00249_2023 crossref_primary_10_1016_S0140_6736_21_00790_X crossref_primary_10_1016_j_addr_2021_02_004 crossref_primary_10_1016_j_idnow_2021_02_007 crossref_primary_10_1080_15257770_2021_1914851 crossref_primary_10_1016_S0140_6736_23_02467_4 crossref_primary_10_1111_all_15461 crossref_primary_10_1182_bloodadvances_2022009054 crossref_primary_10_1016_j_vaccine_2025_126987 crossref_primary_10_1111_cts_13395 crossref_primary_10_1136_annrheumdis_2021_221244 crossref_primary_10_51894_001c_35628 crossref_primary_10_1161_STROKEAHA_121_035613 crossref_primary_10_1038_s41467_024_45180_8 crossref_primary_10_1186_s12889_021_12386_0 crossref_primary_10_3390_ijms232314670 crossref_primary_10_1021_jacs_1c07965 crossref_primary_10_1038_s41598_021_00065_4 crossref_primary_10_1136_rmdopen_2022_002293 crossref_primary_10_3389_fimmu_2022_892331 crossref_primary_10_3390_pharmaceutics13122090 crossref_primary_10_3390_pharmaceutics13122091 crossref_primary_10_1155_2022_3180004 crossref_primary_10_4103_cmrp_cmrp_6_21 crossref_primary_10_7759_cureus_56310 crossref_primary_10_3389_fpubh_2022_937794 crossref_primary_10_1080_08998280_2023_2165344 crossref_primary_10_1371_journal_ppat_1013432 crossref_primary_10_1016_j_smim_2021_101505 crossref_primary_10_3310_FFSS9010 crossref_primary_10_3390_vaccines12020130 crossref_primary_10_3390_vaccines9050435 crossref_primary_10_1080_21645515_2022_2104059 crossref_primary_10_3390_vaccines13020113 crossref_primary_10_1186_s12916_022_02509_8 crossref_primary_10_3390_vaccines9050431 crossref_primary_10_4103_npmj_npmj_299_22 crossref_primary_10_1038_s43856_022_00090_y crossref_primary_10_1016_j_ymthe_2022_01_024 crossref_primary_10_3390_diagnostics12061349 crossref_primary_10_2217_fvl_2023_0169 crossref_primary_10_1186_s12882_022_02680_3 crossref_primary_10_1016_j_jneuroim_2021_577765 crossref_primary_10_1007_s13596_023_00698_y crossref_primary_10_1371_journal_pone_0274309 crossref_primary_10_1016_j_puhe_2021_07_037 crossref_primary_10_1080_22221751_2022_2097479 crossref_primary_10_1016_j_vacune_2023_07_005 crossref_primary_10_1016_j_virol_2025_110509 crossref_primary_10_1038_s41541_021_00327_2 crossref_primary_10_1007_s11356_021_17642_9 crossref_primary_10_1016_j_jinf_2024_106129 crossref_primary_10_1038_s41541_024_00912_1 crossref_primary_10_3390_vaccines10030350 crossref_primary_10_1016_j_ymthe_2022_01_034 crossref_primary_10_3390_jcm10132813 crossref_primary_10_1002_mus_27657 crossref_primary_10_1080_22221751_2022_2037398 crossref_primary_10_1016_j_eswa_2021_115190 crossref_primary_10_1093_ajcp_aqab107 crossref_primary_10_3390_ijerph18052407 crossref_primary_10_3389_fmolb_2022_797132 crossref_primary_10_1038_s41598_021_98216_0 crossref_primary_10_1016_j_vacune_2024_02_013 crossref_primary_10_1371_journal_pone_0296521 crossref_primary_10_1017_S0950268821002776 crossref_primary_10_3390_vaccines12101168 crossref_primary_10_1038_s41590_023_01513_1 crossref_primary_10_3390_ijerph20064796 crossref_primary_10_3389_fmicb_2022_816778 crossref_primary_10_1371_journal_pone_0273402 crossref_primary_10_1007_s43440_022_00424_6 crossref_primary_10_1016_j_cell_2021_02_030 crossref_primary_10_1016_j_jinf_2025_106423 crossref_primary_10_1038_s41598_022_20118_6 crossref_primary_10_1038_s41541_022_00566_x crossref_primary_10_1007_s00467_021_05330_2 crossref_primary_10_1111_jocd_14521 crossref_primary_10_3390_ctn6020011 crossref_primary_10_3390_molecules26113213 crossref_primary_10_1016_j_cell_2021_02_033 crossref_primary_10_1016_j_jiac_2022_12_007 crossref_primary_10_1128_spectrum_02676_23 crossref_primary_10_1016_j_cell_2021_02_037 crossref_primary_10_1007_s00203_021_02606_x crossref_primary_10_1016_j_vaccine_2021_10_079 crossref_primary_10_1093_cid_ciab714 crossref_primary_10_1136_bmjph_2024_002331 crossref_primary_10_3390_v14112541 crossref_primary_10_3389_fimmu_2022_882972 crossref_primary_10_1097_JCMA_0000000000000712 crossref_primary_10_1016_j_envres_2021_112342 crossref_primary_10_1128_aem_01036_24 crossref_primary_10_1038_s41541_022_00531_8 crossref_primary_10_3349_ymj_2024_0129 crossref_primary_10_3390_vaccines10030373 crossref_primary_10_3390_vaccines10030374 crossref_primary_10_1001_jamanetworkopen_2021_30800 crossref_primary_10_1002_mco2_539 crossref_primary_10_1016_j_arr_2021_101494 crossref_primary_10_1097_CND_0000000000000383 crossref_primary_10_1186_s40794_022_00183_5 crossref_primary_10_1016_S0140_6736_21_00502_X crossref_primary_10_1681_ASN_2021010023 crossref_primary_10_4168_aair_2021_13_4_526 crossref_primary_10_1016_j_jneuroim_2021_577755 crossref_primary_10_1371_journal_pone_0256080 crossref_primary_10_1016_j_vaccine_2021_10_050 crossref_primary_10_1097_ICO_0000000000002898 crossref_primary_10_1111_petr_14031 crossref_primary_10_1128_JVI_00974_21 crossref_primary_10_47102_annals_acadmedsg_2022302 crossref_primary_10_1038_s43018_022_00398_7 crossref_primary_10_1161_STROKEAHA_122_040430 crossref_primary_10_3390_v14030651 crossref_primary_10_3390_vaccines12101149 crossref_primary_10_3390_v15030621 crossref_primary_10_1093_bmb_ldac025 crossref_primary_10_1111_adb_13090 crossref_primary_10_1177_13524585211066771 crossref_primary_10_1186_s13027_021_00406_y crossref_primary_10_1016_j_vaccine_2022_05_067 crossref_primary_10_1093_ofid_ofae144 crossref_primary_10_1016_j_ejca_2021_10_013 crossref_primary_10_3390_diagnostics12071555 crossref_primary_10_3390_vaccines10122065 crossref_primary_10_1007_s11739_023_03231_w crossref_primary_10_1016_S1473_3099_21_00460_6 crossref_primary_10_1080_21645515_2022_2140549 crossref_primary_10_1016_j_jpp_2021_06_001 crossref_primary_10_1111_ajd_13593 crossref_primary_10_3390_vaccines9050479 crossref_primary_10_1038_s41423_023_01095_w crossref_primary_10_4018_JGIM_294578 crossref_primary_10_1080_21645515_2022_2127572 crossref_primary_10_3390_vaccines9050475 crossref_primary_10_1177_00494755241308003 crossref_primary_10_1001_jamainternmed_2023_1921 crossref_primary_10_3389_fmed_2021_770381 crossref_primary_10_1007_s10072_023_06676_1 crossref_primary_10_1016_j_jmii_2023_10_001 crossref_primary_10_1080_21645515_2021_1995283 crossref_primary_10_1016_j_jacc_2025_07_003 crossref_primary_10_1182_bloodadvances_2021004629 crossref_primary_10_1016_j_nrleng_2023_06_002 crossref_primary_10_1016_j_cellsig_2022_110559 crossref_primary_10_1016_j_ejca_2021_10_009 crossref_primary_10_1111_jebm_12492 crossref_primary_10_1016_j_heliyon_2023_e18540 crossref_primary_10_1007_s43615_021_00051_y crossref_primary_10_3389_fneur_2022_845755 crossref_primary_10_1016_S1473_3099_21_00264_4 crossref_primary_10_1371_journal_pone_0250797 crossref_primary_10_1007_s40290_021_00402_y crossref_primary_10_1111_epi_18102 crossref_primary_10_1002_rth2_12572 crossref_primary_10_1158_2159_8290_CD_21_1072 crossref_primary_10_3390_vaccines10122075 crossref_primary_10_1016_j_archger_2021_104487 crossref_primary_10_1016_j_chembiol_2025_07_005 crossref_primary_10_3390_vaccines10122074 crossref_primary_10_1002_jmv_27639 crossref_primary_10_3389_fimmu_2021_701501 crossref_primary_10_3390_vaccines10030393 crossref_primary_10_1177_13524585221109397 crossref_primary_10_3390_vaccines9050467 crossref_primary_10_1177_09622802231176807 crossref_primary_10_1038_s41541_025_01103_2 crossref_primary_10_3389_fimmu_2021_744206 crossref_primary_10_1002_mco2_513 crossref_primary_10_1038_s41541_021_00336_1 crossref_primary_10_1016_j_jaut_2023_103054 crossref_primary_10_3390_healthcare9101245 crossref_primary_10_4103_jpbs_jpbs_1084_23 crossref_primary_10_3390_medicina57030253 crossref_primary_10_1177_23779608231196662 crossref_primary_10_3390_life12091318 |
| Cites_doi | 10.1016/j.eclinm.2020.100630 10.1016/S0140-6736(20)31304-0 10.1016/S1473-3099(20)30483-7 10.1016/S0140-6736(20)30566-3 10.1016/j.amepre.2020.06.011 10.1016/S0140-6736(20)32466-1 10.1016/S0140-6736(20)31604-4 10.1093/aje/kwh090 10.1136/bmj.h1554 10.1007/s00134-020-06267-0 |
| ContentType | Journal Article |
| Contributor | Akhalwaya, Saajida Bormans, Daan Ahmed, Khatija Bates, Louise Bhorat, Asad E Bird, Adam Buchan, Ruaridh Bradley, Penny Adewetan, Gbadebo Barrett, Jessica Barbosa, Marcella A S Allen, Elizabeth R Budd, William Boettger, Bruno C Barnes, Eleanor Berg, Adam Bisnauthsing, Karen Barr, Andrew S Boland, Elena Abayomi, Fatola Burhan, Hassan Batten, Alexander Adamson, James Bexhell, Helen Birch, Sarah Barker, Debbie Andritsou, Foteini Arns, Beatriz Bijker, Else Berzenyi, Daniella Aban, Marites Barlow, Gavin D Bletchly, Heather Adelaja, Yemi A Abeyskera, Kushala Bolam, Emma Baker, Megan Brown, Claire Azi, Lorena Adlou, Syed Appleby, Matthew Bowring, Francesca Adam, Matthew Baleanu, Ioana Bellei, Nancy Ariaans, Mark P Amorim, Fabio Aboagye, Jeremy Baldwin, Lisa Bulbulia, Yusuf A Brown, Phillip Borthwick, Nicola Baker, Philip Anslow, Rachel Bailey, Catherine Bellamy, Duncan Beales, Emily Belij-Rammerstorfer, Sandra Bruce, Scott Allen, Lauren Azi, Paula Alcock, Andrew Berrie, Eleanor Akhalwaya, Yasmeen Alves, Mariana P S Bermejo, Laura Bird, Olivia Boyd, Amy Arruda, |
| Contributor_xml | – sequence: 1 givenname: Marites surname: Aban fullname: Aban, Marites – sequence: 2 givenname: Fatola surname: Abayomi fullname: Abayomi, Fatola – sequence: 3 givenname: Kushala surname: Abeyskera fullname: Abeyskera, Kushala – sequence: 4 givenname: Jeremy surname: Aboagye fullname: Aboagye, Jeremy – sequence: 5 givenname: Matthew surname: Adam fullname: Adam, Matthew – sequence: 6 givenname: Kirsty surname: Adams fullname: Adams, Kirsty – sequence: 7 givenname: James surname: Adamson fullname: Adamson, James – sequence: 8 givenname: Yemi A surname: Adelaja fullname: Adelaja, Yemi A – sequence: 9 givenname: Gbadebo surname: Adewetan fullname: Adewetan, Gbadebo – sequence: 10 givenname: Syed surname: Adlou fullname: Adlou, Syed – sequence: 11 givenname: Khatija surname: Ahmed fullname: Ahmed, Khatija – sequence: 12 givenname: Yasmeen surname: Akhalwaya fullname: Akhalwaya, Yasmeen – sequence: 13 givenname: Saajida surname: Akhalwaya fullname: Akhalwaya, Saajida – sequence: 14 givenname: Andrew surname: Alcock fullname: Alcock, Andrew – sequence: 15 givenname: Aabidah surname: Ali fullname: Ali, Aabidah – sequence: 16 givenname: Elizabeth R surname: Allen fullname: Allen, Elizabeth R – sequence: 17 givenname: Lauren surname: Allen fullname: Allen, Lauren – sequence: 18 givenname: Thamires C D S C surname: Almeida fullname: Almeida, Thamires C D S C – sequence: 19 givenname: Mariana P S surname: Alves fullname: Alves, Mariana P S – sequence: 20 givenname: Fabio surname: Amorim fullname: Amorim, Fabio – sequence: 21 givenname: Foteini surname: Andritsou fullname: Andritsou, Foteini – sequence: 22 givenname: Rachel surname: Anslow fullname: Anslow, Rachel – sequence: 23 givenname: Matthew surname: Appleby fullname: Appleby, Matthew – sequence: 24 givenname: Edward H surname: Arbe-Barnes fullname: Arbe-Barnes, Edward H – sequence: 25 givenname: Mark P surname: Ariaans fullname: Ariaans, Mark P – sequence: 26 givenname: Beatriz surname: Arns fullname: Arns, Beatriz – sequence: 27 givenname: Laiana surname: Arruda fullname: Arruda, Laiana – sequence: 28 givenname: Paula surname: Azi fullname: Azi, Paula – sequence: 29 givenname: Lorena surname: Azi fullname: Azi, Lorena – sequence: 30 givenname: Gavin surname: Babbage fullname: Babbage, Gavin – sequence: 31 givenname: Catherine surname: Bailey fullname: Bailey, Catherine – sequence: 32 givenname: Kenneth F surname: Baker fullname: Baker, Kenneth F – sequence: 33 givenname: Megan surname: Baker fullname: Baker, Megan – sequence: 34 givenname: Natalie surname: Baker fullname: Baker, Natalie – sequence: 35 givenname: Philip surname: Baker fullname: Baker, Philip – sequence: 36 givenname: Lisa surname: Baldwin fullname: Baldwin, Lisa – sequence: 37 givenname: Ioana surname: Baleanu fullname: Baleanu, Ioana – sequence: 38 givenname: Danieli surname: Bandeira fullname: Bandeira, Danieli – sequence: 39 givenname: Anna surname: Bara fullname: Bara, Anna – sequence: 40 givenname: Marcella A S surname: Barbosa fullname: Barbosa, Marcella A S – sequence: 41 givenname: Debbie surname: Barker fullname: Barker, Debbie – sequence: 42 givenname: Gavin D surname: Barlow fullname: Barlow, Gavin D – sequence: 43 givenname: Eleanor surname: Barnes fullname: Barnes, Eleanor – sequence: 44 givenname: Andrew S surname: Barr fullname: Barr, Andrew S – sequence: 45 givenname: Jordan R surname: Barrett fullname: Barrett, Jordan R – sequence: 46 givenname: Jessica surname: Barrett fullname: Barrett, Jessica – sequence: 47 givenname: Louise surname: Bates fullname: Bates, Louise – sequence: 48 givenname: Alexander surname: Batten fullname: Batten, Alexander – sequence: 49 givenname: Kirsten surname: Beadon fullname: Beadon, Kirsten – sequence: 50 givenname: Emily surname: Beales fullname: Beales, Emily – sequence: 51 givenname: Rebecca surname: Beckley fullname: Beckley, Rebecca – sequence: 52 givenname: Sandra surname: Belij-Rammerstorfer fullname: Belij-Rammerstorfer, Sandra – sequence: 53 givenname: Jonathan surname: Bell fullname: Bell, Jonathan – sequence: 54 givenname: Duncan surname: Bellamy fullname: Bellamy, Duncan – sequence: 55 givenname: Nancy surname: Bellei fullname: Bellei, Nancy – sequence: 56 givenname: Sue surname: Belton fullname: Belton, Sue – sequence: 57 givenname: Adam surname: Berg fullname: Berg, Adam – sequence: 58 givenname: Laura surname: Bermejo fullname: Bermejo, Laura – sequence: 59 givenname: Eleanor surname: Berrie fullname: Berrie, Eleanor – sequence: 60 givenname: Lisa surname: Berry fullname: Berry, Lisa – sequence: 61 givenname: Daniella surname: Berzenyi fullname: Berzenyi, Daniella – sequence: 62 givenname: Amy surname: Beveridge fullname: Beveridge, Amy – sequence: 63 givenname: Kevin R surname: Bewley fullname: Bewley, Kevin R – sequence: 64 givenname: Helen surname: Bexhell fullname: Bexhell, Helen – sequence: 65 givenname: Sutika surname: Bhikha fullname: Bhikha, Sutika – sequence: 66 givenname: Asad E surname: Bhorat fullname: Bhorat, Asad E – sequence: 67 givenname: Zaheda E surname: Bhorat fullname: Bhorat, Zaheda E – sequence: 68 givenname: Else surname: Bijker fullname: Bijker, Else – sequence: 69 givenname: Geeta surname: Birch fullname: Birch, Geeta – sequence: 70 givenname: Sarah surname: Birch fullname: Birch, Sarah – sequence: 71 givenname: Adam surname: Bird fullname: Bird, Adam – sequence: 72 givenname: Olivia surname: Bird fullname: Bird, Olivia – sequence: 73 givenname: Karen surname: Bisnauthsing fullname: Bisnauthsing, Karen – sequence: 74 givenname: Mustapha surname: Bittaye fullname: Bittaye, Mustapha – sequence: 75 givenname: Katherine surname: Blackstone fullname: Blackstone, Katherine – sequence: 76 givenname: Luke surname: Blackwell fullname: Blackwell, Luke – sequence: 77 givenname: Heather surname: Bletchly fullname: Bletchly, Heather – sequence: 78 givenname: Caitlin L surname: Blundell fullname: Blundell, Caitlin L – sequence: 79 givenname: Susannah R surname: Blundell fullname: Blundell, Susannah R – sequence: 80 givenname: Pritesh surname: Bodalia fullname: Bodalia, Pritesh – sequence: 81 givenname: Bruno C surname: Boettger fullname: Boettger, Bruno C – sequence: 82 givenname: Emma surname: Bolam fullname: Bolam, Emma – sequence: 83 givenname: Elena surname: Boland fullname: Boland, Elena – sequence: 84 givenname: Daan surname: Bormans fullname: Bormans, Daan – sequence: 85 givenname: Nicola surname: Borthwick fullname: Borthwick, Nicola – sequence: 86 givenname: Francesca surname: Bowring fullname: Bowring, Francesca – sequence: 87 givenname: Amy surname: Boyd fullname: Boyd, Amy – sequence: 88 givenname: Penny surname: Bradley fullname: Bradley, Penny – sequence: 89 givenname: Tanja surname: Brenner fullname: Brenner, Tanja – sequence: 90 givenname: Phillip surname: Brown fullname: Brown, Phillip – sequence: 91 givenname: Claire surname: Brown fullname: Brown, Claire – sequence: 92 givenname: Charlie surname: Brown-O'Sullivan fullname: Brown-O'Sullivan, Charlie – sequence: 93 givenname: Scott surname: Bruce fullname: Bruce, Scott – sequence: 94 givenname: Emily surname: Brunt fullname: Brunt, Emily – sequence: 95 givenname: Ruaridh surname: Buchan fullname: Buchan, Ruaridh – sequence: 96 givenname: William surname: Budd fullname: Budd, William – sequence: 97 givenname: Yusuf A surname: Bulbulia fullname: Bulbulia, Yusuf A – sequence: 98 givenname: Melanie surname: Bull fullname: Bull, Melanie – sequence: 99 givenname: Jamie surname: Burbage fullname: Burbage, Jamie – sequence: 100 givenname: Hassan surname: Burhan fullname: Burhan, Hassan |
| Copyright | 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. 2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 |
| Copyright_xml | – notice: 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license – notice: Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. – notice: 2021. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2021 |
| CorporateAuthor | Oxford COVID Vaccine Trial Group |
| CorporateAuthor_xml | – name: Oxford COVID Vaccine Trial Group |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7TK 7U7 7U9 7X7 7XB 88A 88C 88E 88G 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AN0 ASE AZQEC BBNVY BEC BENPR BHPHI C1K CCPQU DWQXO FPQ FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K6X K9- K9. KB0 KB~ LK8 M0R M0S M0T M1P M2M M2O M2P M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U S0X 7X8 5PM |
| DOI | 10.1016/S0140-6736(20)32661-1 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) Psychology Database (Alumni) Science Database (Alumni Edition) STEM Database ProQuest Pharma Collection Public Health Database Lancet Titles ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland British Nursing Database British Nursing Index ProQuest Central Essentials Biological Science Collection eLibrary ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea British Nursing Index (BNI) (1985 to Present) Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts SciTech Premium Collection British Nursing Index Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Newsstand Professional ProQuest Biological Science Collection Consumer Health Database Health & Medical Collection (Alumni Edition) Healthcare Administration Database Medical Database Psychology Database Research Library Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic SIRS Editorial MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials Lancet Titles elibrary ProQuest AP Science SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Newsstand Professional Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Science Journals British Nursing Index with Full Text ProQuest Health Management British Nursing Index ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest SciTech Collection ProQuest Medical Library ProQuest Psychology Journals ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE ProQuest One Psychology MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1474-547X |
| EndPage | 111 |
| ExternalDocumentID | PMC7723445 33306989 10_1016_S0140_6736_20_32661_1 S0140673620326611 |
| Genre | Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Brazil South Africa United Kingdom United Kingdom--UK |
| GeographicLocations_xml | – name: South Africa – name: United Kingdom – name: Brazil – name: United Kingdom--UK |
| GrantInformation | UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca. |
| GrantInformation_xml | – fundername: Medical Research Council grantid: MC_UU_12023/22 – fundername: Wellcome Trust grantid: 109965/Z/15/Z – fundername: Medical Research Council grantid: MC_UU_12014/8 – fundername: Medical Research Council grantid: MR/L006588/1 – fundername: Medical Research Council grantid: MR/N008219/1 – fundername: Wellcome Trust grantid: 211153/Z/18/Z – fundername: Medical Research Council grantid: MC_UU_00004/04 – fundername: Medical Research Council grantid: MC_PC_18058 – fundername: Medical Research Council grantid: MR/T031891/1 – fundername: Medical Research Council grantid: MR/T001151/1 |
| GroupedDBID | --- --K --M .1- .55 .CO .FO 0R~ 123 1B1 1P~ 1RT 1~5 29L 4.4 457 4G. 53G 5VS 7-5 71M 7RV 7X7 88E 88I 8AF 8AO 8C1 8C2 8FE 8FH 8FI 8FJ 8G5 9JM AABNK AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AAMRU AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABCQX ABFNM ABIVO ABJNI ABLJU ABMAC ABMZM ABOCM ABUFD ABUWG ACGFS ACGOD ACIEU ACIUM ACLOT ACPRK ACRLP ACVFH ADBBV ADCNI AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGAPS AGHFR AHMBA AIGII AIIUN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AN0 ANZVX APXCP AQUVI AXJTR AZQEC BBNVY BCU BEC BENPR BHPHI BKEYQ BKNYI BKOJK BKOMP BNPGV BNQBC BPHCQ BVXVI CCPQU CS3 DU5 DWQXO EAU EBS EFJIC EFKBS EO8 EO9 EP2 EP3 EWM EX3 F5P FD8 FDB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HMCUK IHE J1W K-O K9- KOM L7B LK8 LZ2 M0R M0T M1P M2M M2O M2P M7P MJL MO0 N9A NAPCQ O-L O9- OD. OO~ OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PRG PROAC PSQYO PSYQQ ROL RPZ S0X SAD SDG SEL SES SJFOW SJN SPCBC SSH SSZ T5K TLN TWZ UAP UBE UKHRP UV1 WOW X7M XAX XDU YYM Z5R ZMT ~HD 04C 6I. 88A AACTN AAFTH ABLVK ABYKQ AFKWA AJOXV AMFUW M41 SDF XFK ZA5 .GJ 3EH 3O- 41~ 8WZ 9DU A6W AAEJM AAKAS AAQQT AAQXK AAYXX ABDBF ABWVN ACRPL ACUHS ADMUD ADNMO ADXHL ADZCM AFFHD AFFNX AGQPQ AHHHB AHQJS AJJEV AKVCP ARTTT ASPBG AVWKF AZFZN CITATION D0S EAP EAS EAZ EBC EBD EBU EGS EHN EIHBH EJD EMB EMK EMOBN ENC EPL EPS EPT ESX EVS FEDTE FGOYB HVGLF HZ~ J5H MVM OVD Q~Q R2- SV3 TEORI TH9 UHU UQL WOQ WUQ XPP YYQ ZGI ZXP ZY4 ~G0 AFCTW AGCQF AGRNS ALIPV CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7TK 7U7 7U9 7XB 8FK ASE C1K FPQ H94 K6X K9. KB~ M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 PUEGO 5PM |
| ID | FETCH-LOGICAL-c4641-92e57d5dba245aad67e2ed91cd7f6b6a5be2cbaee589402ff0bc7f68f831504c3 |
| IEDL.DBID | M7P |
| ISSN | 0140-6736 1474-547X |
| IngestDate | Tue Nov 04 02:02:02 EST 2025 Sun Sep 28 09:30:39 EDT 2025 Tue Oct 07 07:19:45 EDT 2025 Mon Jul 21 05:34:53 EDT 2025 Sat Nov 29 07:21:12 EST 2025 Tue Nov 18 21:05:24 EST 2025 Fri Feb 23 02:43:57 EST 2024 Tue Oct 14 19:30:45 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 10269 |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4641-92e57d5dba245aad67e2ed91cd7f6b6a5be2cbaee589402ff0bc7f68f831504c3 |
| Notes | ObjectType-Article-1 ObjectType-Evidence Based Healthcare-3 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3 Members are listed in appendix 1 (pp 21–44) Contributed equally |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC7723445 |
| PMID | 33306989 |
| PQID | 2476119909 |
| PQPubID | 40246 |
| PageCount | 13 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7723445 proquest_miscellaneous_2470035019 proquest_journals_2476119909 pubmed_primary_33306989 crossref_primary_10_1016_S0140_6736_20_32661_1 crossref_citationtrail_10_1016_S0140_6736_20_32661_1 elsevier_sciencedirect_doi_10_1016_S0140_6736_20_32661_1 elsevier_clinicalkey_doi_10_1016_S0140_6736_20_32661_1 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-01-09 |
| PublicationDateYYYYMMDD | 2021-01-09 |
| PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-09 day: 09 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: London |
| PublicationTitle | The Lancet (British edition) |
| PublicationTitleAlternate | Lancet |
| PublicationYear | 2021 |
| Publisher | Elsevier Ltd Elsevier Limited Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited – name: Elsevier |
| References | (in press). Marshall, Murthy, Diaz (bib8) 2020; 20 (bib18) Oct 2, 2020 (bib4) 2020 Ramasamy, Minassian (bib6) 2020 (bib17) Aug 7, 2020 Sze, Pan, Gray (bib20) 2020 Zou (bib9) 2004; 159 (bib1) 2020 (bib15) April 9, 2020 Barret JR, Belij-Rammerstorfer S. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. Stringhini, Wisniak, Piumatti (bib3) 2020; 396 (bib14) June, 2020 Richards-Belle, Orzechowska, Gould (bib19) 2020; 46 Pace, Khatami, McKenna (bib10) 2015; 350 Zhou, Yu, Du (bib2) 2020; 395 (bib11) Nov 9, 2020 Folegatti, Ewer, Aley (bib5) 2020; 396 (bib12) Nov 11, 2020 (bib13) Nov 16, 2020 Bartsch, O'Shea, Ferguson (bib16) 2020; 59 Marshall (10.1016/S0140-6736(20)32661-1_bib8) 2020; 20 Sze (10.1016/S0140-6736(20)32661-1_bib20) 2020 Bartsch (10.1016/S0140-6736(20)32661-1_bib16) 2020; 59 Richards-Belle (10.1016/S0140-6736(20)32661-1_bib19) 2020; 46 Zhou (10.1016/S0140-6736(20)32661-1_bib2) 2020; 395 Pace (10.1016/S0140-6736(20)32661-1_bib10) 2015; 350 Folegatti (10.1016/S0140-6736(20)32661-1_bib5) 2020; 396 Stringhini (10.1016/S0140-6736(20)32661-1_bib3) 2020; 396 Zou (10.1016/S0140-6736(20)32661-1_bib9) 2004; 159 10.1016/S0140-6736(20)32661-1_bib7 Ramasamy (10.1016/S0140-6736(20)32661-1_bib6) 2020 33646835 - Ann Intern Med. 2021 Mar;174(3):JC29. doi: 10.7326/ACPJ202103160-029. 33306990 - Lancet. 2021 Jan 9;397(10269):72-74. doi: 10.1016/S0140-6736(20)32623-4. 33422262 - Lancet. 2021 Jan 9;397(10269):98. doi: 10.1016/S0140-6736(20)32720-3. 33765410 - Lancet. 2021 Apr 3;397(10281):1263-1264. doi: 10.1016/S0140-6736(21)00468-2. 34061319 - Virol Sin. 2021 Oct;36(5):1097-1103. doi: 10.1007/s12250-021-00408-5. 33293710 - Nature. 2020 Dec;588(7838):378-379. doi: 10.1038/d41586-020-03504-w. 33820618 - Public Health. 2021 Aug;197:e27. doi: 10.1016/j.puhe.2021.02.024. |
| References_xml | – volume: 20 start-page: e192 year: 2020 end-page: e197 ident: bib8 article-title: A minimal common outcome measure set for COVID-19 clinical research publication-title: Lancet Infect Dis – volume: 46 start-page: 2035 year: 2020 end-page: 2047 ident: bib19 article-title: COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland publication-title: Intensive Care Med – year: Nov 16, 2020 ident: bib13 article-title: Moderna's COVID-19 vaccine candidate meets its primary efficacy endpoint in the first interim analysis of the phase 3 COVE study – volume: 59 start-page: 493 year: 2020 end-page: 503 ident: bib16 article-title: Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention publication-title: Am J Prev Med – year: Nov 9, 2020 ident: bib11 article-title: Pfizer and BioNTech announce vaccine candidate against COVID-19 achieved success in first interim analysis from phase 3 study – year: 2020 ident: bib6 article-title: Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine administered in a prime-boost regimen in older adults (COV002): a phase 2/3 single blind, randomised controlled trial publication-title: Lancet – year: April 9, 2020 ident: bib15 article-title: WHO target product profiles for COVID-19 vaccines – volume: 350 year: 2015 ident: bib10 article-title: Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial publication-title: BMJ – year: 2020 ident: bib1 article-title: WHO coronavirus disease (COVID-19) dashboard – year: Oct 2, 2020 ident: bib18 article-title: COVID-19: investigation and initial clinical management of possible cases – year: 2020 ident: bib4 article-title: DRAFT landscape of COVID-19 candidate vaccines—20 March 2020 – volume: 395 start-page: 1054 year: 2020 end-page: 1062 ident: bib2 article-title: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study publication-title: Lancet – year: June, 2020 ident: bib14 article-title: Development and licensure of vaccines to prevent COVID-19 – volume: 396 start-page: 467 year: 2020 end-page: 478 ident: bib5 article-title: Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial publication-title: Lancet – volume: 396 start-page: 313 year: 2020 end-page: 319 ident: bib3 article-title: Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study publication-title: Lancet – year: Aug 7, 2020 ident: bib17 article-title: WHO COVID-19 case definition – reference: Barret JR, Belij-Rammerstorfer S. Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses. – year: 2020 ident: bib20 article-title: Ethnicity and clinical outcomes in COVID-19: a systematic Review and Meta-analysis publication-title: EClinicalMedicine – reference: (in press). – volume: 159 start-page: 702 year: 2004 end-page: 706 ident: bib9 article-title: A modified Poisson regression approach to prospective studies with binary data publication-title: Am J Epidemiol – year: Nov 11, 2020 ident: bib12 article-title: The first interim data analysis of the Sputnik V vaccine against COVID-19 phase III clinical trials in the Russian Federation demonstrated 92% efficacy – year: 2020 ident: 10.1016/S0140-6736(20)32661-1_bib20 article-title: Ethnicity and clinical outcomes in COVID-19: a systematic Review and Meta-analysis publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2020.100630 – volume: 396 start-page: 313 year: 2020 ident: 10.1016/S0140-6736(20)32661-1_bib3 article-title: Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study publication-title: Lancet doi: 10.1016/S0140-6736(20)31304-0 – volume: 20 start-page: e192 year: 2020 ident: 10.1016/S0140-6736(20)32661-1_bib8 article-title: A minimal common outcome measure set for COVID-19 clinical research publication-title: Lancet Infect Dis doi: 10.1016/S1473-3099(20)30483-7 – volume: 395 start-page: 1054 year: 2020 ident: 10.1016/S0140-6736(20)32661-1_bib2 article-title: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study publication-title: Lancet doi: 10.1016/S0140-6736(20)30566-3 – ident: 10.1016/S0140-6736(20)32661-1_bib7 – volume: 59 start-page: 493 year: 2020 ident: 10.1016/S0140-6736(20)32661-1_bib16 article-title: Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention publication-title: Am J Prev Med doi: 10.1016/j.amepre.2020.06.011 – year: 2020 ident: 10.1016/S0140-6736(20)32661-1_bib6 article-title: Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine administered in a prime-boost regimen in older adults (COV002): a phase 2/3 single blind, randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(20)32466-1 – volume: 396 start-page: 467 year: 2020 ident: 10.1016/S0140-6736(20)32661-1_bib5 article-title: Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial publication-title: Lancet doi: 10.1016/S0140-6736(20)31604-4 – volume: 159 start-page: 702 year: 2004 ident: 10.1016/S0140-6736(20)32661-1_bib9 article-title: A modified Poisson regression approach to prospective studies with binary data publication-title: Am J Epidemiol doi: 10.1093/aje/kwh090 – volume: 350 year: 2015 ident: 10.1016/S0140-6736(20)32661-1_bib10 article-title: Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial publication-title: BMJ doi: 10.1136/bmj.h1554 – volume: 46 start-page: 2035 year: 2020 ident: 10.1016/S0140-6736(20)32661-1_bib19 article-title: COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northern Ireland publication-title: Intensive Care Med doi: 10.1007/s00134-020-06267-0 – reference: 33646835 - Ann Intern Med. 2021 Mar;174(3):JC29. doi: 10.7326/ACPJ202103160-029. – reference: 33306990 - Lancet. 2021 Jan 9;397(10269):72-74. doi: 10.1016/S0140-6736(20)32623-4. – reference: 33422262 - Lancet. 2021 Jan 9;397(10269):98. doi: 10.1016/S0140-6736(20)32720-3. – reference: 33765410 - Lancet. 2021 Apr 3;397(10281):1263-1264. doi: 10.1016/S0140-6736(21)00468-2. – reference: 34061319 - Virol Sin. 2021 Oct;36(5):1097-1103. doi: 10.1007/s12250-021-00408-5. – reference: 33820618 - Public Health. 2021 Aug;197:e27. doi: 10.1016/j.puhe.2021.02.024. – reference: 33293710 - Nature. 2020 Dec;588(7838):378-379. doi: 10.1038/d41586-020-03504-w. |
| SSID | ssj0004605 |
| Score | 2.7532225 |
| Snippet | A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the... Summary Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could... |
| SourceID | pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 99 |
| SubjectTerms | Adolescent Adult Adverse events Aged Brazil ChAdOx1 nCoV-19 Charities Clinical trials Coronaviruses COVID-19 COVID-19 - prevention & control COVID-19 vaccines COVID-19 Vaccines - adverse effects Double-Blind Method Female Humans Innovations Male Middle Aged Nucleic acids Older people Pandemics Regression analysis Regression models Regulatory agencies Research facilities Robustness (mathematics) Safety Severe acute respiratory syndrome coronavirus 2 Single-Blind Method South Africa Statistical analysis Treatment Outcome United Kingdom Vaccine efficacy Vaccines Viral diseases Young Adult |
| Title | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0140673620326611 https://dx.doi.org/10.1016/S0140-6736(20)32661-1 https://www.ncbi.nlm.nih.gov/pubmed/33306989 https://www.proquest.com/docview/2476119909 https://www.proquest.com/docview/2470035019 https://pubmed.ncbi.nlm.nih.gov/PMC7723445 |
| Volume | 397 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M7P dateStart: 19920104 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Consumer Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0R dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/familyhealth providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7X7 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M0T dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 7RV dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: BENPR dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Psychology Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2M dateStart: 19920104 isFulltext: true titleUrlDefault: https://www.proquest.com/psychology providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: 8C1 dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2O dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1474-547X dateEnd: 20250909 omitProxy: false ssIdentifier: ssj0004605 issn: 0140-6736 databaseCode: M2P dateStart: 19920104 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYhhAvfH8URmUkHjZpYbHjJA4vqCubkFC7qt2mipfI8QeLVJLRdhPjf-J_5Ox8jMFgSLyckvjOcpTL3dk-_w6hV4r6XFH4AS3mqceMZh7nKvIM1wHlKvPhiSs2EQ-HfDpNRvWC26JOq2xsojPUqpR2jXybMphwE7CdyduTL56tGmV3V-sSGitozaIkBC51b3TVuUiX4n5xgmd70j7coP5mYN2UR_7km36PPX9NofzJJ-3d_d-3uYfu1NEo7lXqcx_d0MUDdGtQ77c_RN8nwujlORaFwtqCTQh5jkuDIWrE_eOe2v9KcNEvjzyS4DMhrRDe6H18RyAe2MTik8gh-sST3njiWS76BnrCFqFinn-GywoPxXZoYCQY3KYqQe-0wnUG_QwuXV2RBUjhnbn4ls-2sCv7h6sKR1tubHY8hx8eocO93YP-e68u8OBJFjHiJVSHsQpVJigLhVBRrKlWCZEqNlEWiTDTVGZC65AnMM81xs8ktHDDA4hjmQweo9WiLPRThA2VcZJxERNFmDSEJ1qRINKxkMCoWQex5tOmskY_t0U4ZukVaW7UT51GpKSDXrdiJxX8x3UCUaM3aXO2FaxxCg7qOkHeCtbBTxXU_IvoeqNkaW2BFumFhnXQy7YZvqHdEBKFLk8dT7WzDDxPKn1u3zIIYDKZcGiJL2l6y2BxyS-3FPmxwyeHCVvAWPjs78N6jm5Tmx9kl7OSdbS6nJ_qF-imPFvmi3kXrcTjI0unsaMcKO-TLlrb2R2OxnA38Ct6YCkdOLrv6KjrzMAPMV9ULA |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R3bbtMw1BoDAS_cB4UBRgJpk5YtdpzEQUKodEybuhZEOzTxEhxfWKSSjLYblH-Cb-Q4tzEYjJc98BbZ51hOfK7xuSD0WFGXKwoMaGueOsxo5nCuAsdw7VGuEhdGimYTYb_Pd3ej13Poe50LY8Mqa5lYCGqVS_uPfI0ycLgJyM7o-f4nx3aNsrerdQuNkiy6evYZXLbJs611ON8nlG68HHY2naqrgCNZwIgTUe2HyleJoMwXQgWhplpFRKrQBEkg_ERTmQitfR6Bc2WMm0iY4YZ7YDwx6cG659B5W1fPhhD23OFJeZhFSP1RxtDaoBlcou6yZ9WiQ_6kC3-3dX8N2fxJB25c_d--3jV0pbK2cbtkj-toTmc30MVeFU9wE30bCKOnMywyhbUtpiHkDOcGg1WMO3tt9eoLwVknf-uQCB8KaZHwUvvdOgF7ZxmLDyIF6xoP2m8GjoWiT2ElbCtwjNOP8FjWe7ELGtgJBrNA5cBXWuEqQ2AEj0XflAlg4Rdj8TUdreCirSEuOzitFHuz-9np3kI7Z_KxFtB8lmf6DsKGyjBKuAiJIkwawiOtiBfoUEgA1KyFWE1Ksayqu9smI6P4hDA-6sYFBcakhVYbtP2yvMlpCEFNp3GduwvaJgYFfBoibxAr46402v4FdbEm6riSsJP4iKJb6FEzDWdoL7xEpvODAqa8OQeY2yX_NG_peeAsRxxmwmOc1QDYuuvHZ7J0r6i_Dg6px5h_9-_beogubQ572_H2Vr97D12mNhbK_rqLFtH8dHyg76ML8nCaTsYPCiGC0fuz5rsf8cqpjw |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1R3bbtMw1BoDTbxwZxQGGAmkTVpo7DiJg4RQaamYCmWiG5p4yRxfWKSSjLYblH_iB_g6jnMbg8F42QNvkX2O5cTnGp8LQg8VdbmiwIC25qnDjGYO5ypwDNce5SpxYaRoNhEOh3xnJ9pcQN_rXBgbVlnLxEJQq1zaf-RtysDhJiA7o7apwiI2e_1n-58c20HK3rTW7TRKEhno-Wdw36ZPN3pw1o8o7b_Y6r50qg4DjmQBI05EtR8qXyWCMl8IFYSaahURqUITJIHwE01lIrT2eQSOljFuImGGG-6BIcWkB-ueQ-dDD6jYZql3yUk5mUV4_VH2UHvUDK5Sd82zKtIhf9KLv9u9v4Zv_qQP-5f_5y95BV2qrHDcKdnmKlrQ2TW09LqKM7iOvo2E0bM5FpnC2hbZEHKOc4PBWsbdvY5684XgrJu_c0iED4W0SHi1875HwA5aw-KDSMHqxqPO25FjoegTWAnbyhyT9CM8lnVg7IIGdoLBXFA58JtWuMocGMNj0U9lClj4-UR8TcfruGh3iMvOTuvF3ux-tgc30PaZfKybaDHLM30LYUNlGCVchEQRJg3hkVbEC3QoJABq1kKsJqtYVlXfbfORcXxCeB9144IaY9JCjxu0_bLsyWkIQU2zcZ3TC1ooBsV8GiJvECujrzTm_gV1pSbwuJK80_iIulvoQTMNZ2gvwkSm84MCprxRB5jlkpeat_Q8cKIjDjPhMS5rAGw99uMzWbpX1GUHR9VjzL_9923dR0vAbvGrjeHgDrpIbYiU_aMXraDF2eRA30UX5OEsnU7uFfIEo92zZrsfr7eyDQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+and+efficacy+of+the+ChAdOx1+nCoV-19+vaccine+%28AZD1222%29+against+SARS-CoV-2%3A+an+interim+analysis+of+four+randomised+controlled+trials+in+Brazil%2C+South+Africa%2C+and+the+UK&rft.jtitle=The+Lancet+%28British+edition%29&rft.au=Voysey%2C+Merryn&rft.au=Clemens%2C+Sue+Ann+Costa&rft.au=Madhi%2C+Shabir+A&rft.au=Weckx%2C+Lily+Y&rft.date=2021-01-09&rft.issn=1474-547X&rft.eissn=1474-547X&rft.volume=397&rft.issue=10269&rft.spage=99&rft_id=info:doi/10.1016%2FS0140-6736%2820%2932661-1&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0140-6736&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0140-6736&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0140-6736&client=summon |